3rkd:C   (GLY128) to   (ASN210)  HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY  |   HEPATITIS E VIRUS CAPSID PROTEIN, NEUTRALIZING ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4gt7:D   (LYS352) to   (THR434)  AN ENGINEERED DISULFIDE BOND REVERSIBLY TRAPS THE IGE-FC3-4 IN A CLOSED, NON-RECEPTOR BINDING CONFORMATION  |   IMMUNOGLOBULIN, ANTIBODY, IGE, FC FRAGMENT, IMMUNE SYSTEM, FC RECEPTOR 
1a6t:A   (GLY128) to   (ARG211)  FAB FRAGMENT OF MAB1-IA MONOCLONAL ANTIBODY TO HUMAN RHINOVIRUS 14 NIM-IA SITE  |   IMMUNOGLOBULIN, NEUTRALIZES HUMAN RHINOVIRUS, IGG1 
4wht:D   (GLY132) to   (ASN214)  STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P1 CRYSTAL FORM  |   NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN 
4wht:F   (GLY133) to   (ARG215)  STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P1 CRYSTAL FORM  |   NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN 
4wht:H   (GLY133) to   (ASN214)  STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P1 CRYSTAL FORM  |   NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN 
4wht:N   (GLY132) to   (ARG215)  STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P1 CRYSTAL FORM  |   NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN 
4wht:P   (GLY132) to   (ARG215)  STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P1 CRYSTAL FORM  |   NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN 
4wht:T   (ASN142) to   (ARG215)  STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P1 CRYSTAL FORM  |   NEUTRALIZING EPITOPE, ENVELOPE GLYCOPROTEIN, E2, RECEPTOR-BINDING, VIRAL PROTEIN 
4wi2:A   (SER254) to   (SER337)  STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC (WILD-TYPE)  |   HUMAN IGG1, FCRN BINDING SITE, THERAPEUTIC ANTIBODY, IMMUNE SYSTEM 
4wi2:A   (GLY371) to   (LEU443)  STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC (WILD-TYPE)  |   HUMAN IGG1, FCRN BINDING SITE, THERAPEUTIC ANTIBODY, IMMUNE SYSTEM 
4wi2:B   (SER254) to   (LYS338)  STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC (WILD-TYPE)  |   HUMAN IGG1, FCRN BINDING SITE, THERAPEUTIC ANTIBODY, IMMUNE SYSTEM 
4wi9:B   (ARG255) to   (LYS338)  STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION I253A/H310A  |   HUMAN IGG1, FCRN BINDING SITE, THERAPEUTIC ANTIBODY, IMMUNE SYSTEM 
4wi7:B   (SER254) to   (LYS338)  STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION H435A  |   HUMAN IGG1, FCRN BINDING SITE, THERAPEUTIC ANTIBODY, IMMUNE SYSTEM 
4wi8:A   (SER254) to   (LYS338)  STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION Y436A  |   HUMAN IGG1, FCRN BINDING SITE, THERAPEUTIC ANTIBODY, IMMUNE SYSTEM 
4wi8:B   (CYS261) to   (LYS338)  STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION Y436A  |   HUMAN IGG1, FCRN BINDING SITE, THERAPEUTIC ANTIBODY, IMMUNE SYSTEM 
4gxu:Q   (GLY134) to   (PRO213)  CRYSTAL STRUCTURE OF ANTIBODY 1F1 BOUND TO THE 1918 INFLUENZA HEMAGGLUTININ  |   VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
1adq:L   (ASN128) to   (PRO211)  CRYSTAL STRUCTURE OF A HUMAN IGM RHEUMATOID FACTOR FAB IN COMPLEX WITH ITS AUTOANTIGEN IGG FC  |   COMPLEX (IMMUNOGLOBULIN/AUTOANTIGEN), RHEUMATOID FACTOR AUTO-ANTIBODY COMPLEX 
2omb:D   (LYS134) to   (PRO213)  BENCE JONES KWR PROTEIN- IMMUNOGLOBULIN LIGHT CHAIN DIMER, P3(1)21 CRYSTAL FORM  |   IMMUNOGLOBULIN LIGHT CHAIN, IMMUNE SYSTEM 
3eff:A   (GLY130) to   (PHE211)  THE CRYSTAL STRUCTURE OF FULL-LENGTH KCSA IN ITS CLOSED CONFORMATION  |   FULL LENGTH KCSA, BULGE HELIX, CELL MEMBRANE, ION TRANSPORT, IONIC CHANNEL, MEMBRANE, TRANSMEMBRANE, TRANSPORT, VOLTAGE- GATED CHANNEL, MEMBRANE PROTEIN 
1nj9:L   (ASN129) to   (ALA210)  COCAINE HYDROLYTIC ANTIBODY 15A10  |   IMMUNOGLOBULIN, IMMUNE SYSTEM 
1ai1:L   (GLY128) to   (ASN210)  HIV-1 V3 LOOP MIMIC  |   COMPLEX (ANTIBODY/PEPTIDE), ANTIBODY, CONSTRAINED HIV-1 V3 LOOP PEPTIDE, IMMUNOGLOBULIN 
3rug:H   (GLN152) to   (ALA256)  CRYSTAL STRUCTURE OF VALPHA10-VBETA8.1 NKT TCR IN COMPLEX WITH CD1D- ALPHAGLUCOSYLCERAMIDE (C20:2)  |   MOUSE CD1D, MOUSE NKT, IMMUNE SYSTEM 
4wnq:D   (GLN148) to   (TRP249)  THE MOLECULAR BASES OF DELTA/ALPHA-BETA T-CELL MEDIATED ANTIGEN RECOGNITION  |   IMMUNITY, IMMUNE SYSTEM 
3rvu:C   (GLY128) to   (ASN210)  STRUCTURE OF 4C1 FAB IN C2221 SPACE GROUP  |   IGG, ANTIBODY, DER F 1, DER P 1, IMMUNE SYSTEM 
2or9:L   (GLY128) to   (ASN212)  THE STRUCTURE OF THE ANTI-C-MYC ANTIBODY 9E10 FAB FRAGMENT/EPITOPE PEPTIDE COMPLEX REVEALS A NOVEL BINDING MODE DOMINATED BY THE HEAVY CHAIN HYPERVARIABLE LOOPS  |   ANTIGEN-ANTIBODY COMPLEX, ANTIGEN RECOGNITION, MYC-TAG, LONG CDR H3, IMMUNE SYSTEM 
2or9:M   (GLY128) to   (ASN212)  THE STRUCTURE OF THE ANTI-C-MYC ANTIBODY 9E10 FAB FRAGMENT/EPITOPE PEPTIDE COMPLEX REVEALS A NOVEL BINDING MODE DOMINATED BY THE HEAVY CHAIN HYPERVARIABLE LOOPS  |   ANTIGEN-ANTIBODY COMPLEX, ANTIGEN RECOGNITION, MYC-TAG, LONG CDR H3, IMMUNE SYSTEM 
3eob:L   (ASN137) to   (SER208)  CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN, FORM II  |   EFALIZUMAB, FAB, ANTIBODY, LFA-1, CD11A, I DOMAIN, ALTERNATIVE SPLICING, CALCIUM, CELL ADHESION, GLYCOPROTEIN, INTEGRIN, MAGNESIUM, MEMBRANE, POLYMORPHISM, RECEPTOR, TRANSMEMBRANE, IMMUNE SYSTEM/CELL ADHESION COMPLEX 
1axs:L   (THR129) to   (ARG211)  MATURE OXY-COPE CATALYTIC ANTIBODY WITH HAPTEN  |   OXY-COPE, CATALYTIC ANTIBODY, FAB FRAGMENT 
4haf:A   (ARG255) to   (LYS338)  CRYSTAL STRUCTURE OF FC-FRAGMENT OF HUMAN IGG2 ANTIBODY (PRIMITIVE CRYSTAL FORM)  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
4haf:B   (SER254) to   (LYS338)  CRYSTAL STRUCTURE OF FC-FRAGMENT OF HUMAN IGG2 ANTIBODY (PRIMITIVE CRYSTAL FORM)  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
4hag:A   (SER254) to   (LYS338)  CRYSTAL STRUCTURE OF FC-FRAGMENT OF HUMAN IGG2 ANTIBODY (CENTERED CRYSTAL FORM)  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
4wwi:D   (CYS261) to   (LYS338)  CRYSTAL STRUCTURE OF THE C DOMAIN OF STAPHYLOCOCCAL PROTEIN A IN COMPLEX WITH THE FC FRAGMENT OF HUMAN IGG AT 2.3 ANGSTROM RESOLUTION  |   THREE-HELIX BUNDLE, CONFORMATIONAL HETEROGENEITY, S. AUREUS, ANTIBODY BINDING, PROTEIN BINDING 
4wwi:F   (VAL259) to   (SER337)  CRYSTAL STRUCTURE OF THE C DOMAIN OF STAPHYLOCOCCAL PROTEIN A IN COMPLEX WITH THE FC FRAGMENT OF HUMAN IGG AT 2.3 ANGSTROM RESOLUTION  |   THREE-HELIX BUNDLE, CONFORMATIONAL HETEROGENEITY, S. AUREUS, ANTIBODY BINDING, PROTEIN BINDING 
1o0v:A   (PRO249) to   (LYS327)  THE CRYSTAL STRUCTURE OF IGE FC REVEALS AN ASYMMETRICALLY BENT CONFORMATION  |   IGE FC, IMMUNOGLOBULIN E, IMMUNE SYSTEM 
1o0v:B   (THR250) to   (LYS327)  THE CRYSTAL STRUCTURE OF IGE FC REVEALS AN ASYMMETRICALLY BENT CONFORMATION  |   IGE FC, IMMUNOGLOBULIN E, IMMUNE SYSTEM 
1baf:L   (GLY128) to   (ARG211)  2.9 ANGSTROMS RESOLUTION STRUCTURE OF AN ANTI-DINITROPHENYL-SPIN-LABEL MONOCLONAL ANTIBODY FAB FRAGMENT WITH BOUND HAPTEN  |   IMMUNOGLOBULIN, IMMUNE SYSTEM 
1bbj:L   (GLY128) to   (SER208)  CRYSTAL STRUCTURE OF A CHIMERIC FAB' FRAGMENT OF AN ANTIBODY BINDING TUMOUR CELLS  |   IMMUNOGLOBULIN 
1bbj:A   (GLY128) to   (SER208)  CRYSTAL STRUCTURE OF A CHIMERIC FAB' FRAGMENT OF AN ANTIBODY BINDING TUMOUR CELLS  |   IMMUNOGLOBULIN 
4hh9:A   (GLY128) to   (ASN210)  ANTI-HUMAN CYTOMEGALOVIRUS (HCMV) FAB KE5  |   FAB, ANTIBODY, IMMUNE SYSTEM 
4hh9:C   (GLY128) to   (ASN210)  ANTI-HUMAN CYTOMEGALOVIRUS (HCMV) FAB KE5  |   FAB, ANTIBODY, IMMUNE SYSTEM 
4x0k:B   (ASN137) to   (SER208)  ENGINEERED FAB FRAGMENT SPECIFIC FOR EYMPME (EE) PEPTIDE  |   ANTIBODY FRAGMENT, CRYSTALLIZATION CHAPERONE, FAB FRAGMENT, IMMUNE SYSTEM 
1bd2:E   (GLN142) to   (ALA246)  COMPLEX BETWEEN HUMAN T-CELL RECEPTOR B7, VIRAL PEPTIDE (TAX) AND MHC CLASS I MOLECULE HLA-A 0201  |   COMPLEX (MHC-VIRAL PEPTIDE-RECEPTOR), COMPLEX (MHC-VIRAL PEPTIDE- RECEPTOR) COMPLEX 
4hie:A   (GLY128) to   (SER208)  ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102  |   IMMUNOGLOBIN, ANTIBODY, STREPTOCOCCUS PNEUMONIAE 23F, IMMUNE SYSTEM 
4hih:C   (GLY128) to   (SER208)  ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102 WITH BOUND RHAMNOSE.  |   IMMUNOGLOBIN, ANTIBODY, STREPTOCOCCUS PNEUMONIAE 23F, IMMUNE SYSTEM 
3s35:L   (GLY132) to   (ASN214)  STRUCTURAL BASIS FOR THE FUNCTION OF TWO ANTI-VEGF RECEPTOR ANTIBODIES  |   ANTIBODY, KDR, VEGF RECEPTOR, CANCER, IMMUNE SYSTEM-TRANSFERASE COMPLEX 
4hj0:D   (ASN131) to   (GLU213)  CRYSTAL STRUCTURE OF THE HUMAN GIPR ECD IN COMPLEX WITH GIPG013 FAB AT 3-A RESOLUTION  |   GLUCAGON RECEPTOR SUB-FAMILY RECOGNITION FOLD, IMMUNE SYSTEM 
4hjg:A   (GLY128) to   (SER208)  MEDITOPE-ENABLED TRASTUZUMAB  |   MONOCLONAL ANTIBODY, IMMUNE SYSTEM, CANCER THERAPEUTIC 
3eyf:C   (THR130) to   (SER209)  CRYSTAL STRUCTURE OF ANTI-HUMAN CYTOMEGALOVIRUS ANTIBODY 8F9 PLUS GB PEPTIDE  |   CYTOMEGALOVIRUS, ANTIBODY, IMMUNOGLOBULIN DOMAIN, CLEAVAGE ON PAIR OF BASIC RESIDUES, ENVELOPE PROTEIN, GLYCOPROTEIN, HOST-VIRUS INTERACTION, MEMBRANE, TRANSMEMBRANE, VIRION, IMMUNE SYSTEM 
4hk3:N   (ASN130) to   (PRO210)  I2 FAB (UNBOUND) FROM CH65-CH67 LINEAGE  |   FAB FRAGMENT, IMMUNE SYSTEM 
4hkx:B   (ASN130) to   (PRO210)  INFLUENZA HEMAGGLUTININ IN COMPLEX WITH CH67 FAB  |   FAB FRAGMENT, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
1bgx:L   (GLY128) to   (ASN210)  TAQ POLYMERASE IN COMPLEX WITH TP7, AN INHIBITORY FAB  |   DNA POLYMERASE, FAB, PCR, INHIBITION, HELIX-COIL DYNAMICS, INHIBITOR DESIGN, COMPLEX (POLYMERASE/INHIBITOR) 
2pcp:D   (SER136) to   (LYS221)  ANTIBODY FAB COMPLEXED WITH PHENCYCLIDINE  |   IMMUNOGLOBULIN 
4hlz:H   (GLY130) to   (ARG213)  CRYSTAL STRUCTURE OF FAB C179 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ  |   NEUTRALIZING ANTIBODIES, ANTIBODY AFFINITY, ANTIGENS, EPITOPES, GLYCOSYLATION, HEMAGGLUTININ GLYCOPROTEINS, IMMUNOGLOBULIN FAB FRAGMENTS, H2N2 SUBTYPE, INFLUENZA VACCINES, AVIAN FLU, ENVELOPE PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
3f12:C   (GLY129) to   (SER209)  GERMLINE V-GENES SCULPT THE BINDING SITE OF A FAMILY OF ANTIBODIES NEUTRALIZING HUMAN CYTOMEGALOVIRUS  |   HUMAN CYTOMEGALOVIRUS, ANTIBODY, GERMLINE, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
2bmk:A   (GLY128) to   (GLU213)  FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-D-ALANINE  |   CATALYTIC ANTIBODY, TRANSAMINATION, PYRIDOXAL-PHOSPHATE, HAPTEN, PHOSPHOPYRIDOXYL-L-LYSINE, IMMUNE SYSTEM 
2bnq:E   (GLN137) to   (ALA241)  STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES  |   IMMUNE SYSTEM/RECEPTOR, IMMUNE SYSTEM/RECEPTOR/COMPLEX, TCR, MHC, IMMUNODOMINANCE, FLU, COMPLEX, PEPTIDE, TRANSMEMBRANE, GLYCOPROTEIN, SIGNAL, POLYMORPHISM, T-CELL, RECEPTOR, SUPERAGONIST PEPTIDE T-CELL VACCINES 
4x6b:B   (GLN140) to   (ALA244)  BK6 TCR APO STRUCTURE  |   T CELL RECEPTOR, CD1A, AUTOIMMUNITY, LIPID ANTIGEN, IMMUNE SYSTEM 
4x6b:D   (GLN140) to   (GLY242)  BK6 TCR APO STRUCTURE  |   T CELL RECEPTOR, CD1A, AUTOIMMUNITY, LIPID ANTIGEN, IMMUNE SYSTEM 
4x7t:B   (ASN141) to   (GLY216)  STRUCTURE OF OMALIZUMAB FAB FRAGMENT, CRYSTAL FORM 2  |   ANTIBODY FAB FRAGMENT, ANTI-IGE ANTIBODY, ANTI-INFLAMMATORY, IMMUNE SYSTEM 
1oak:L   (GLY128) to   (SER208)  CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR (VWF) A1 DOMAIN IN COMPLEX WITH THE FUNCTION BLOCKING NMC-4 FAB  |   VON WILLEBRAND FACTOR, GLYCOPROTEIN IBA (A:ALPHA) BINDING, COMPLEX (WILLEBRAND/IMMUNOGLOBULIN), BLOOD COAGULATION 
4x98:A   (SER254) to   (LYS338)  IMMUNOGLOBULIN FC HETERODIMER VARIANT  |   BISPECIFIC ANTIBODY, IMMUNOGLOBULIN FC HETERODIMER, CH3 DOMAIN INTERFACE, ASYMMETRIC DISULFIDE BONDS, THERMAL STABILITY, FC ENGINEERING, IMMUNE SYSTEM 
4x98:B   (SER254) to   (SER337)  IMMUNOGLOBULIN FC HETERODIMER VARIANT  |   BISPECIFIC ANTIBODY, IMMUNOGLOBULIN FC HETERODIMER, CH3 DOMAIN INTERFACE, ASYMMETRIC DISULFIDE BONDS, THERMAL STABILITY, FC ENGINEERING, IMMUNE SYSTEM 
4x98:B   (ASN361) to   (LEU443)  IMMUNOGLOBULIN FC HETERODIMER VARIANT  |   BISPECIFIC ANTIBODY, IMMUNOGLOBULIN FC HETERODIMER, CH3 DOMAIN INTERFACE, ASYMMETRIC DISULFIDE BONDS, THERMAL STABILITY, FC ENGINEERING, IMMUNE SYSTEM 
4x99:A   (SER254) to   (LYS338)  IMMUNOGLOBULIN FC HETERODIMERS VARIANT  |   BISPECIFIC ANTIBODY, IMMUNOGLOBULIN FC HETERODIMER, CH3 DOMAIN INTERFACE, ASYMMETRIC DISULFIDE BONDS, THERMAL STABILITY, FC ENGINEERING, IMMUNE SYSTEM 
4x99:B   (SER254) to   (SER337)  IMMUNOGLOBULIN FC HETERODIMERS VARIANT  |   BISPECIFIC ANTIBODY, IMMUNOGLOBULIN FC HETERODIMER, CH3 DOMAIN INTERFACE, ASYMMETRIC DISULFIDE BONDS, THERMAL STABILITY, FC ENGINEERING, IMMUNE SYSTEM 
1ob1:A   (GLY127) to   (ASN209)  CRYSTAL STRUCTURE OF A FAB COMPLEX WHITH PLASMODIUM FALCIPARUM MSP1-19  |   IMMUNE SYSTEM, IMMUNOGLOBULIN/COMPLEX, IMMUNOGLOBULIN, ANTIBODY FAB FRAGMENT, MSP1-19, EGF-LIKE DOMAIN, SURFACE ANTIGEN, MALARIA VACCINE COMPONENT 
1ob1:D   (GLY127) to   (ASN209)  CRYSTAL STRUCTURE OF A FAB COMPLEX WHITH PLASMODIUM FALCIPARUM MSP1-19  |   IMMUNE SYSTEM, IMMUNOGLOBULIN/COMPLEX, IMMUNOGLOBULIN, ANTIBODY FAB FRAGMENT, MSP1-19, EGF-LIKE DOMAIN, SURFACE ANTIGEN, MALARIA VACCINE COMPONENT 
4xcn:I   (GLY128) to   (SER208)  CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA); 2.9 A RESOLUTION  |   HUMAN ANTI GP41 HIV-1 4E10 FAB, MEMBRANE LIPIDS, PHOSPHATIDIC ACID, IMMUNE SYSTEM 
3ffc:E   (GLN155) to   (TRP256)  CRYSTAL STRUCTURE OF CF34 TCR IN COMPLEX WITH HLA-B8/FLR  |   TCR-PEPTIDE-MHC, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
3ffc:J   (GLN155) to   (TRP256)  CRYSTAL STRUCTURE OF CF34 TCR IN COMPLEX WITH HLA-B8/FLR  |   TCR-PEPTIDE-MHC, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
4hzl:L   (GLY133) to   (ASN215)  NEUTRALIZING ANTIBODY MAB#8 IN COMPLEX WITH THE EPITOPE II OF HCV E2 ENVELOPE PROTEIN  |   IG DOMAIN, NEUTRALIZING ANTIBODY, IMMUNE SYSTEM 
4xgz:D   (GLY128) to   (SER208)  CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD2 MOTIF IN COMPLEX WITH FAB FRAGMENT  |   SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION 
4xgz:V   (GLY128) to   (SER208)  CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD2 MOTIF IN COMPLEX WITH FAB FRAGMENT  |   SYNTHETIC ANTIBODY, PAXILLIN, LD MOTIF, IMMUNOGLOBULIN, FAB FRAGMENT, COMPLEX, FOCAL ADHESION, CELL ADHESION 
3sgd:I   (GLY133) to   (ASN217)  CRYSTAL STRUCTURE OF THE MOUSE MAB 17.2  |   IMMUNOGLOBULIN FOLD, ANTIBODY, ANTIGEN BINDING, IMMUNE SYSTEM 
3sgj:A   (VAL259) to   (LYS338)  UNIQUE CARBOHYDRATE-CARBOHYDRATE INTERACTIONS ARE REQUIRED FOR HIGH AFFINITY BINDING BETWEEN FCGIII AND ANTIBODIES LACKING CORE FUCOSE  |   RECEPTOR COMPLEX, FC RECEPTOR, ANTIBODY, IMMUNE SYSTEM 
3sgj:B   (SER254) to   (SER337)  UNIQUE CARBOHYDRATE-CARBOHYDRATE INTERACTIONS ARE REQUIRED FOR HIGH AFFINITY BINDING BETWEEN FCGIII AND ANTIBODIES LACKING CORE FUCOSE  |   RECEPTOR COMPLEX, FC RECEPTOR, ANTIBODY, IMMUNE SYSTEM 
3sgk:A   (SER254) to   (LYS338)  UNIQUE CARBOHYDRATE/CARBOHYDRATE INTERACTIONS ARE REQUIRED FOR HIGH AFFINITY BINDING OF FCGIII AND ANTIBODIES LACKING CORE FUCOSE  |   FC RECEPTOR, ANTIBODY, AFUCOSYLATION, IMMUNE SYSTEM 
3sgk:B   (SER254) to   (LYS338)  UNIQUE CARBOHYDRATE/CARBOHYDRATE INTERACTIONS ARE REQUIRED FOR HIGH AFFINITY BINDING OF FCGIII AND ANTIBODIES LACKING CORE FUCOSE  |   FC RECEPTOR, ANTIBODY, AFUCOSYLATION, IMMUNE SYSTEM 
3skj:M   (GLY128) to   (SER208)  STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF AN AGONISTIC ANTI-HUMAN EPHA2 MONOCLONAL ANTIBODY  |   FAB, RECEPTOR, IG FOLD, EPHRIN RECEPTOR, ANTIBODY, ANTIGEN, EXTRA- CELLULAR, IMMUNE SYSTEM 
1cgs:L   (GLY133) to   (ASN215)  LOCAL AND TRANSMITTED CONFORMATIONAL CHANGES ON COMPLEXATION OF AN ANTI-SWEETENER FAB  |   IMMUNOGLOBULIN 
1op5:K   (THR129) to   (SER208)  CRYSTAL STRUCTURE OF FAB 2G12 BOUND TO MAN9GLCNAC2  |   DOMAIN-SWAPPED FAB 2G12 MAN9GLCNAC2 ANTI-CARBOHYDRATE ANTIBODY, IMMUNE SYSTEM 
3sm5:L   (ASN130) to   (PRO210)  INFLUENZA HEMAGGLUTININ IN COMPLEX WITH A NEUTRALIZING ANTIBODY  |   INFLUENZA HEMAGGLUTININ, IMMUNE SYSTEM 
3sm5:M   (ASN130) to   (PRO210)  INFLUENZA HEMAGGLUTININ IN COMPLEX WITH A NEUTRALIZING ANTIBODY  |   INFLUENZA HEMAGGLUTININ, IMMUNE SYSTEM 
3sm5:N   (ASN130) to   (PRO210)  INFLUENZA HEMAGGLUTININ IN COMPLEX WITH A NEUTRALIZING ANTIBODY  |   INFLUENZA HEMAGGLUTININ, IMMUNE SYSTEM 
1oqo:A   (SER254) to   (LYS338)  COMPLEX BETWEEN G0 VERSION OF AN FC BOUND TO A MINIMIZED VERSION OF PROTEIN A CALLED MINI-Z  |   ANTIBODY, GLYCOSYLATION, OLIGOSACCHARIDES, IGG, FC FRAGMENT, Z34C, PROTEIN A, IMMUNE SYSTEM 
1oqo:A   (GLY371) to   (LEU443)  COMPLEX BETWEEN G0 VERSION OF AN FC BOUND TO A MINIMIZED VERSION OF PROTEIN A CALLED MINI-Z  |   ANTIBODY, GLYCOSYLATION, OLIGOSACCHARIDES, IGG, FC FRAGMENT, Z34C, PROTEIN A, IMMUNE SYSTEM 
1oqo:B   (SER254) to   (LYS338)  COMPLEX BETWEEN G0 VERSION OF AN FC BOUND TO A MINIMIZED VERSION OF PROTEIN A CALLED MINI-Z  |   ANTIBODY, GLYCOSYLATION, OLIGOSACCHARIDES, IGG, FC FRAGMENT, Z34C, PROTEIN A, IMMUNE SYSTEM 
1oqx:A   (SER254) to   (LYS338)  G-2 GLYCOVARIANT OF HUMAN IGG FC BOUND TO MINIMIZED VERSION OF PROTEIN A CALLED Z34C  |   ANTIBODY, GLYCOSYLATION, OLIGOSACCHARIDES, IGG, PEPTIDE COMPLEX, Z34C, PROTEIN A, IMMUNE SYSTEM 
1oqx:B   (SER254) to   (LYS338)  G-2 GLYCOVARIANT OF HUMAN IGG FC BOUND TO MINIMIZED VERSION OF PROTEIN A CALLED Z34C  |   ANTIBODY, GLYCOSYLATION, OLIGOSACCHARIDES, IGG, PEPTIDE COMPLEX, Z34C, PROTEIN A, IMMUNE SYSTEM 
1orq:A   (GLY129) to   (ARG212)  X-RAY STRUCTURE OF A VOLTAGE-DEPENDENT POTASSIUM CHANNEL IN COMPLEX WITH AN FAB  |   POTASSIUM CHANNEL, VOLTAGE-DEPENDENT, KVAP, FAB COMPLEX, MEMBRANE PROTEIN 
1osp:L   (GLY128) to   (ASN212)  CRYSTAL STRUCTURE OF OUTER SURFACE PROTEIN A OF BORRELIA BURGDORFERI COMPLEXED WITH A MURINE MONOCLONAL ANTIBODY FAB  |   COMPLEX (IMMUNOGLOBULIN-LIPOPROTEIN), OUTER SURFACE PROTEIN A COMPLEXED WITH FAB184.1, BORRELIA BURGDORFERI STRAIN B31, COMPLEX (IMMUNOGLOBULIN-LIPOPROTEIN) COMPLEX 
1ow0:A   (SER260) to   (LYS340)  CRYSTAL STRUCTURE OF HUMAN FCARI BOUND TO IGA1-FC  |   IGA1, FCARI, CD89, ANTIBODY, FC RECEPTOR, IMMUNOGLOBULIN-LIKE DOMAIN, IMMUNE SYSTEM 
1ow0:B   (SER260) to   (LYS340)  CRYSTAL STRUCTURE OF HUMAN FCARI BOUND TO IGA1-FC  |   IGA1, FCARI, CD89, ANTIBODY, FC RECEPTOR, IMMUNOGLOBULIN-LIKE DOMAIN, IMMUNE SYSTEM 
3sqo:L   (GLY128) to   (SER208)  PCSK9 J16 FAB COMPLEX  |   CHOLESTEROL REGULATION, LDLR, HYDROLASE-IMMUNE SYSTEM COMPLEX 
4xp1:L   (GLY129) to   (ASN213)  X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER BOUND TO NEUROTRANSMITTER DOPAMINE  |   INTEGRAL MEMBRANE PROTEIN, MEMBRANE PROTEIN-TRANSPORT PROTEIN COMPLEX 
4iiq:B   (GLN140) to   (GLY242)  CRYSTAL STRUCTURE OF A HUMAN MAIT TCR IN COMPLEX WITH BOVINE MR1  |   MHC-CLASS I, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM, ANTIGEN PRESENTATION, ANTIGEN RECOGNITION, CELL MEMBRANE 
4ij3:B   (GLY128) to   (ASN210)  OXIDOREDUCTASE FRAGMENT OF HUMAN QSOX1 IN COMPLEX WITH A FAB FRAGMENT FROM AN ANTI- HUMAN QSOX1 ANTIBODY  |   INHIBITOR, ANTIBODY BINDING, OXIDOREDUCTASE-OXIDOREDUCTASE INHIBITOR COMPLEX 
2qej:B   (ALA262) to   (LYS340)  CRYSTAL STRUCTURE OF A STAPHYLOCOCCUS AUREUS PROTEIN (SSL7) IN COMPLEX WITH FC OF HUMAN IGA1  |   IGA1, ANTIBODY, IMMUNOGLOBULIN, OB-FOLD, BETA-GRASP, SSL, IMMUNE SYSTEM 
1dba:L   (GLY128) to   (ARG211)  THREE-DIMENSIONAL STRUCTURE OF AN ANTI-STEROID FAB' AND PROGESTERONE-FAB' COMPLEX  |   IMMUNOGLOBULIN 
1dbb:L   (GLY128) to   (ARG211)  THREE-DIMENSIONAL STRUCTURE OF AN ANTI-STEROID FAB' AND PROGESTERONE-FAB' COMPLEX  |   IMMUNOGLOBULIN 
4imk:C   (GLY129) to   (SER209)  UNCROSSED FAB BINDING TO HUMAN ANGIOPOIETIN 2  |   ANTIGEN-BINDING FRAGMENT (FAB), HUMAN ANGIOPOIETIN 2, IMMUNE SYSTEM 
4iml:A   (GLY150) to   (ASN232)  CROSSFAB BINDING TO HUMAN ANGIOPOIETIN 2  |   CROSSFAB, ANTIGEN BINDING, HUMAN ANGIOPOIETIN 2, IMMUNE SYSTEM 
1dee:E  (ASN2137) to  (ARG2211)  CRYSTAL STRUCTURE AT 2.7A RESOLUTION OF A COMPLEX BETWEEN A STAPHYLOCOCCUS AUREUS DOMAIN AND A FAB FRAGMENT OF A HUMAN IGM ANTIBODY  |   FAB-IBP COMPLEX CRYSTAL STRUCTURE 2.7A RESOLUTION BINDING OUTSIDE THE ANTIGEN COMBINING SITE SUPERANTIGEN FAB VH3 SPECIFICITY, IMMUNE SYSTEM 
4xtr:F   (GLY131) to   (SER211)  STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF PEP12  |   MEMBRANE PROTEIN TARGETING COMPLEX, HYDROLASE-TRANSPORT PROTEIN COMPLEX 
1dn0:A   (ASN138) to   (ASN211)  STRUCTURE OF THE FAB FRAGMENT FROM A HUMAN IGM COLD AGGLUTININ  |   FAB, IGM, ANTIBODY, COLD AGGLUTININ, HUMAN, IMMUNE SYSTEM 
1dn2:A   (SER254) to   (LYS338)  FC FRAGMENT OF HUMAN IGG1 IN COMPLEX WITH AN ENGINEERED 13 RESIDUE PEPTIDE DCAWHLGELVWCT-NH2  |   FC IGG PHAGE DISPLAY PEPTIDE, IMMUNE SYSTEM 
1dn2:B   (SER254) to   (LYS338)  FC FRAGMENT OF HUMAN IGG1 IN COMPLEX WITH AN ENGINEERED 13 RESIDUE PEPTIDE DCAWHLGELVWCT-NH2  |   FC IGG PHAGE DISPLAY PEPTIDE, IMMUNE SYSTEM 
3t3m:F   (GLY128) to   (ASN210)  A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS  |   INTEGRIN, CELL ADHESION, BLOOD CLOTTING, FIBRINOGEN, PLATELET 
4xwg:L   (ASN129) to   (PRO209)  CRYSTAL STRUCTURE OF LCAT (C31Y) IN COMPLEX WITH FAB1  |   A-B HYDROLASE COMPLEX, ESTERASE, ACYL TRANSFERASE, HYDROLASE-IMMUNE SYSTEM COMPLEX 
4xwo:D   (ASN140) to   (ARG214)  STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF SEC22  |   MEMBRANE PROTEIN TARGETING COMPLEX, HYDROLASE-TRANSPORT PROTEIN COMPLEX 
4xwo:R   (THR132) to   (ASN213)  STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF SEC22  |   MEMBRANE PROTEIN TARGETING COMPLEX, HYDROLASE-TRANSPORT PROTEIN COMPLEX 
2qqk:L   (GLY128) to   (ARG211)  NEUROPILIN-2 A1A2B1B2 DOMAINS IN COMPLEX WITH A SEMAPHORIN-BLOCKING FAB  |   VEGF RECEPTOR, SEMAPHORIN RECEPTOR, PHAGE-DERIVED ANTIBODY, DEVELOPMENTAL PROTEIN, DIFFERENTIATION, GLYCOPROTEIN, MEMBRANE, NEUROGENESIS, TRANSMEMBRANE, HORMONE, SIGNALING PROTEIN 
2qql:L   (GLY128) to   (GLY212)  NEUROPILIN-2 A1A2B1B2 DOMAINS IN COMPLEX WITH A SEMAPHORIN-BLOCKING FAB  |   VEGF RECEPTOR, SEMAPHORIN RECEPTOR, PHAGE-DERIVED ANTIBODY, DEVELOPMENTAL PROTEIN, DIFFERENTIATION, GLYCOPROTEIN, MEMBRANE, NEUROGENESIS, TRANSMEMBRANE, HORMONE, SIGNALING PROTEIN 
2qr0:E   (ASN137) to   (ARG211)  STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS  |   VEGF; ANTIBODY RECOGNITION; SPECIFICITY; PHAGE DISPLAY, IMMUNE SYSTEM 
2qr0:Q   (ASN137) to   (ARG211)  STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS  |   VEGF; ANTIBODY RECOGNITION; SPECIFICITY; PHAGE DISPLAY, IMMUNE SYSTEM 
1dqd:L   (GLY127) to   (ASN209)  CRYSTAL STRUCTURE OF FAB HGR-2 F6, A COMPETITIVE ANTAGONIST OF THE GLUCAGON RECEPTOR  |   GLUCAGON RECEPTOR, MONOCLONAL ANTIBODY, FAB, RECEPTOR ANTAGONIST, TYPICAL IMMUNOGLOBULIN FOLD, LIGHT CHAIN, HEAVY CHAIN, ANTIGEN BINDING SITE, COMPLEMENTARITY-DETERMINING REGIONS, IMMUNE SYSTEM 
4j12:A   (SER254) to   (LYS338)  MONOMERIC FC  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
4y4f:H   (GLN136) to   (TRP237)  CRYSTAL STRUCTURE OF THE MCD1D/GCK127/INKTCR TERNARY COMPLEX  |   MHC-FOLD, IG-FOLD, GLYCOLIPID ANTIGEN PRESENTATION, T CELL RECEPTOR 
4y4h:D   (GLN136) to   (TRP237)  CRYSTAL STRUCTURE OF THE MCD1D/GCK152/INKTCR TERNARY COMPLEX  |   MHC-FOLD, IG-FOLD, GLYCOLIPID ANTIGEN PRESENTATION, T CELL RECEPTOR, IMMUNE SYSTEM 
4y4h:H   (GLN136) to   (TRP237)  CRYSTAL STRUCTURE OF THE MCD1D/GCK152/INKTCR TERNARY COMPLEX  |   MHC-FOLD, IG-FOLD, GLYCOLIPID ANTIGEN PRESENTATION, T CELL RECEPTOR, IMMUNE SYSTEM 
1e4k:A   (SER254) to   (SER337)  CRYSTAL STRUCTURE OF SOLUBLE HUMAN IGG1 FC FRAGMENT-FC-GAMMA RECEPTOR III COMPLEX  |   IMMUNE SYSTEM, FC FRAGMENT, IGG, RECEPTOR, 
2r29:L   (GLY133) to   (ASN210)  NEUTRALIZATION OF DENGUE VIRUS BY A SEROTYPE CROSS-REACTIVE ANTIBODY ELUCIDATED BY CRYOELECTRON MICROSCOPY AND X-RAY CRYSTALLOGRAPHY  |   FAB-ANTIGEN COMPLEX, ATP-BINDING, CAPSID PROTEIN, CLEAVAGE ON PAIR OF BASIC RESIDUES, ENDOPLASMIC RETICULUM, ENVELOPE PROTEIN, GLYCOPROTEIN, HELICASE, HYDROLASE, MEMBRANE, METAL- BINDING, MULTIFUNCTIONAL ENZYME, NUCLEOTIDE-BINDING, NUCLEOTIDYLTRANSFERASE, NUCLEUS, PHOSPHORYLATION, PROTEASE, RIBONUCLEOPROTEIN, RNA REPLICATION, RNA-BINDING, RNA- DIRECTED RNA POLYMERASE, SECRETED, SERINE PROTEASE, TRANSCRIPTION, TRANSCRIPTION REGULATION, TRANSFERASE, TRANSMEMBRANE, VIRAL NUCLEOPROTEIN, VIRION, VIRAL PROTEIN/IMMUNE SYSTEM COMPLEX 
4j4p:A   (PRO249) to   (LYS327)  THE COMPLEX OF HUMAN IGE-FC WITH TWO BOUND FAB FRAGMENTS  |   IG LIKE DOMAIN, IMMUNE SYSTEM 
4j4p:A   (SER353) to   (PRO439)  THE COMPLEX OF HUMAN IGE-FC WITH TWO BOUND FAB FRAGMENTS  |   IG LIKE DOMAIN, IMMUNE SYSTEM 
4j4p:B   (THR250) to   (LYS327)  THE COMPLEX OF HUMAN IGE-FC WITH TWO BOUND FAB FRAGMENTS  |   IG LIKE DOMAIN, IMMUNE SYSTEM 
4j4p:B   (LYS352) to   (PRO439)  THE COMPLEX OF HUMAN IGE-FC WITH TWO BOUND FAB FRAGMENTS  |   IG LIKE DOMAIN, IMMUNE SYSTEM 
4j4p:B   (ARG460) to   (VAL543)  THE COMPLEX OF HUMAN IGE-FC WITH TWO BOUND FAB FRAGMENTS  |   IG LIKE DOMAIN, IMMUNE SYSTEM 
4j4p:L   (ASN151) to   (PRO231)  THE COMPLEX OF HUMAN IGE-FC WITH TWO BOUND FAB FRAGMENTS  |   IG LIKE DOMAIN, IMMUNE SYSTEM 
4j4p:D   (ASN151) to   (PRO231)  THE COMPLEX OF HUMAN IGE-FC WITH TWO BOUND FAB FRAGMENTS  |   IG LIKE DOMAIN, IMMUNE SYSTEM 
3tfk:D   (GLN136) to   (TRP237)  42F3-P4B10/H2-LD  |   IG MHC, ANTIGEN RECOGNITION, TCR-PMHC, CHIMERA PROTEIN, MEMBRANE RECEPTOR, IMMUNE SYSTEM 
4jb9:L   (ASN132) to   (ASN205)  CRYSTAL STRUCTURE OF ANTIBODY VRC06 IN COMPLEX WITH HIV-1 GP120 CORE  |   HIV-1, GP120, ANTIBODY, VRC06, GLYCOPROTEIN, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4jfd:E   (GLN139) to   (TRP240)  PRESERVATION OF PEPTIDE SPECIFICITY DURING TCR-MHC CONTACT DOMINATED AFFINITY ENHANCEMENT OF A MELANOMA-SPECIFIC TCR  |   HLA, TCR, MELANOMA, IMMUNE SYSTEM, HIGH AFFINITY, IMMUNOGLOBULIN 
4jff:E   (LYS140) to   (ALA243)  PRESERVATION OF PEPTIDE SPECIFICITY DURING TCR-MHC CONTACT DOMINATED AFFINITY ENHANCEMENT OF A MELANOMA-SPECIFIC TCR  |   HLA, TCR, MELANOMA MOTIF, IMMUNE SYSTEM, HIGH AFFINITY 
4jg0:L   (GLY128) to   (SER208)  STRUCTURE OF PHOSPHOSERINE/THREONINE (PSTAB) SCAFFOLD BOUND TO PSER PEPTIDE  |   IMMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
4jg1:L   (GLY128) to   (SER208)  STRUCTURE OF PHOSPHOSERINE/THREONINE (PSTAB) SCAFFOLD BOUND TO PTHR PEPTIDE  |   IMMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
2dts:A   (SER254) to   (LYS338)  CRYSTAL STRUCTURE OF THE DEFUCOSYLATED FC FRAGMENT FROM HUMAN IMMUNOGLOBULIN G1  |   IMMUNOGLOBULIN, IGG1, DEFUCOSYLATED GLYCOFORM, IMMUNE SYSTEM 
2dts:B   (CYS261) to   (SER337)  CRYSTAL STRUCTURE OF THE DEFUCOSYLATED FC FRAGMENT FROM HUMAN IMMUNOGLOBULIN G1  |   IMMUNOGLOBULIN, IGG1, DEFUCOSYLATED GLYCOFORM, IMMUNE SYSTEM 
4jha:L   (GLY128) to   (SER208)  CRYSTAL STRUCTURE OF RSV-NEUTRALIZING HUMAN ANTIBODY D25  |   IMMUNOGLOBULIN, IG, IMMUNE SYSTEM 
4jhw:L   (GLY128) to   (SER208)  CRYSTAL STRUCTURE OF RESPIRATORY SYNCYTIAL VIRUS FUSION GLYCOPROTEIN STABILIZED IN THE PREFUSION CONFORMATION BY HUMAN ANTIBODY D25  |   IMMUNOGLOBULIN; TYPE I FUSION PROTEIN, MEMBRANE FUSION, IMMUNE SYSTEM 
4ydi:L   (GLY128) to   (SER208)  CRYSTAL STRUCTURE OF BROAD AND POTENTLY NEUTRALIZING VRC01-CLASS ANTIBODY Z258-VRC27.01, ISOLATED FROM HUMAN DONOR Z258, IN COMPLEX WITH HIV-1 GP120 FROM CLADE A STRAIN Q23.17  |   ANTIBODY, HIV-1, IMMUNE SYSTEM 
1qfu:L   (GLY127) to   (ASN209)  INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY  |   COMPLEX (HEMAGGLUTININ-IMMMUNOGLOBULIN), HEMAGGLUTININ, IMMUNOGLOBULIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4ye4:L   (ASN144) to   (ARG218)  CRYSTAL STRUCTURE OF NEUTRALIZING ANTIBODY HJ16 IN COMPLEX WITH HIV-1 GP120  |   HIV1, ANTIBODY, GP120, COMPLEX, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
2rgs:A   (SER254) to   (SER337)  FC-FRAGMENT OF MONOCLONAL ANTIBODY IGG2B FROM MUS MUSCULUS  |   FC-FRAGMENT, IMMUNOGLOBULIN, GLYCOSYLATION, IMMUNE SYSTEM 
2rgs:B   (SER254) to   (SER337)  FC-FRAGMENT OF MONOCLONAL ANTIBODY IGG2B FROM MUS MUSCULUS  |   FC-FRAGMENT, IMMUNOGLOBULIN, GLYCOSYLATION, IMMUNE SYSTEM 
4yfl:L   (LEU132) to   (GLU203)  CRYSTAL STRUCTURE OF VH1-46 GERMLINE-DERIVED CD4-BINDING SITE-DIRECTED ANTIBODY 1B2530 IN COMPLEX WITH HIV-1 CLADE A/E 93TH057 GP120  |   HIV-1 CD4 BINDING SITE, BROADLY NEUTRALIZING ANTIBODY, IMMUNE SYSTEM 
1etz:L   (ASN131) to   (ARG211)  THE THREE-DIMENSIONAL STRUCTURE OF AN ANTI-SWEETENER FAB, NC10.14, SHOWS THE EXTENT OF STRUCTURAL DIVERSITY IN ANTIGEN RECOGNITION BY IMMUNOGLOBULINS  |   ANTI-SWEETENER FAB, ANTIGEN-ANTIBODY, COMPLEX, CRYSTAL STRUCTURE, RECEPTOR MIMICRY, ANTIGEN RECOGNITION, IMMUNE SYSTEM 
1etz:A   (ASN131) to   (ARG211)  THE THREE-DIMENSIONAL STRUCTURE OF AN ANTI-SWEETENER FAB, NC10.14, SHOWS THE EXTENT OF STRUCTURAL DIVERSITY IN ANTIGEN RECOGNITION BY IMMUNOGLOBULINS  |   ANTI-SWEETENER FAB, ANTIGEN-ANTIBODY, COMPLEX, CRYSTAL STRUCTURE, RECEPTOR MIMICRY, ANTIGEN RECOGNITION, IMMUNE SYSTEM 
4jo4:L   (GLY128) to   (ASN207)  CRYSTAL STRUCTURE OF RABBIT MAB R20 FAB  |   IG, ANTIBODY, IMMUNE SYSTEM 
4jo4:M   (GLY128) to   (ASN207)  CRYSTAL STRUCTURE OF RABBIT MAB R20 FAB  |   IG, ANTIBODY, IMMUNE SYSTEM 
4jo3:L   (GLY128) to   (ASN207)  CRYSTAL STRUCTURE OF RABBIT MAB R20 FAB IN COMPLEX WITH V3 C-TERMINUS OF HIV-1 CONSENSUS B GP120  |   IG, ANTIBODY, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
4jo3:M   (GLY128) to   (ASN207)  CRYSTAL STRUCTURE OF RABBIT MAB R20 FAB IN COMPLEX WITH V3 C-TERMINUS OF HIV-1 CONSENSUS B GP120  |   IG, ANTIBODY, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
4jpk:L   (GLY130) to   (SER210)  CRYSTAL STRUCTURE OF THE GERMLINE-TARGETING HIV-1 GP120 ENGINEERED OUTER DOMAIN EOD-GT6 IN COMPLEX WITH A PUTATIVE VRC01 GERMLINE PRECURSOR FAB  |   HIV-1 GP120, CD4 BINDING, VRC01-LIKE BROADLY NEUTRALIZING ANTIBODIES, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
4jpv:L   (GLY128) to   (ASN210)  CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY 3BNC117 IN COMPLEX WITH HIV-1 GP120  |   HIV, GP120, CD4-BINDING SITE, 3BNC117, NEUTRALIZATION, VACCINE, ANTIBODY, ENVELOPE PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4yhp:D   (ASN138) to   (ARG212)  CRYSTAL STRUCTURE OF 309M3-B FAB IN COMPLEX WITH H3K9ME3 PEPTIDE  |   ANTIBODY, FAB, HEAD-TO-HEAD DIMERIZATION, H3K9ME3, IMMUNE SYSTEM 
4yhp:L   (ASN138) to   (SER209)  CRYSTAL STRUCTURE OF 309M3-B FAB IN COMPLEX WITH H3K9ME3 PEPTIDE  |   ANTIBODY, FAB, HEAD-TO-HEAD DIMERIZATION, H3K9ME3, IMMUNE SYSTEM 
4jre:L   (GLY127) to   (SER207)  CRYSTAL STRUCTURE OF NITRATE/NITRITE EXCHANGER NARK WITH NITRITE BOUND  |   TRANSPORTER, IMMUNOGLOBULIN, MAJOR FACILITATOR SUPERFAMILY, EXCHANGER, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX 
4yk4:B   (GLY128) to   (ARG211)  HUMAN ANTIBODY 641 I-9 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 SOLOMON ISLANDS/03/2006  |   INFLUENZA, ANTIBODY, COMPLEX, HEMAGGLUTININ, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
1qsf:E   (LYS142) to   (TRP242)  STRUCTURE OF A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE Y8A  |   HUMAN T CELL RECEPTOR, TCR/PEPTIDE/MHC COMPLEX, HLA-A2, IMMUNE SYSTEM 
3h9s:E   (GLN141) to   (ALA245)  THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND TEL1P PEPTIDE  |   TEL1P PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS- REACTIVITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
3h9y:A   (SER353) to   (PRO439)  CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS  |   IMMUNOGLOBIN, IGE, FC, FLEXIBILITY, HYDROPHOBIC POCKET, DISULFIDE BOND, GLYCOPROTEIN, IMMUNOGLOBULIN C REGION, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
3h9y:B   (CYS358) to   (THR434)  CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS  |   IMMUNOGLOBIN, IGE, FC, FLEXIBILITY, HYDROPHOBIC POCKET, DISULFIDE BOND, GLYCOPROTEIN, IMMUNOGLOBULIN C REGION, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
3ha0:A   (SER353) to   (THR434)  CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS  |   IMMUNOGLOBIN, IGE, FC, FLEXIBILITY, HYDROPHOBIC POCKET, DISULFIDE BOND, GLYCOPROTEIN, IMMUNOGLOBULIN C REGION, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
3ha0:B   (SER353) to   (PRO439)  CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS  |   IMMUNOGLOBIN, IGE, FC, FLEXIBILITY, HYDROPHOBIC POCKET, DISULFIDE BOND, GLYCOPROTEIN, IMMUNOGLOBULIN C REGION, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
3ha0:D   (SER353) to   (THR434)  CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS  |   IMMUNOGLOBIN, IGE, FC, FLEXIBILITY, HYDROPHOBIC POCKET, DISULFIDE BOND, GLYCOPROTEIN, IMMUNOGLOBULIN C REGION, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
3ha0:F   (SER353) to   (THR434)  CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS  |   IMMUNOGLOBIN, IGE, FC, FLEXIBILITY, HYDROPHOBIC POCKET, DISULFIDE BOND, GLYCOPROTEIN, IMMUNOGLOBULIN C REGION, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
3ha0:F   (ASP458) to   (VAL543)  CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS  |   IMMUNOGLOBIN, IGE, FC, FLEXIBILITY, HYDROPHOBIC POCKET, DISULFIDE BOND, GLYCOPROTEIN, IMMUNOGLOBULIN C REGION, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
3hae:L   (ASN131) to   (PRO211)  RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES  |   FAB, MAJOR HISTOCOMPATABILITY COMPLEX, IMMUNITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
3hae:N   (ASN131) to   (PRO211)  RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES  |   FAB, MAJOR HISTOCOMPATABILITY COMPLEX, IMMUNITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
3hae:S   (ASN131) to   (PRO211)  RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES  |   FAB, MAJOR HISTOCOMPATABILITY COMPLEX, IMMUNITY, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
1f6a:B   (LYS352) to   (LYS435)  STRUCTURE OF THE HUMAN IGE-FC BOUND TO ITS HIGH AFFINITY RECEPTOR FC(EPSILON)RI(ALPHA)  |   IMMUNOGLOBULIN FOLD, GLYCOPROTEIN, RECEPTOR, IGE-BINDING PROTEIN, IGE ANTIBODY, IGE-FC, IMMUNE SYSTEM 
4jvw:C   (GLU468) to   (LYS554)  IGM C4-DOMAIN FROM MOUSE  |   IMMUNOGLOBULIN M, ANTIBODY, OLIGOMERIZATION, IMMUNOGLOBULIN FOLD, RECEPTOR, PROTEIN BINDING 
4jvw:D   (GLU468) to   (LYS554)  IGM C4-DOMAIN FROM MOUSE  |   IMMUNOGLOBULIN M, ANTIBODY, OLIGOMERIZATION, IMMUNOGLOBULIN FOLD, RECEPTOR, PROTEIN BINDING 
1fc1:A   (ARG255) to   (LYS338)  CRYSTALLOGRAPHIC REFINEMENT AND ATOMIC MODELS OF A HUMAN FC FRAGMENT AND ITS COMPLEX WITH FRAGMENT B OF PROTEIN A FROM STAPHYLOCOCCUS AUREUS AT 2.9-AND 2.8-ANGSTROMS RESOLUTION  |   IMMUNOGLOBULIN 
1fc2:D   (SER254) to   (LYS338)  CRYSTALLOGRAPHIC REFINEMENT AND ATOMIC MODELS OF A HUMAN FC FRAGMENT AND ITS COMPLEX WITH FRAGMENT B OF PROTEIN A FROM STAPHYLOCOCCUS AUREUS AT 2.9-AND 2.8-ANGSTROMS RESOLUTION  |   IMMUNOGLOBULIN 
1fc2:D   (ASN361) to   (LEU443)  CRYSTALLOGRAPHIC REFINEMENT AND ATOMIC MODELS OF A HUMAN FC FRAGMENT AND ITS COMPLEX WITH FRAGMENT B OF PROTEIN A FROM STAPHYLOCOCCUS AUREUS AT 2.9-AND 2.8-ANGSTROMS RESOLUTION  |   IMMUNOGLOBULIN 
1fcc:A   (SER254) to   (SER337)  CRYSTAL STRUCTURE OF THE C2 FRAGMENT OF STREPTOCOCCAL PROTEIN G IN COMPLEX WITH THE FC DOMAIN OF HUMAN IGG  |   COMPLEX (ANTIBODY/ANTIGEN) 
1fcc:B   (SER254) to   (SER337)  CRYSTAL STRUCTURE OF THE C2 FRAGMENT OF STREPTOCOCCAL PROTEIN G IN COMPLEX WITH THE FC DOMAIN OF HUMAN IGG  |   COMPLEX (ANTIBODY/ANTIGEN) 
3u7w:L   (GLY128) to   (ASN210)  CRYSTAL STRUCTURE OF NIH45-46 FAB  |   IG FOLD, ANTIBODY, HIV GP120, IMMUNE SYSTEM 
3he6:D   (GLN142) to   (ALA246)  CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-GALACTOSYLCERAMIDE WITH MOUSE VALPHA14-VBETA8.2 NKT TCR  |   MOUSE CD1D, MOUSE NKT T-CELL RECEPTORS, CELL MEMBRANE, DISULFIDE BOND, ENDOSOME, GLYCOPROTEIN, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, INNATE IMMUNITY, LYSOSOME, MEMBRANE, TRANSMEMBRANE, MHC I, IMMUNE SYSTEM 
1r3i:L   (GLY128) to   (ASN212)  POTASSIUM CHANNEL KCSA-FAB COMPLEX IN RB+  |   MEMBRANE PROTEIN, POTASSIUM CHANNEL, KCSA-FAB COMPLEX, RUBIDIUM 
1fig:L   (GLY128) to   (ARG211)  ROUTES TO CATALYSIS: STRUCTURE OF A CATALYTIC ANTIBODY AND COMPARISON WITH ITS NATURAL COUNTERPART  |   IMMUNOGLOBULIN 
4k24:L   (GLY128) to   (ASN210)  STRUCTURE OF ANTI-UPAR FAB ATN-658 IN COMPLEX WITH UPAR  |   IMMUNE SYSTEM 
3hi6:Y   (GLY127) to   (ARG210)  CRYSTAL STRUCTURE OF INTERMEDIATE AFFINITY I DOMAIN OF INTEGRIN LFA-1 WITH THE FAB FRAGMENT OF ITS ANTIBODY AL-57  |   INTEGRIN, I DOMAIN, FAB, LIGAND MIMETIC ANTIBODY, CELL ADHESION, ALTERNATIVE SPLICING, CALCIUM, DISULFIDE BOND, GLYCOPROTEIN, MAGNESIUM, MEMBRANE, POLYMORPHISM, RECEPTOR, TRANSMEMBRANE, CELL ADHESION/IMMUNE SYSTEM COMPLEX 
1fp5:A   (CYS358) to   (THR434)  CRYSTAL STRUCTURE ANALYSIS OF THE HUMAN IGE-FC CEPSILON3- CEPSILON4 FRAGMENT.  |   ANTIBODY, FC, IMMUNOGLOBIN FOLD, "CLOSED" IGE-FC, IMMUNE SYSTEM 
2v7h:A   (GLY128) to   (ARG211)  CRYSTAL STRUCTURE OF AN IMMUNOGEN SPECIFIC ANTI- MANNOPYRANOSIDE MONOCLONAL ANTIBODY FAB FRAGMENT  |   MONOCLONAL ANTIBODY, MANNOPYRANOSIDE SPECIFICITY, MOLECULAR MIMICRY, IMMUNE SYSTEM 
1rhh:A   (GLY127) to   (GLY211)  CRYSTAL STRUCTURE OF THE BROADLY HIV-1 NEUTRALIZING FAB X5 AT 1.90 ANGSTROM RESOLUTION  |   FAB, ANTIBODY, X5, HIV-1, BROADLY NEUTRALIZING, IMMUNE SYSTEM 
4yx2:L   (GLY128) to   (ARG211)  CRYSTAL STRUCTURE OF BOVINE PRION PROTEIN COMPLEXED WITH POM1 FAB  |   PRION, ANTIBODY, COMPLEX, IMMUNE SYSTEM COMPLEX, IMMUNE SYSTEM 
3ulu:E   (GLY129) to   (ASN211)  STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM1)  |   TOLL-LIKE RECEPTOR-3, TLR3,INNATE IMMUNITY, LEUCINE RICH REPEAT, LRR, IMMUNOGLOBULIN, IMMUNE SYSTEM 
4khx:L   (ASN130) to   (VAL208)  CRYSTAL STRUCTURE OF GP41 HELIX COMPLEXED WITH ANTIBODY 8062  |   IMMUNE SYSTEM, GP41 
1rzi:A   (THR129) to   (SER208)  CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB  |   HIV-1; GP120; CD4I; ANTIBODIES; TYROSINE SULFATION; VH-GENE USAGE, IMMUNE SYSTEM 
1rzi:E   (THR129) to   (SER208)  CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB  |   HIV-1; GP120; CD4I; ANTIBODIES; TYROSINE SULFATION; VH-GENE USAGE, IMMUNE SYSTEM 
1rzk:L   (THR129) to   (SER208)  HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B  |   COMPLEX (HIV ENVELOPE PROTEIN-CD4-FAB); HIV-1 EXTERIOR ENVELOPE GP120 FROM LABORATORY-ADAPTED ISOLATE; HXBC2; SURFACE T-CELL GLYCOPROTEIN CD4; ANTIGEN-BINDING FRAGMENT OF HUMAN IMMUNOGLOBULIN 17B, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4z5r:J   (ASN137) to   (SER208)  RONTALIZUMAB FAB BOUND TO INTERFERON-A2  |   ANTIBODY, INTERFERON, CYTOKINE-IMMUNE SYSTEM COMPLEX 
2vis:A   (ASN131) to   (SER210)  INFLUENZA VIRUS HEMAGGLUTININ, (ESCAPE) MUTANT WITH THR 131 REPLACED BY ILE, COMPLEXED WITH A NEUTRALIZING ANTIBODY  |   COMPLEX (HEMAGGLUTININ-IMMUNOGLOBULIN), GLYCOPROTEIN, COMPLEX (HEMAGGLUTININ-IMMUNOGLOBULIN) COMPLEX 
2fjf:E   (GLY128) to   (SER208)  STRUCTURE OF THE G6 FAB, A PHAGE DERIVED VEGF BINDING FAB  |   ANTIBODY, FAB, DODECAMER, IMMUNE SYSTEM 
3utp:E   (GLY151) to   (TRP242)  1E6 TCR SPECIFIC FOR HLA-A*0201-ALWGPDPAAA  |   T CELL RECEPTOR, TYPE I DIABETES, IMMUNE SYSTEM 
3utz:A   (GLY133) to   (ARG216)  ENDOGENOUS-LIKE INHIBITORY ANTIBODIES TARGETING ACTIVATED METALLOPROTEINASE MOTIFS SHOW THERAPEUTIC POTENTIAL  |   STRUCTURAL GENOMICS, ISRAEL STRUCTURAL PROTEOMICS CENTER, ISPC, FAB DOMAIN, IMMUNE SYSTEM 
4z7q:L   (GLY128) to   (ASN210)  INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV-NH2 PEPTIDE  |   CELL ADHESION, PLATELET AGGREGATION, MEMBRANE PROTEIN-IMMUNE SYSTEM COMPLEX 
3huj:F   (GLN142) to   (TRP243)  CRYSTAL STRUCTURE OF HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE IN COMPLEX WITH SEMI-INVARIANT NKT CELL RECEPTOR  |   CD1D, NKT T CELL RECEPTOR, ALPHA-GALACTOSYLCERAMIDE, PROTEIN RECEPTOR COMPLEX, CELL MEMBRANE, DISULFIDE BOND, ENDOSOME, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, INNATE IMMUNITY, LYSOSOME, MEMBRANE, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED, IMMUNE SYSTEM 
1s78:E   (GLY128) to   (GLY212)  INSIGHTS INTO ERBB SIGNALING FROM THE STRUCTURE OF THE ERBB2- PERTUZUMAB COMPLEX  |   RECEPTOR-ANTIBODY COMPLEX, FAB FRAGMENT, CYSTEINE-RICH DOMAIN, LEUCINE-RICH REPEAT, TRANSFERASE 
3v0v:B   (GLY128) to   (ARG211)  FAB WN1 222-5 UNLIGANDED  |   BETA SHEETS, ANTIBODY, FAB, IMMUNE SYSTEM 
3v2a:R   (LYS241) to   (GLU326)  VEGFR-2/VEGF-A COMPLEX STRUCTURE  |   IG-HOMOLOGY DOMAIN, VEGFR-2, GROWTH FACTOR RECEPTOR, VEGF LIGAND, HORMONE-SIGNALING PROTEIN COMPLEX, ANGIOGENESIS, MEMBRANE, VEGF-A 
2vlm:E   (GLN139) to   (TRP240)  THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN  |   IMMUNE SYSTEM, HOST-VIRUS INTERACTION, IMMUNE SYSTEM/RECEPTOR/COMPLEX, IMMUNODOMINANCE, IMMUNOGLOBULIN DOMAIN, TCR, MHC, FLU, MHC I, T-CELL, COMPLEX, MEMBRANE, RECEPTOR, IMMUNE RESPONSE 
2fx8:L   (GLY128) to   (SER208)  CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH AN AIB-INDUCED PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41  |   IMMUNOGLOBULIN FOLD, BETA-SANDWICH, ANTIBODY-EPITOPE COMPLEX, IMMUNE SYSTEM 
3v6o:E   (GLY130) to   (ARG213)  LEPTIN RECEPTOR-ANTIBODY COMPLEX  |   RECEPTOR-ANTIBODY COMPLEX, CYTOKINE RECEPTOR, ANTIBODY FAB FRAGMENT, IMMUNOGLOBULIN FOLD, LEPTIN RECEPTOR-ANTIBODY COMPLEX, IMMUNE SYSTEM 
3i02:A   (GLY127) to   (ASN209)  CRYSTAL STRUCTURE OF S54-10 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO(2.4)KDO  |   ANTIBODY, FAB, IGG, CARBOHYDRATE, IMMUNE SYSTEM 
3v8c:A   (SER254) to   (LYS338)  CRYSTAL STRUCTURE OF MONOCLONAL HUMAN ANTI-RHESUS D FC IGG1 T125(YB2/0) DOUBLE MUTANT (H310 AND H435 IN K)  |   FC IGG1, FC-GAMMA RECEPTOR, IMMUNE SYSTEM 
3v8c:B   (VAL259) to   (LYS338)  CRYSTAL STRUCTURE OF MONOCLONAL HUMAN ANTI-RHESUS D FC IGG1 T125(YB2/0) DOUBLE MUTANT (H310 AND H435 IN K)  |   FC IGG1, FC-GAMMA RECEPTOR, IMMUNE SYSTEM 
4kro:C   (GLY128) to   (SER208)  NANOBODY/VHH DOMAIN EGA1 IN COMPLEX WITH THE EXTRACELLULAR REGION OF EGFR  |   CELL SURFACE RECEPTOR, GLYCOPROTEIN, NANOBODY, VHH DOMAIN, CAMELID VH DOMAIN, ANTIBODY, ANTIGEN, ANTIBODY COMPLEX, TRANSFERASE-IMMUNE SYSTEM COMPLEX 
4krp:C   (GLY128) to   (SER208)  NANOBODY/VHH DOMAIN 9G8 IN COMPLEX WITH THE EXTRACELLULAR REGION OF EGFR  |   CELL SURFACE RECEPTOR, GLYCOPROTEIN, NANOBODY, VHH DOMAIN, CAMELID VH DOMAIN, ANTIBODY, ANTIGEN, ANTIBODY COMPLEX, TRANSFERASE-IMMUNE SYSTEM COMPLEX 
3v95:A   (SER254) to   (SER337)  CRYSTAL STRUCTURE OF MONOCLONAL HUMAN ANTI-RHESUS D FC AND IGG1 T125(YB2/0) IN THE PRESENCE OF EDTA  |   FC IGG1, FC-GAMMA RECEPTOR, IMMUNE SYSTEM 
4ku1:A   (SER254) to   (LYS338)  ROLE OF THE HINGE AND C-GAMMA-2/C-GAMMA-3 INTERFACE IN IMMUNOGLOBIN G1 FC DOMAIN MOTIONS: IMPLICATIONS FOR FC ENGINEERING  |   HUMAN FC FRAGMENT, IMMUNE RESPONSE, IMMUNE SYSTEM 
4ku1:B   (SER254) to   (LYS338)  ROLE OF THE HINGE AND C-GAMMA-2/C-GAMMA-3 INTERFACE IN IMMUNOGLOBIN G1 FC DOMAIN MOTIONS: IMPLICATIONS FOR FC ENGINEERING  |   HUMAN FC FRAGMENT, IMMUNE RESPONSE, IMMUNE SYSTEM 
4kuc:D   (GLY147) to   (ARG228)  CRYSTAL STRUCTURE OF RICIN-A CHAIN IN COMPLEX WITH THE ANTIBODY 6C2  |   RNA-N-GLYCOSIDASE, HYDROLASE-IMMUNE SYSTEM COMPLEX 
2g60:L   (ASN137) to   (SER208)  STRUCTURE OF ANTI-FLAG M2 FAB DOMAIN  |   ANTIBODY, FAB DOMAIN, ANTI-FLAG, IMMUNE SYSTEM 
2gcy:A   (GLY132) to   (SER212)  HUMANIZED ANTIBODY C25 FAB FRAGMENT  |   ANTIBODY FRAGMENT MOUSE HUMANIZED, IMMUNE SYSTEM 
3vga:B   (GLY128) to   (ASN212)  CRYSTAL STRUCTURE OF HUMAN ADENOSINE A2A RECEPTOR WITH AN ALLOSTERIC INVERSE-AGONIST ANTIBODY AT 3.1 A RESOLUTION  |   7 TRANSMEMBRANE RECEPTOR, SIGNAL TRANSDUCTION, SIGNALING PROTEIN 
2gj7:A   (SER254) to   (LYS338)  CRYSTAL STRUCTURE OF A GE-GI/FC COMPLEX  |   FC RECEPTOR, LOW RESOLUTION, IMMUNE SYSTEM-VIRUS-VIRAL PROTEIN COMPLEX 
2gj7:B   (SER254) to   (LYS338)  CRYSTAL STRUCTURE OF A GE-GI/FC COMPLEX  |   FC RECEPTOR, LOW RESOLUTION, IMMUNE SYSTEM-VIRUS-VIRAL PROTEIN COMPLEX 
4l3e:E   (GLN140) to   (ALA244)  THE COMPLEX BETWEEN HIGH AFFINITY TCR DMF5(ALPHA-D26Y,BETA-L98W) AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) PEPTIDE  |   RECEPTORS, MEMBRANE, IMMUNE SYSTEM 
4l4j:A   (SER254) to   (LYS338)  CRYSTAL STRUCTURE OF FC-FRAGMENT OF HUMAN IGG2-SIGMA ANTIBODY  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
4l4j:B   (SER254) to   (LYS338)  CRYSTAL STRUCTURE OF FC-FRAGMENT OF HUMAN IGG2-SIGMA ANTIBODY  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
1h3t:A   (SER254) to   (LYS338)  CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (MN2F)2  |   IMMUNOGLOBULIN, IMMUNE SYSTEM, GLYCOSYLATION, FCGR, ANTIBODY, EFFECTOR FUNCTIONS 
1h3u:A   (ARG255) to   (SER337)  CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (M3N2F)2  |   IMMUNE SYSTEM, FC-FRAGMENT, GLYCOSYLATION, FCGR, ANTIBODY, EFFECTOR FUNCTIONS 
1h3u:B   (SER254) to   (LYS338)  CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (M3N2F)2  |   IMMUNE SYSTEM, FC-FRAGMENT, GLYCOSYLATION, FCGR, ANTIBODY, EFFECTOR FUNCTIONS 
1h3v:A   (CYS261) to   (SER337)  CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (G2F)2,SG P212121  |   IMMUNOGLOBULIN/FC-FRAGMENT, FC-FRAGMENT, GLYCOSYLATION, FCGR, ANTIBODY, EFFECTOR FUNCTIONS, IMMUNE SYSTEM 
1h3v:A   (GLY371) to   (SER442)  CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (G2F)2,SG P212121  |   IMMUNOGLOBULIN/FC-FRAGMENT, FC-FRAGMENT, GLYCOSYLATION, FCGR, ANTIBODY, EFFECTOR FUNCTIONS, IMMUNE SYSTEM 
1h3v:B   (SER254) to   (LYS338)  CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (G2F)2,SG P212121  |   IMMUNOGLOBULIN/FC-FRAGMENT, FC-FRAGMENT, GLYCOSYLATION, FCGR, ANTIBODY, EFFECTOR FUNCTIONS, IMMUNE SYSTEM 
1h3w:M   (ARG255) to   (LYS338)  CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (G2F)2, SG C2221  |   IMMUNOGLOBULIN/FC-FRAGMENT, FC-FRAGMENT, GLYCOSYLATION, FCGR, ANTIBODY, EFFECTOR FUNCTIONS, IMMUNE SYSTEM 
1h3x:A   (ARG255) to   (SER337)  CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (G0F)2  |   IMMUNOGLOBIN/FC-FRAGMENT, FC-FRAGMENT, GLYCOSYLATION, FCGR, ANTIBODY, EFFECTOR FUNCTIONS, IMMUNE SYSTEM 
1h3x:B   (SER254) to   (LYS338)  CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (G0F)2  |   IMMUNOGLOBIN/FC-FRAGMENT, FC-FRAGMENT, GLYCOSYLATION, FCGR, ANTIBODY, EFFECTOR FUNCTIONS, IMMUNE SYSTEM 
1h3y:A   (SER254) to   (LYS338)  CRYSTAL STRUCTURE OF A HUMAN IGG1 FC-FRAGMENT,HIGH SALT CONDITION  |   IMMUNE SYSTEM, FC-FRAGMENT, GLYCOSYLATION, FCGR, ANTIBODY, EFFECTOR FUNCTIONS 
4l4v:E   (GLN140) to   (ALA244)  STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-RL-6-ME-7-OH  |   MHC CLASS I-RELATED PROTEIN, MAIT TCR, IMMUNE SYSTEM, VITAMIN B METABOLITES, MEMBRANE PROTEIN-IMMUNE SYSTEM COMPLEX 
3idj:B   (ASP144) to   (PRO213)  CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 FAB' FRAGMENT IN COMPLEX WITH GP41 PEPTIDE ANALOG ELD(ORN)WAS  |   HIV-1, GP41, MPER, 2F5, IMMUNE SYSTEM 
4znc:E   (SER254) to   (LYS338)  FC FRAGMENT OF HUMAN IGG IN COMPLEX WITH THE C DOMAIN OF STAPHYLOCOCCAL PROTEIN A MUTANT - Q9W  |   STAPHYLOCOCCAL PROTEIN A, SPA, THREE-HELIX-BUNDLE, ANTIBODY, IGG, PROTEIN-BINDING DOMAIN, PROTEIN BINDING 
4znc:F   (SER254) to   (LYS338)  FC FRAGMENT OF HUMAN IGG IN COMPLEX WITH THE C DOMAIN OF STAPHYLOCOCCAL PROTEIN A MUTANT - Q9W  |   STAPHYLOCOCCAL PROTEIN A, SPA, THREE-HELIX-BUNDLE, ANTIBODY, IGG, PROTEIN-BINDING DOMAIN, PROTEIN BINDING 
4zne:E   (SER254) to   (LYS338)  IGG1 FC-FCGAMMARI ECD COMPLEX  |   ANTIBODY, CONSTANT REGION, RECEPTOR, HIGH AFFINITY, IMMUNE SYSTEM 
4zne:J   (SER254) to   (LYS338)  IGG1 FC-FCGAMMARI ECD COMPLEX  |   ANTIBODY, CONSTANT REGION, RECEPTOR, HIGH AFFINITY, IMMUNE SYSTEM 
3ifn:L   (GLY133) to   (ASN215)  X-RAY STRUCTURE OF AMYLOID BETA PEPTIDE:ANTIBODY (ABETA1-40:12A11) COMPLEX  |   ANTIBODY, AMYLOID BETA PEPTIDE, IMMUNE SYSTEM 
3iga:B   (GLY128) to   (ASN212)  POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LI+ AND K+  |   KCSA, LITHIUM, LITHIUM BLOCK, POTASSIUM CHANNEL, MEMBRANE PROTEIN, CELL MEMBRANE, ION TRANSPORT, IONIC CHANNEL, MEMBRANE, TRANSMEMBRANE, TRANSPORT, VOLTAGE-GATED CHANNEL, TRANSPORT PROTEIN 
1t83:A   (CYS261) to   (LYS338)  CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (ORTHORHOMBIC)  |   FC GAMMA RECEPTOR, IGG1, CD16, FCGRIII, IMMUNOGLOBULIN, IMMUNE SYSTEM 
1t83:B   (SER254) to   (LYS338)  CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (ORTHORHOMBIC)  |   FC GAMMA RECEPTOR, IGG1, CD16, FCGRIII, IMMUNOGLOBULIN, IMMUNE SYSTEM 
1t89:A   (SER254) to   (SER337)  CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (HEXAGONAL)  |   FC GAMMA RECEPTOR, IGG1, CD16, FCGRIII, IMMUNOGLOBULIN, IMMUNE SYSTEM 
3inu:L   (GLY128) to   (SER208)  CRYSTAL STRUCTURE OF AN UNBOUND KZ52 NEUTRALIZING ANTI-EBOLAVIRUS ANTIBODY.  |   ANTIBODY FRAGMENT (FAB), IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
3inu:N   (GLY128) to   (SER208)  CRYSTAL STRUCTURE OF AN UNBOUND KZ52 NEUTRALIZING ANTI-EBOLAVIRUS ANTIBODY.  |   ANTIBODY FRAGMENT (FAB), IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
4ztp:L   (GLY128) to   (ASN207)  FAB STRUCTURE OF RABBIT MONOCLONAL ANTIBODY R53 TARGETING AN EPITOPE IN HIV-1 GP120 C4 REGION  |   HIV-1, ENV, C4, CD4, MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
2h2p:D   (GLY127) to   (ASN209)  CRYSTAL STRUCTURE OF CLC-EC1 IN COMPLEX WITH FAB FRAGMENT IN SECN-  |   CLC; TRANSPORTER; CHLORIDE; ANTIPORT, ION TRANSPORT 
1him:J   (GLY128) to   (ASN210)  STRUCTURAL EVIDENCE FOR INDUCED FIT AS A MECHANISM FOR ANTIBODY- ANTIGEN RECOGNITION  |   IMMUNOGLOBULIN 
1tqc:C   (GLY128) to   (ASN212)  OVINE RECOMBINANT PRP(114-234), ARR VARIANT IN COMPLEX WITH THE VRQ14 FAB FRAGMENT (IGG2A)  |   PRION, ANTIBODY, UNKNOWN FUNCTION/IMMUNE SYSTEM COMPLEX 
1hq4:A   (GLY128) to   (ASN210)  STRUCTURE OF NATIVE CATALYTIC ANTIBODY HA5-19A4  |   CATALYTIC ANTIBODY, TERPENOID SYNTHASE, CARBOCATION, CYCLIZATION CASCADE, IMMUNOGLOBULIN, IMMUNE SYSTEM 
1hq4:C   (GLY128) to   (ASN210)  STRUCTURE OF NATIVE CATALYTIC ANTIBODY HA5-19A4  |   CATALYTIC ANTIBODY, TERPENOID SYNTHASE, CARBOCATION, CYCLIZATION CASCADE, IMMUNOGLOBULIN, IMMUNE SYSTEM 
2hff:A   (ASN136) to   (SER207)  CRYSTAL STRUCTURE OF CB2 FAB  |   FAB FRAGMENT, PHAGE LIBRARIES, COMBINATORIAL SELECTION, IMMUNE SYSTEM 
2hff:L   (ASN136) to   (ARG210)  CRYSTAL STRUCTURE OF CB2 FAB  |   FAB FRAGMENT, PHAGE LIBRARIES, COMBINATORIAL SELECTION, IMMUNE SYSTEM 
2hjf:B   (GLY128) to   (ASN210)  POTASSIUM CHANNEL KCSA-FAB COMPLEX WITH TETRABUTYLAMMONIUM (TBA)  |   POTASSIUM CHANNEL, ION TRANSPORT, METAL TRANSPORT 
1tzh:A   (GLY128) to   (ARG211)  CRYSTAL STRUCTURE OF THE FAB YADS1 COMPLEXED WITH H-VEGF  |   PHAGE DISPLAY, ANTIBODY LIBRARY, PROTEIN ENGINEERING, IMMUNE SYSTEM 
1hzh:L   (ASN137) to   (ASN210)  CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN  |   IMMUNOGLOBULIN, ANTIBODY, B12, IMMUNE SYSTEM 
1i1c:A   (THR256) to   (LYS338)  NON-FCRN BINDING FC FRAGMENT OF RAT IGG2A  |   IGG, FC, IMMUNE SYSTEM 
1i1c:B   (THR256) to   (LYS338)  NON-FCRN BINDING FC FRAGMENT OF RAT IGG2A  |   IGG, FC, IMMUNE SYSTEM 
3vxm:E   (GLN138) to   (TRP239)  THE COMPLEX BETWEEN C1-28 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE  |   HIV-1, NEF, IMMUNE SYSTEM, HLA-A24, T CELL RECEPTOR, MHC CLASS I, IMMUNOGLOBURIN DOMAIN, TCR, MHC, IMMUNE RESPONSE 
3vxr:E   (GLN138) to   (ALA242)  THE COMPLEX BETWEEN H27-14 TCR AND HLA-A24 BOUND TO HIV-1 NEF134- 10(WT) PEPTIDE  |   HIV-1, NEF, IMMUNE SYSTEM, HLA-A24, T CELL RECEPTOR, MHC CLASS I, IMMUNOGLOBURIN DOMAIN, TCR, MHC, IMMUNE RESPONSE 
3vxs:E   (GLN138) to   (ASP243)  THE COMPLEX BETWEEN H27-14 TCR AND HLA-A24 BOUND TO HIV-1 NEF134- 10(6L) PEPTIDE  |   HIV-1, NEF, IMMUNE SYSTEM, HLA-A24, T CELL RECEPTOR, MHC CLASS I, IMMUNOGLOBURIN DOMAIN, TCR, MHC, IMMUNE RESPONSE 
3vxu:E   (LYS137) to   (TRP237)  THE COMPLEX BETWEEN T36-5 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE  |   HIV-1, NEF, IMMUNE SYSTEM, HLA-A24, T CELL RECEPTOR, MHC CLASS I, IMMUNOGLOBURIN DOMAIN, TCR, MHC, IMMUNE RESPONSE 
4lsp:L   (GLY128) to   (SER208)  CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC- CH31 IN COMPLEX WITH HIV-1 CLADE A/E GP120 93TH057  |   NEUTRALIZING ANTIBODY VRC-CH31, HIV ENVELOPE GLYCOPROTEIN GP120, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
3w2d:L   (GLY151) to   (ARG234)  CRYSTAL STRUCTURE OF STAPHYLOCOCCAL EENTEROTOXIN B IN COMPLEX WITH A NOVEL NEUTRALIZATION MONOCLONAL ANTIBODY FAB FRAGMENT  |   STAPHYLOCOCCAL EENTEROTOXIN B, IMMUNE SYSTEM 
1u8l:A   (GLY128) to   (SER208)  CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE DLDRWAS  |   FAB COMPLEX, HIV-1 NEUTRALIZATION, GP41 PEPTIDE, IMMUNE SYSTEM 
1ub6:L   (GLY133) to   (SER213)  CRYSTAL STRUCTURE OF ANTIBODY 19G2 WITH SERA LIGAND  |   ANTIBODY FLUORSCENCE DYNAMICS, SERA LIGAND, IMMUNE SYSTEM 
1ub6:B   (GLY133) to   (SER213)  CRYSTAL STRUCTURE OF ANTIBODY 19G2 WITH SERA LIGAND  |   ANTIBODY FLUORSCENCE DYNAMICS, SERA LIGAND, IMMUNE SYSTEM 
1iai:L   (GLY128) to   (ARG211)  IDIOTYPE-ANTI-IDIOTYPE FAB COMPLEX  |   COMPLEX (IMMUNOGLOBULIN IGG1/IGG2A) 
1igj:C   (GLY128) to   (ASN210)  26-10 FAB:DIGOXIN COMPLEX-AFFINITY AND SPECIFICITY DUE TO SURFACE COMPLEMENTARITY  |   IMMUNOGLOBULIN 
1igj:D   (SER136) to   (PRO227)  26-10 FAB:DIGOXIN COMPLEX-AFFINITY AND SPECIFICITY DUE TO SURFACE COMPLEMENTARITY  |   IMMUNOGLOBULIN 
1igt:B   (VAL272) to   (SER357)  STRUCTURE OF IMMUNOGLOBULIN  |   INTACT IMMUNOGLOBULIN V REGION C REGION, IMMUNOGLOBULIN 
1igt:C   (GLY128) to   (ASN210)  STRUCTURE OF IMMUNOGLOBULIN  |   INTACT IMMUNOGLOBULIN V REGION C REGION, IMMUNOGLOBULIN 
1igt:D   (VAL272) to   (SER357)  STRUCTURE OF IMMUNOGLOBULIN  |   INTACT IMMUNOGLOBULIN V REGION C REGION, IMMUNOGLOBULIN 
1igy:A   (GLY128) to   (ARG211)  STRUCTURE OF IMMUNOGLOBULIN  |   INTACT IMMUNOGLOBULIN, V REGION, C REGION, HINGE REGION, IMMUNOGLOBULIN 
1igy:B   (ASP384) to   (HIS474)  STRUCTURE OF IMMUNOGLOBULIN  |   INTACT IMMUNOGLOBULIN, V REGION, C REGION, HINGE REGION, IMMUNOGLOBULIN 
1igy:C   (GLY128) to   (ASN212)  STRUCTURE OF IMMUNOGLOBULIN  |   INTACT IMMUNOGLOBULIN, V REGION, C REGION, HINGE REGION, IMMUNOGLOBULIN 
1igy:D   (ASP384) to   (HIS474)  STRUCTURE OF IMMUNOGLOBULIN  |   INTACT IMMUNOGLOBULIN, V REGION, C REGION, HINGE REGION, IMMUNOGLOBULIN 
5a7x:C   (THR129) to   (SER208)  NEGATIVE STAIN EM OF BG505 SOSIP.664 IN COMPLEX WITH SCD4, 17B, AND 8ANC195  |   VIRAL PROTEIN 
5a7x:G   (THR129) to   (SER208)  NEGATIVE STAIN EM OF BG505 SOSIP.664 IN COMPLEX WITH SCD4, 17B, AND 8ANC195  |   VIRAL PROTEIN 
5a7x:K   (THR129) to   (SER208)  NEGATIVE STAIN EM OF BG505 SOSIP.664 IN COMPLEX WITH SCD4, 17B, AND 8ANC195  |   VIRAL PROTEIN 
5a8h:C   (THR129) to   (SER208)  CRYO-ET SUBTOMOGRAM AVERAGING OF BG505 SOSIP.664 IN COMPLEX WITH SCD4, 17B, AND 8ANC195  |   VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, VIRUS 
5a8h:I   (THR129) to   (SER208)  CRYO-ET SUBTOMOGRAM AVERAGING OF BG505 SOSIP.664 IN COMPLEX WITH SCD4, 17B, AND 8ANC195  |   VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, VIRUS 
5a8h:O   (THR129) to   (SER208)  CRYO-ET SUBTOMOGRAM AVERAGING OF BG505 SOSIP.664 IN COMPLEX WITH SCD4, 17B, AND 8ANC195  |   VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, VIRUS 
4m43:L   (GLY128) to   (ASN210)  CRYSTAL STRUCTURE OF ANTI-RABIES GLYCOPROTEIN FAB 523-11  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
1um6:L   (GLY130) to   (SER210)  CATALYTIC ANTIBODY 21H3  |   CATALYTIC ANTIBODY LIGAND TRANSESTERIFICATION, IMMUNE SYSTEM 
4m6n:L   (ASN133) to   (PRO213)  CRYSTAL STRUCTURE OF ANTI-IL-23 ANTIBODY CNTO1959 AT PH 6.5  |   IMMUNOGLOBULIN FOLD, ANTIBODY, IMMUNE SYSTEM 
4m93:C   (GLY128) to   (ASN210)  UNLIGANDED 2 CRYSTAL STRUCTURE OF S25-26 FAB  |   CARBOHYDRATE/SUGAR BINDING, IMMUNE SYSTEM 
4ma3:A   (GLY134) to   (SER214)  CRYSTAL STRUCTURE OF ANTI-HINGE RABBIT ANTIBODY C2095  |   IMMUNOGLOBULIN FOLD, ANTIBODY, IMMUNE SYSTEM 
3wkn:C   (SER254) to   (LYS338)  CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG  |   IMMUNOGLOBULIN-LIKE BETA-SANDWICH, BINDING PROTEIN, IMMUNE SYSTEM 
3wkn:A   (CYS261) to   (LYS338)  CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG  |   IMMUNOGLOBULIN-LIKE BETA-SANDWICH, BINDING PROTEIN, IMMUNE SYSTEM 
3wkn:I   (SER254) to   (LYS338)  CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG  |   IMMUNOGLOBULIN-LIKE BETA-SANDWICH, BINDING PROTEIN, IMMUNE SYSTEM 
3wkn:J   (VAL259) to   (SER337)  CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG  |   IMMUNOGLOBULIN-LIKE BETA-SANDWICH, BINDING PROTEIN, IMMUNE SYSTEM 
3wkn:M   (ASN361) to   (LEU443)  CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG  |   IMMUNOGLOBULIN-LIKE BETA-SANDWICH, BINDING PROTEIN, IMMUNE SYSTEM 
3wkn:N   (SER254) to   (LYS338)  CRYSTAL STRUCTURE OF THE ARTIFICIAL PROTEIN AFFINGER P17 (AF.P17) COMPLEXED WITH FC FRAGMENT OF HUMAN IGG  |   IMMUNOGLOBULIN-LIKE BETA-SANDWICH, BINDING PROTEIN, IMMUNE SYSTEM 
4mji:E   (LYS142) to   (GLY243)  T CELL RESPONSE TO A HIV REVERSE TRANSCRIPTASE EPITOPE PRESENTED BY THE PROTECTIVE ALLELE HLA-B*51:01  |   HIV, PEPTIDE-MAJOR HISTOCOMPATIBILITY COMPLEX, PMHC, SURFACE PLASMON RESONANCE, SPR, T-CELL, T-CELL RECEPTOR, TCR, IMMUNOGLOBULIN, CLASS I MHC, ANTIGEN PRESENTATION, IMMUNE SYSTEM 
4mji:J   (LYS142) to   (GLY243)  T CELL RESPONSE TO A HIV REVERSE TRANSCRIPTASE EPITOPE PRESENTED BY THE PROTECTIVE ALLELE HLA-B*51:01  |   HIV, PEPTIDE-MAJOR HISTOCOMPATIBILITY COMPLEX, PMHC, SURFACE PLASMON RESONANCE, SPR, T-CELL, T-CELL RECEPTOR, TCR, IMMUNOGLOBULIN, CLASS I MHC, ANTIGEN PRESENTATION, IMMUNE SYSTEM 
3wlw:C   (GLY138) to   (PRO217)  MOLECULAR ARCHITECTURE OF THE ERBB2 EXTRACELLULAR DOMAIN HOMODIMER  |   HYDROLASE-IMMUNE SYSTEM COMPLEX 
1v7n:N   (GLY127) to   (ASN211)  HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB  |   THROMBOPOIETIN, FAB FRAGMENT, COMPLEX (CYTOKINE/ANTIBODY), IMMUNE SYSTEM/CYTOKINE COMPLEX 
3wn5:A   (VAL259) to   (LYS338)  CRYSTAL STRUCTURE OF ASYMMETRICALLY ENGINEERED FC VARIANT IN COMPLEX WITH FCGRIIIA  |   RECEPTOR COMPLEX, FC RECEPTOR, ANTIBODY, IMMUNE SYSTEM 
3wn5:D   (SER254) to   (SER337)  CRYSTAL STRUCTURE OF ASYMMETRICALLY ENGINEERED FC VARIANT IN COMPLEX WITH FCGRIIIA  |   RECEPTOR COMPLEX, FC RECEPTOR, ANTIBODY, IMMUNE SYSTEM 
3wn5:E   (VAL259) to   (LYS338)  CRYSTAL STRUCTURE OF ASYMMETRICALLY ENGINEERED FC VARIANT IN COMPLEX WITH FCGRIIIA  |   RECEPTOR COMPLEX, FC RECEPTOR, ANTIBODY, IMMUNE SYSTEM 
2iwg:A   (SER254) to   (LYS338)  COMPLEX BETWEEN THE PRYSPRY DOMAIN OF TRIM21 AND IGG FC  |   ZINC, RNA-BINDING, ZINC-FINGER, DNA-BINDING, RIBONUCLEOPROTEIN, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN C REGION, SYSTEMIC LUPUS ERYTHEMATOSUS, POLYMORPHISM, GLYCOPROTEIN, METAL-BINDING 
2iwg:D   (SER254) to   (LYS338)  COMPLEX BETWEEN THE PRYSPRY DOMAIN OF TRIM21 AND IGG FC  |   ZINC, RNA-BINDING, ZINC-FINGER, DNA-BINDING, RIBONUCLEOPROTEIN, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN C REGION, SYSTEMIC LUPUS ERYTHEMATOSUS, POLYMORPHISM, GLYCOPROTEIN, METAL-BINDING 
4mnh:C   (GLN141) to   (TRP242)  STRUCTURE OF THE DP10.7 TCR  |   IMMUNOGLOBULIN, HISTOCOMPATIBILITY ANTIGENS, T CELL RECEPTOR, IMMUNOLOGICAL, LYMPHOCYTES, T CELL RECOGNITION, ACTIVATION, GAMMA DELTA T CELL, HUMAN, INTRAEPITHELIAL LYMPHOCYTES, CD1D, GLYCOLIPIDS, NON-CLASSICAL MHC, GLYCOPROTEINS, CELL-SURFACE RECEPTORS, IMMUNE SYSTEM 
5anm:E   (LYS352) to   (LYS435)  CRYSTAL STRUCTURE OF IGE FC IN COMPLEX WITH A NEUTRALIZING ANTIBODY  |   IMMUNE SYSTEM, THERAPEUTIC ANTIBODY, IGG, IGE, ASTHMA 
5anm:F   (CYS358) to   (PRO439)  CRYSTAL STRUCTURE OF IGE FC IN COMPLEX WITH A NEUTRALIZING ANTIBODY  |   IMMUNE SYSTEM, THERAPEUTIC ANTIBODY, IGG, IGE, ASTHMA 
5anm:G   (SER353) to   (LYS435)  CRYSTAL STRUCTURE OF IGE FC IN COMPLEX WITH A NEUTRALIZING ANTIBODY  |   IMMUNE SYSTEM, THERAPEUTIC ANTIBODY, IGG, IGE, ASTHMA 
2j5l:B   (GLY128) to   (ASN212)  STRUCTURE OF A PLASMODIUM FALCIPARUM APICAL MEMBRANE ANTIGEN 1-FAB F8.12.19 COMPLEX  |   MALARIA VACCINE CANDIDATE, APICAL MEMBRANE ANTIGEN 1, HYPOTHETICAL PROTEIN, IMMUNOGLOBULIN DOMAIN, MEMBRANE, MEROZOITE, TRANSMEMBRANE, IMMUNE SYSTEM, IMMUNOGLOBULIN C REGION, ANTIBODY CROSS-REACTIVITY 
2j6e:B   (SER254) to   (LYS338)  CRYSTAL STRUCTURE OF AN AUTOIMMUNE COMPLEX BETWEEN A HUMAN IGM RHEUMATOID FACTOR AND IGG1 FC REVEALS A NOVEL FC EPITOPE AND EVIDENCE FOR AFFINITY MATURATION  |   AUTOIMMUNE COMPLEX HUMAN IGM RHEUMATOID FACTOR IGG1-FC, IMMUNOGLOBULIN C REGION, MEMBRANE, GLYCOPROTEIN, TRANSMEMBRANE, HYPOTHETICAL PROTEIN, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN 
2j6e:L   (ASN128) to   (ALA207)  CRYSTAL STRUCTURE OF AN AUTOIMMUNE COMPLEX BETWEEN A HUMAN IGM RHEUMATOID FACTOR AND IGG1 FC REVEALS A NOVEL FC EPITOPE AND EVIDENCE FOR AFFINITY MATURATION  |   AUTOIMMUNE COMPLEX HUMAN IGM RHEUMATOID FACTOR IGG1-FC, IMMUNOGLOBULIN C REGION, MEMBRANE, GLYCOPROTEIN, TRANSMEMBRANE, HYPOTHETICAL PROTEIN, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN 
1jpt:L   (GLY128) to   (ARG211)  CRYSTAL STRUCTURE OF FAB D3H44  |   ANTIGEN-ANTIBODY RECOGNITION, HUMANIZED ANTIBODY, BLOOD COAGULATION, CRYSTAL STRUCTURE, IMMUNE SYSTEM 
2j8u:F   (GLN141) to   (TRP242)  LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION.  |   GLYCOPROTEIN, IMMUNE SYSTEM, TRANSMEMBRANE, MHC I, MEMBRANE, SECRETED, GLYCATION, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, IMMUNE RESPONSE, DISEASE MUTATION, IMUNOREGULATORY COMPLEX, CLASS I MHC-TCR CO-CRYSTAL 
4mxq:D   (LYS137) to   (ALA240)  42F3 TCR PCPC5/H-2LD COMPLEX  |   IG, TCR, MHC, IMMUNE SYSTEM, ANTIGEN 
3zdx:L   (GLY128) to   (ASN212)  INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX  |   CELL ADHESION-IMMUNE SYSTEM COMPLEX 
5bo1:L   (ASN137) to   (SER208)  CRYSTAL STRUCTURE OF A HUMAN JAG1 FRAGMENT IN COMPLEX WITH AN ANTI- JAG1 FAB  |   JAG, NOTCH, ANTAGONIST, SIGNALING PROTEIN-IMMUNE SYSTEM COMPLEX 
4n8c:L   (GLY134) to   (ASN216)  THREE-DIMENSIONAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF MATRIX PROTEIN 2 OF INFLUENZA A VIRUS  |   ANTIBODY-PEPTIDE COMPLEX, INFLUENZA A VIRUS PROTEIN, IMMUNE SYSTEM 
4n90:E   (GLY129) to   (SER209)  CRYSTAL STRUCTURE OF TERNARY COMPLEX OF TRAIL, DR5, AND FAB FRAGMENT FROM A DR5 AGONIST ANTIBODY  |   DR5, TRAIL, AGONIST, ANTIBODY, COOPERATION, CLUSTERING, APOPTOSIS- IMMUNE SYSTEM COMPLEX 
4n9g:B   (GLY128) to   (SER208)  CRYSTAL STRUCTURE OF A COMPUTATIONALLY DESIGNED RSV-PRESENTING EPITOPE SCAFFOLD AND ITS ELICITED ANTIBODY 17HD9  |   ANTIBODY, HAIRPIN, EPITOPE SCAFFOLD, IMMUNE SYSTEM 
4n9g:F   (GLY128) to   (SER208)  CRYSTAL STRUCTURE OF A COMPUTATIONALLY DESIGNED RSV-PRESENTING EPITOPE SCAFFOLD AND ITS ELICITED ANTIBODY 17HD9  |   ANTIBODY, HAIRPIN, EPITOPE SCAFFOLD, IMMUNE SYSTEM 
1wc7:L   (GLY128) to   (ASN212)  FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-L-ALANINE  |   ANTIBODY, CATALYTIC ANTIBODY, TRANSAMINATION, PYRIDOXAL-PHOSPHATE, PHOSPHOPYRIDOXYL-L-ALANINE 
5bw7:A   (SER254) to   (LYS338)  CRYSTAL STRUCTURE OF NONFUCOSYLATED FC Y296W MUTANT COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA  |   IMMUNE SYSTEM, COMPLEX, FC FRAGMENT, IGG, RECEPTOR, CD16, GAMMA 
5bw7:B   (SER254) to   (LYS338)  CRYSTAL STRUCTURE OF NONFUCOSYLATED FC Y296W MUTANT COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA  |   IMMUNE SYSTEM, COMPLEX, FC FRAGMENT, IGG, RECEPTOR, CD16, GAMMA 
4nhg:K   (GLY128) to   (SER208)  CRYSTAL STRUCTURE OF 2G12 IGG DIMER  |   IG FOLD, ANTIBODY, IMMUNE SYSTEM 
4nhg:F   (GLY128) to   (SER208)  CRYSTAL STRUCTURE OF 2G12 IGG DIMER  |   IG FOLD, ANTIBODY, IMMUNE SYSTEM 
4nhg:X   (ARG255) to   (SER337)  CRYSTAL STRUCTURE OF 2G12 IGG DIMER  |   IG FOLD, ANTIBODY, IMMUNE SYSTEM 
4nhg:Y   (SER254) to   (LYS338)  CRYSTAL STRUCTURE OF 2G12 IGG DIMER  |   IG FOLD, ANTIBODY, IMMUNE SYSTEM 
4nhg:J   (ARG255) to   (SER337)  CRYSTAL STRUCTURE OF 2G12 IGG DIMER  |   IG FOLD, ANTIBODY, IMMUNE SYSTEM 
4nhg:N   (SER254) to   (LYS338)  CRYSTAL STRUCTURE OF 2G12 IGG DIMER  |   IG FOLD, ANTIBODY, IMMUNE SYSTEM 
4nhg:O   (ARG255) to   (SER337)  CRYSTAL STRUCTURE OF 2G12 IGG DIMER  |   IG FOLD, ANTIBODY, IMMUNE SYSTEM 
4nhg:P   (SER254) to   (LYS338)  CRYSTAL STRUCTURE OF 2G12 IGG DIMER  |   IG FOLD, ANTIBODY, IMMUNE SYSTEM 
4nhh:A   (ARG255) to   (SER337)  STRUCTURE OF 2G12 IGG DIMER  |   IG, ANTIBODY, IMMUNE SYSTEM 
4nhh:B   (SER254) to   (LYS338)  STRUCTURE OF 2G12 IGG DIMER  |   IG, ANTIBODY, IMMUNE SYSTEM 
4nhh:C   (ARG255) to   (SER337)  STRUCTURE OF 2G12 IGG DIMER  |   IG, ANTIBODY, IMMUNE SYSTEM 
4nhh:D   (SER254) to   (LYS338)  STRUCTURE OF 2G12 IGG DIMER  |   IG, ANTIBODY, IMMUNE SYSTEM 
4nhh:J   (ARG255) to   (SER337)  STRUCTURE OF 2G12 IGG DIMER  |   IG, ANTIBODY, IMMUNE SYSTEM 
4nhh:N   (SER254) to   (LYS338)  STRUCTURE OF 2G12 IGG DIMER  |   IG, ANTIBODY, IMMUNE SYSTEM 
5c07:J   (GLN141) to   (TRP242)  1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING YQFGPDFPIA  |   IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM 
5c0b:E   (GLN141) to   (ALA245)  1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING RQFGPDFPTI  |   IMMUNO, HLA-A02, 1E6-TCR, IMMUNE SYSTEM 
5c0a:E   (LYS142) to   (ALA245)  1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING MVW PEPTIDE  |   IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM 
5c0c:E   (GLN141) to   (ALA245)  1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING RQFGPDWIVA  |   IMMUNO, HLA-A02, 1E6-TCR, IMMUNE SYSTEM 
5c0c:J   (GLN141) to   (TRP242)  1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING RQFGPDWIVA  |   IMMUNO, HLA-A02, 1E6-TCR, IMMUNE SYSTEM 
5c0n:D   (GLY133) to   (ARG216)  DEVELOPMENT OF A MONOCLONAL ANTIBODY TARGETING SECRETED AP2 TO TREAT DIABETES AND FATTY LIVER DISEASE  |   AP2, FABP4, FAB, TYPE II DIABETES, LIPID TRANSPORT 
1ken:L   (GLY129) to   (SER209)  INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH AN ANTIBODY THAT PREVENTS THE HEMAGGLUTININ LOW PH FUSOGENIC TRANSITION  |   HEMAGGLUTININ, ENVELOPE PROTEIN, GLYCOPROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
1ken:U   (GLY129) to   (SER209)  INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH AN ANTIBODY THAT PREVENTS THE HEMAGGLUTININ LOW PH FUSOGENIC TRANSITION  |   HEMAGGLUTININ, ENVELOPE PROTEIN, GLYCOPROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
1kgc:E   (GLN142) to   (GLY244)  IMMUNE RECEPTOR  |   T-CELL RECEPTOR, LC13 CLONE, IMMUNE SYSTEM 
2y7q:B   (PRO249) to   (LYS327)  THE HIGH-AFFINITY COMPLEX BETWEEN IGE AND ITS RECEPTOR FC EPSILON RI  |   ALLERGY, ANTIBODY, IGE-BINDING PROTEIN, HIGH-AFFINITY RECEPTOR, IMMUNOGLOBULIN C REGION, IMMUNE SYSTEM 
2y7q:B   (LYS352) to   (THR434)  THE HIGH-AFFINITY COMPLEX BETWEEN IGE AND ITS RECEPTOR FC EPSILON RI  |   ALLERGY, ANTIBODY, IGE-BINDING PROTEIN, HIGH-AFFINITY RECEPTOR, IMMUNOGLOBULIN C REGION, IMMUNE SYSTEM 
2y7q:D   (PRO249) to   (LYS327)  THE HIGH-AFFINITY COMPLEX BETWEEN IGE AND ITS RECEPTOR FC EPSILON RI  |   ALLERGY, ANTIBODY, IGE-BINDING PROTEIN, HIGH-AFFINITY RECEPTOR, IMMUNOGLOBULIN C REGION, IMMUNE SYSTEM 
2y7q:D   (LYS352) to   (THR434)  THE HIGH-AFFINITY COMPLEX BETWEEN IGE AND ITS RECEPTOR FC EPSILON RI  |   ALLERGY, ANTIBODY, IGE-BINDING PROTEIN, HIGH-AFFINITY RECEPTOR, IMMUNOGLOBULIN C REGION, IMMUNE SYSTEM 
4nqu:A   (VAL259) to   (SER337)  ANTI-PARALLEL FC-KNOB (T366W) HOMODIMER  |   IMMUNOGLOBULIN, IMMUNE SYSTEM 
5c8j:F   (GLY129) to   (SER209)  A YIDC-LIKE PROTEIN IN THE ARCHAEAL PLASMA MEMBRANE  |   MEMBRANE PROTEIN INSERTASE, MEMBRANE PROTEIN 
2nlj:A   (GLY128) to   (ASN212)  POTASSIUM CHANNEL KCSA(M96V)-FAB COMPLEX IN KCL  |   VOLTAGE-GATED CHANNEL, TRANSMEMBRANE, IONIC CHANNEL, ION TRANSPORT, K CHANNEL, PROTEIN-ANTIBODY FAB COMPLEX, MEMBRANE PROTEIN 
4o02:L   (GLY128) to   (ARG211)  ALPHAVBETA3 INTEGRIN IN COMPLEX WITH MONOCLONAL ANTIBODY FAB FRAGMENT.  |   PROTEIN BINDING 
1l0y:A   (GLN141) to   (TRP242)  T CELL RECEPTOR BETA CHAIN COMPLEXED WITH SUPERANTIGEN SPEA SOAKED WITH ZINC  |   TCR, SUPERANTIGEN, SPEA, IMMUNE SYSTEM 
1xf5:A   (GLY134) to   (ASN216)  COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (H74C, Y64W)IN SPACE GROUP P21212  |   CRYSTAL PACKING, FAB, PROTEIN L, PEPTIDE COMPLEX, IMMUNE SYSTEM 
1l6x:A   (SER254) to   (LYS338)  FC FRAGMENT OF RITUXIMAB BOUND TO A MINIMIZED VERSION OF THE B-DOMAIN FROM PROTEIN A CALLED Z34C  |   IGG1 FC, PROTEIN A, FC COMPLEX, B-DOMAIN, IMMUNE SYSTEM 
4o9h:L   (ASN131) to   (PRO211)  STRUCTURE OF INTERLEUKIN-6 IN COMPLEX WITH A CAMELID FAB FRAGMENT  |   IL6: ALL ALPHA PROTEIN, FAB: ALL BETA PROTEIN, IMMUNE SYSTEM 
2nx5:E   (GLN142) to   (TRP243)  CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A  |   TCR-PMHC, IMMUNE COMPLEX, IMMUNE SYSTEM 
2nx5:P   (GLN142) to   (ASP247)  CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A  |   TCR-PMHC, IMMUNE COMPLEX, IMMUNE SYSTEM 
2ny5:L  (GLY2130) to  (SER2210)  HIV-1 GP120 ENVELOPE GLYCOPROTEIN (M95W, W96C, I109C, T257S, V275C, S334A, S375W, Q428C, A433M) COMPLEXED WITH CD4 AND ANTIBODY 17B  |   HIV, GP120, ANTIBODY, CD4, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4odu:L   (GLY128) to   (ASN212)  UNLIGANDED FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY S1-15  |   CARBOHYDRATE BINDING, IMMUNE SYSTEM 
5cjq:L   (LYS129) to   (PRO208)  CRYSTAL STRUCTURE OF A TRIMERIC INFLUENZA HEMAGGLUTININ STEM IN COMPLEX WITH AN BROADLY NEUTRALIZING ANTIBODY CR9114  |   HEMAGGLUTININ, TRIMER, INFLUENZA, IMMUNOGEN, MONOCLONAL, ANTIBODY, NEUTRALIZING, INFLUENZA VACCINE, GLYCOPROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
1lk3:M   (GLY127) to   (ASN209)  ENGINEERED HUMAN INTERLEUKIN-10 MONOMER COMPLEXED TO 9D7 FAB FRAGMENT  |   ANTIGEN-ANTIBODY COMPLEX, IMMUNE SYSTEM 
4ofp:C   (ASN251) to   (GLY338)  CRYSTAL STRUCTURE OF SYG-2 D3-D4  |   IMMUNOGLOBULIN SUPERFAMILY, CELL ADHESION, SYNAPTOGENESIS, PROTEIN BINDING, N-LINKED GLYCOSYLATION, MEMBRANE, EXTRACELLULAR, SIGNALING PROTEIN 
2nz9:E   (ASN141) to   (ARG215)  CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY AR2  |   BOTULINUM, NEUROTOXIN, FAB, PROTEIN ANTIBODY COMPLEX, TOXIN-IMMUNE SYSTEM COMPLEX 
2z4q:A   (GLY133) to   (ASN217)  CRYSTAL STRUCTURE OF A MURINE ANTIBODY FAB 528  |   IMMUNE SYSTEM 
4oii:L   (GLY128) to   (ASN212)  WEST NILE VIRUS NS1 IN COMPLEX WITH NEUTRALIZING 22NS1 ANTIBODY FAB  |   WEST NILE VIRUS, ANTIBODY, FAB, NEUTRALIZING, FLAVIVIRUS, NON- STRUCTURAL PROTEIN, NS1, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, STRUCTURAL GENOMICS, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID 
4oii:M   (GLY128) to   (ASN212)  WEST NILE VIRUS NS1 IN COMPLEX WITH NEUTRALIZING 22NS1 ANTIBODY FAB  |   WEST NILE VIRUS, ANTIBODY, FAB, NEUTRALIZING, FLAVIVIRUS, NON- STRUCTURAL PROTEIN, NS1, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, STRUCTURAL GENOMICS, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID 
2o26:X    (LEU54) to   (ARG113)  STRUCTURE OF A CLASS III RTK SIGNALING ASSEMBLY  |   STEM CELL FACTOR, RECEPTOR TYROSINE KINASE, CLASS III, RECEPTOR- LIGAND COMPLEX, GROWTH FACTOR, CYTOKINE, 4-HELIX BUNDLE, CYTOKINE- SIGNALING PROTEIN COMPLEX 
2o26:U    (LEU54) to   (ARG113)  STRUCTURE OF A CLASS III RTK SIGNALING ASSEMBLY  |   STEM CELL FACTOR, RECEPTOR TYROSINE KINASE, CLASS III, RECEPTOR- LIGAND COMPLEX, GROWTH FACTOR, CYTOKINE, 4-HELIX BUNDLE, CYTOKINE- SIGNALING PROTEIN COMPLEX 
2o26:W    (LEU54) to   (PHE111)  STRUCTURE OF A CLASS III RTK SIGNALING ASSEMBLY  |   STEM CELL FACTOR, RECEPTOR TYROSINE KINASE, CLASS III, RECEPTOR- LIGAND COMPLEX, GROWTH FACTOR, CYTOKINE, 4-HELIX BUNDLE, CYTOKINE- SIGNALING PROTEIN COMPLEX 
1lo0:X   (GLY133) to   (ASN215)  CATALYTIC RETRO-DIELS-ALDERASE TRANSITION STATE ANALOGUE COMPLEX  |   CATALYTIC ANTIBODY, FAB FRAGMENT, IMMUNE SYSTEM 
5cp7:G   (GLY133) to   (ASN215)  CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT OF MONOCLONAL ANTIBODY AGAINST SULFONAMIDES  |   ANTIGEN-BINDING FRAGMENT, ANTI-SULFONAMIDES ANTIBODY, IMMUNE SYSTEM 
2z91:D   (GLY128) to   (ASN210)  CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9  |   IMMUNOGLOBRIN FOLD, IMMUNE SYSTEM 
2o5y:L   (ASN137) to   (ARG211)  CRYSTAL STRUCTURE OF THE 1E9 LEUH47TRP/ARGH100TRP FAB PROGESTERONE COMPLEX  |   IMMUNOGLOBULIN, CHIMERIC FAB, ANTIBODY ENGINEERING, EVOLUTION OF LIGAND RECOGNITION, IMMUNE SYSTEM 
2o5z:L   (GLY128) to   (SER208)  CRYSTAL STRUCTURE OF THE 1E9 LEUH47TRP/ARGH100TRP FAB 5-BETA- ANDROSTANE-3,17-DIONE COMPLEX  |   IMMUNOGLOBULIN, CHIMERIC FAB, ANTIBODY ENGINEERING, EVOLUTION OF LIGAND RECOGNITION, IMMUNE SYSTEM 
2zcl:L   (GLY128) to   (ASN210)  CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN COMPLEXED WITH AN ACTIVATING ANTIBODY  |   HUMAN PSA, ANTIBODIES, KALLIKREIN RELATED PEPTIDASES, PROSTATE CANCER, GLYCOPROTEIN, HYDROLASE, PROTEASE, SECRETED, SERINE PROTEASE, ZYMOGEN, IMMUNE SYSTEM 
2zjs:L   (GLY128) to   (ASN210)  CRYSTAL STRUCTURE OF SECYE TRANSLOCON FROM THERMUS THERMOPHILUS WITH A FAB FRAGMENT  |   TRANSLOCON, SEC, PROTEIN-CONDUCTING-CHANNEL, MEMBRANE, PROTEIN TRANSPORT, TRANSLOCATION, TRANSMEMBRANE, TRANSPORT, PROTEIN TRANSPORT-IMMUNE SYSTEM COMPLEX 
4org:L   (ASN128) to   (PRO208)  CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.04, A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY  |   FAB, HIV-1, V1V2, CAP256, VRC26, IMMUNE SYSTEM 
4acp:A   (VAL259) to   (SER337)  DEACTIVATION OF HUMAN IGG1 FC BY ENDOGLYCOSIDASE TREATMENT  |   IMMUNE SYSTEM, IGG, ANTIBODY, KIFUNENSINE 
4acp:B   (VAL259) to   (LYS338)  DEACTIVATION OF HUMAN IGG1 FC BY ENDOGLYCOSIDASE TREATMENT  |   IMMUNE SYSTEM, IGG, ANTIBODY, KIFUNENSINE 
1mce:B   (ASN132) to   (ALA211)  PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS  |   IMMUNOGLOBULIN 
1mci:B   (LYS133) to   (PRO212)  PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS  |   IMMUNOGLOBULIN, IMMUNE SYSTEM 
1mck:A   (ASN132) to   (PRO212)  PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS  |   IMMUNOGLOBULIN 
1mco:H   (GLY143) to   (ASP212)  THREE-DIMENSIONAL STRUCTURE OF A HUMAN IMMUNOGLOBULIN WITH A HINGE DELETION  |   IMMUNOGLOBULIN 
1mcr:A   (ASN132) to   (PRO212)  PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS  |   IMMUNOGLOBULIN 
4ozg:F   (LYS153) to   (ALA256)  D2 PROTEIN COMPLEX  |   IMMUNE RECEPTOR-LIGAND COMPLEX, IMMUNE SYSTEM 
4ozg:H   (GLN152) to   (ALA256)  D2 PROTEIN COMPLEX  |   IMMUNE RECEPTOR-LIGAND COMPLEX, IMMUNE SYSTEM 
4ozf:H   (GLN152) to   (ALA256)  JR5.1 PROTEIN COMPLEX  |   IMMUNE RECEPTOR-LIGAND COMPLEX, IMMUNE SYSTEM 
4ozi:F   (THR159) to   (ALA254)  S2 PROTEIN COMPLEX  |   IMMUNE RECEPTOR-LIGAND COMPLEX, IMMUNE SYSTEM 
4ozi:H   (GLN150) to   (ALA254)  S2 PROTEIN COMPLEX  |   IMMUNE RECEPTOR-LIGAND COMPLEX, IMMUNE SYSTEM 
1mhp:L   (GLY127) to   (ASN209)  CRYSTAL STRUCTURE OF A CHIMERIC ALPHA1 INTEGRIN I-DOMAIN IN COMPLEX WITH THE FAB FRAGMENT OF A HUMANIZED NEUTRALIZING ANTIBODY  |   INTEGRIN, CELL ADHESION, RECEPTOR, ANTIBODY, IMMUNE SYSTEM 
4aeh:L   (GLY128) to   (ASN210)  CRYSTAL STRUCTURE OF THE ANTI-AAHI FAB9C2 ANTIBODY  |   IMMUNE SYSTEM, ANDROCTONUS, ALPHA-TOXIN, COMBINING SITE, EPITOPE, PHARMACOLOGICAL SITE, VENOM, VOLTAGE- ACTIVATED SODIUM CHANNEL, SCORPION 
4p2r:E   (LYS140) to   (TRP240)  CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C1/I-EK  |   T CELL RECEPTOR, PEPTIDE-MHC COMPLEX, IMMUNE SYSTEM 
4p2r:J   (GLN139) to   (TRP240)  CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C1/I-EK  |   T CELL RECEPTOR, PEPTIDE-MHC COMPLEX, IMMUNE SYSTEM 
4p2r:O   (GLN139) to   (TRP240)  CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C1/I-EK  |   T CELL RECEPTOR, PEPTIDE-MHC COMPLEX, IMMUNE SYSTEM 
4p46:B   (GLN135) to   (GLY237)  J809.B5 Y31A TCR BOUND TO IAB3K  |   TCR MHCII, IMMUNE SYSTEM 
4p5t:B   (GLN135) to   (GLY237)  14.C6 TCR COMPLEXED WITH MHC CLASS II I-AB/3K PEPTIDE  |   MHC, TCR, IMMUNE RECEPTOR, IG-LIKE DOMAIN, IMMUNE SYSTEM 
4p5t:F   (GLN135) to   (GLY237)  14.C6 TCR COMPLEXED WITH MHC CLASS II I-AB/3K PEPTIDE  |   MHC, TCR, IMMUNE RECEPTOR, IG-LIKE DOMAIN, IMMUNE SYSTEM 
5d4q:A   (SER254) to   (SER337)  CRYSTAL STRUCTURE OF GASDALIE IGG1 FC  |   ADCC, IGG FC, IMMUNE SYSTEM 
5d5m:F   (GLN139) to   (GLY241)  STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT M33.64 TCR  |   ANTIGEN, IMMUNE SYSTEM 
5d5m:H   (GLN139) to   (ALA243)  STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT M33.64 TCR  |   ANTIGEN, IMMUNE SYSTEM 
5d6d:A   (SER254) to   (SER337)  CRYSTAL STRUCTURE OF GASDALIE IGG1 FC IN COMPLEX WITH FCGRIIIA  |   ADCC, IMMUNE SYSTEM, IGG 
5d6d:B   (SER254) to   (SER337)  CRYSTAL STRUCTURE OF GASDALIE IGG1 FC IN COMPLEX WITH FCGRIIIA  |   ADCC, IMMUNE SYSTEM, IGG 
3kr3:L   (GLY129) to   (SER209)  CRYSTAL STRUCTURE OF IGF-II ANTIBODY COMPLEX  |   ANTIBODY-TARGET COMPLEX, CARBOHYDRATE METABOLISM, GLUCOSE METABOLISM, GLYCOPROTEIN, GROWTH FACTOR, HORMONE, MITOGEN, OSTEOGENESIS, SECRETED, IMMUNE SYSTEM 
5d7i:H   (GLN139) to   (ALA243)  STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT M33.64 TCR  |   ANTIGEN, RECEPTOR, IMMUNE SYSTEM 
5d7i:F   (GLN139) to   (ALA243)  STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT M33.64 TCR  |   ANTIGEN, RECEPTOR, IMMUNE SYSTEM 
5d7j:H   (GLN139) to   (ALA243)  STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT M33.64(Y95ALPHAF) TCR  |   RECEPTOR, ANTIGEN, IMMUNE SYSTEM 
5d7l:E   (GLN138) to   (GLY240)  STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAV36 TCR  |   RECEPTOR, ANTIGEN, IMMUNE SYSTEM 
1yed:L   (GLY131) to   (ASN213)  STRUCTURE OF A CATALYTIC ANTIBODY IGG2A FAB FRAGMENT (D2.4)  |   CATALYTIC ANTIBODY, TRANSITION STATE ANALOGUE 
1yed:A   (GLY131) to   (ASN213)  STRUCTURE OF A CATALYTIC ANTIBODY IGG2A FAB FRAGMENT (D2.4)  |   CATALYTIC ANTIBODY, TRANSITION STATE ANALOGUE 
1yek:L   (GLY128) to   (ASN212)  CATALYTIC ANTIBODY D2.3 COMPLEX  |   ABZYME, REACTION PRODUCT, IMMUNE SYSTEM 
5dd1:L   (GLY128) to   (SER208)  CRYSTAL STRUCTURES IN AN ANTI-HIV ANTIBODY LINEAGE FROM IMMUNIZATION OF RHESUS MACAQUES  |   HIV HIV-1 GP41 MPER ANTIBODY, IMMUNE SYSTEM 
5dd3:L   (GLY128) to   (SER208)  CRYSTAL STRUCTURES IN AN ANTI-HIV ANTIBODY LINEAGE FROM IMMUNIZATION OF RHESUS MACAQUES  |   HIV HIV-1 GP41 MPER ANTIBODY, IMMUNE SYSTEM 
3kyk:L   (GLY128) to   (SER208)  CRYSTAL STRUCTURE OF LI33 IGG1 FAB  |   ANTIBODY, IMMUNE SYSTEM 
3kym:A   (GLY128) to   (GLU213)  CRYSTAL STRUCTURE OF LI33 IGG2 DI-FAB  |   IGG2 MONOCLONAL ANTI-LINGO, IMMUNE SYSTEM 
3kym:E   (GLY128) to   (GLY212)  CRYSTAL STRUCTURE OF LI33 IGG2 DI-FAB  |   IGG2 MONOCLONAL ANTI-LINGO, IMMUNE SYSTEM 
3kym:G   (GLY128) to   (SER208)  CRYSTAL STRUCTURE OF LI33 IGG2 DI-FAB  |   IGG2 MONOCLONAL ANTI-LINGO, IMMUNE SYSTEM 
4pj7:H   (GLN137) to   (GLY239)  STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT TRBV6-4 TCR  |   MR1, TCR, IMMUNE COMPLEX, 5-OP-RU, IMMUNE SYSTEM 
5di8:A   (SER254) to   (LYS338)  FC KNOB-HOLE HETERODIMER T366W + T366S/L368A/Y407V  |   HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM 
4pjf:H   (GLN139) to   (GLY241)  STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-C10 TCR  |   MR1, TCR, IMMUNE COMPLEX, AC-6-FP, IMMUNE SYSTEM 
4pjg:H   (GLN139) to   (GLY241)  STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-F3-C1 TCR  |   MR1, TCR, IMMUNE COMPLEX, AC-6-FP, IMMUNE SYSTEM 
4pji:H   (GLN138) to   (GLY240)  STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT C-C10 TCR  |   MR1, TCR, IMMUNE COMPLEX, AC-6-FP, IMMUNE SYSTEM 
5dj0:A   (SER254) to   (LYS338)  FC HETERODIMER DESIGN 11.2 Y349S/K370Y + E357D/S364Q  |   HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM 
5dj2:A   (SER254) to   (LYS338)  FC HETERODIMER DESIGN 7.4 Y407A + T366V/K409V  |   HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM 
5dj2:B   (SER254) to   (LYS338)  FC HETERODIMER DESIGN 7.4 Y407A + T366V/K409V  |   HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM 
5dj6:A   (SER254) to   (LYS338)  FC HETERODIMER DESIGN 6.1 F405W/Y407A + T366M  |   HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM 
5dj6:B   (SER254) to   (LYS338)  FC HETERODIMER DESIGN 6.1 F405W/Y407A + T366M  |   HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM 
5dj8:A   (SER254) to   (LYS338)  FC HETERODIMER DESIGN 7.7 D399M/Y407A + T366V/K409I  |   HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM 
5dj8:B   (VAL259) to   (LYS338)  FC HETERODIMER DESIGN 7.7 D399M/Y407A + T366V/K409I  |   HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM 
5dja:B   (CYS261) to   (LYS338)  FC HETERODIMER DESIGN 9.1 Y407M + T366I  |   HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM 
5djd:A   (SER254) to   (LYS338)  FC HETERODIMER DESIGN 5.1 T366V + Y407F  |   HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM 
5djx:A   (SER254) to   (SER337)  FC HETERODIMER DESIGN 2.9 L368M/K370E + E357A/S364G  |   HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM 
5djx:B   (SER254) to   (LYS338)  FC HETERODIMER DESIGN 2.9 L368M/K370E + E357A/S364G  |   HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM 
5djx:D   (SER254) to   (LYS338)  FC HETERODIMER DESIGN 2.9 L368M/K370E + E357A/S364G  |   HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM 
5djx:E   (SER254) to   (LYS338)  FC HETERODIMER DESIGN 2.9 L368M/K370E + E357A/S364G  |   HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM 
5dk3:G   (SER254) to   (LYS338)  CRYSTAL STRUCTURE OF PEMBROLIZUMAB, A FULL LENGTH IGG4 ANTIBODY  |   CANCER, ANTIBODY, SUBCLASSES, IGG4, MELANOMA, IMMUNE SYSTEM 
5dk0:B   (SER254) to   (LYS338)  FC HETERODIMER DESIGN 20.8.34 Y349S/T366M/K370Y/K409V + E356G/E357D/S364Q/Y407A  |   HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM 
5dk2:A   (SER254) to   (LYS338)  FC HETERODIMER E356K/D399K + K392D/K409D  |   HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM 
5dk2:B   (SER254) to   (LYS338)  FC HETERODIMER E356K/D399K + K392D/K409D  |   HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM 
5dk2:E   (SER254) to   (LYS338)  FC HETERODIMER E356K/D399K + K392D/K409D  |   HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM 
3agv:A   (SER254) to   (LYS338)  CRYSTAL STRUCTURE OF A HUMAN IGG-APTAMER COMPLEX  |   IGG, RNA APTAMER, IMMUNE SYSTEM-RNA COMPLEX 
3agv:B   (SER254) to   (LYS338)  CRYSTAL STRUCTURE OF A HUMAN IGG-APTAMER COMPLEX  |   IGG, RNA APTAMER, IMMUNE SYSTEM-RNA COMPLEX 
5dmg:D  (GLY2020) to  (SER2100)  X-RAY STRUCTURE OF THE FAB FRAGMENT OF THE ANTI TAU ANTIBODY RB86 IN COMPLEX WITH THE PHOSPHORYLATED TAU PEPTIDE (416-430)  |   ANTIBODY, FAB FRAGMENT, TAU PROTEIN, TAU-PSER422, TAU-PSER422 COMPLEX, IMMUNE SYSTEM 
3l95:L   (ASN137) to   (ASN210)  CRYSTAL STRUCTURE OF THE HUMAN NOTCH1 NEGATIVE REGULATORY REGION (NRR) BOUND TO THE FAB FRAGMENT OF AN ANTAGONIST ANTIBODY  |   NRR, FAB FRAGMENT, ANTIBODY, ALPHA-BETA-SANDWICH, SEA DOMAIN, LNR, LIN12 NOTCH CYSTEINE-RICH, HD DOMAIN, CELL CYCLE, SIGNALING PROTEIN, ACTIVATOR, ANK REPEAT, CELL MEMBRANE, DEVELOPMENTAL PROTEIN, DIFFERENTIATION, EGF-LIKE DOMAIN, GLYCOPROTEIN, MEMBRANE, METAL- BINDING, NOTCH SIGNALING PATHWAY, IMMUNE SYSTEM 
4am0:B   (GLY128) to   (ASN212)  STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12  |   VIRAL PROTEIN, ANTIBODY, NEUTRALISATION 
4am0:L   (GLY128) to   (ASN212)  STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12  |   VIRAL PROTEIN, ANTIBODY, NEUTRALISATION 
4prh:E   (GLN149) to   (GLY251)  CRYSTAL STRUCTURE OF TK3 TCR-HLA-B*35:08-HPVG-D5 COMPLEX  |   HUMAN LEUKOCYTE ANTIGEN CLASS I, EPSTEIN-BARR VIRUS, VIRAL ESCAPE, T CELL RECEPTOR, VIRAL IMMUNITY, IMMUNE SYSTEM 
5ds8:B   (GLY128) to   (ARG208)  CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU98 IN COMPLEX WITH HYPUSINE  |   HYPUSINE, ANTIBODY, FABHPU98, EIF5A, IMMUNE SYSTEM 
5dsc:B   (GLY128) to   (ASN207)  CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU24.B IN COMPLEX WITH HYPUSINE  |   HYPUSINE, ANTIBODY, FABHPU24.B, EIF5A, IMMUNE SYSTEM 
5dsc:D   (GLY128) to   (ASN207)  CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU24.B IN COMPLEX WITH HYPUSINE  |   HYPUSINE, ANTIBODY, FABHPU24.B, EIF5A, IMMUNE SYSTEM 
5dsc:L   (GLY128) to   (ASN207)  CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU24.B IN COMPLEX WITH HYPUSINE  |   HYPUSINE, ANTIBODY, FABHPU24.B, EIF5A, IMMUNE SYSTEM 
1zea:L   (GLY128) to   (ARG211)  STRUCTURE OF THE ANTI-CHOLERA TOXIN ANTIBODY FAB FRAGMENT TE33 IN COMPLEX WITH A D-PEPTIDE  |   POLYSPECIFICITY, CROSS-REACTIVITY, ANTI-CHOLERA TOXIN, ANTIGEN-ANTIBODY COMPLEX, ANTIGEN RECOGNITION, SUBSTITUTION MATRIX, IMMUNE SYSTEM 
5dub:B   (GLY128) to   (ASN207)  CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU98 IN COMPLEX WITH DEOXYHYPUSINE  |   DEOXYHYPUSINE, ANTIBODY, FABHPU98, EIF5A, IMMUNE SYSTEM 
5dub:L   (GLY128) to   (ARG208)  CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU98 IN COMPLEX WITH DEOXYHYPUSINE  |   DEOXYHYPUSINE, ANTIBODY, FABHPU98, EIF5A, IMMUNE SYSTEM 
5dvk:A   (SER254) to   (SER337)  FC DESIGN 7.7 B CHAIN HOMODIMER T366V/K409I  |   HEAD-TO-TAIL HOMODIMER, IMMUNOGLOBULIN, FC, IMMUNE SYSTEM 
5dvo:A   (SER254) to   (LYS338)  FC K392D/K409D HOMODIMER  |   HEAD-TO-TAIL HOMODIMER, IMMUNOGLOBULIN, FC, IMMUNE SYSTEM 
5dvo:B   (SER254) to   (LYS338)  FC K392D/K409D HOMODIMER  |   HEAD-TO-TAIL HOMODIMER, IMMUNOGLOBULIN, FC, IMMUNE SYSTEM 
3lrs:L   (ASN128) to   (ALA207)  STRUCTURE OF PG16, AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1  |   NEUTRALIZING ANTIBODIES, LONG CDRH3, HIV-1, IMMUNE SYSTEM 
3lrs:F   (ASN128) to   (ALA207)  STRUCTURE OF PG16, AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1  |   NEUTRALIZING ANTIBODIES, LONG CDRH3, HIV-1, IMMUNE SYSTEM 
1ztx:L   (GLY128) to   (ASN210)  WEST NILE VIRUS ENVELOPE PROTEIN DIII IN COMPLEX WITH NEUTRALIZING E16 ANTIBODY FAB  |   ANTIBODY, FAB, NEUTRALIZING, VIRUS, ENVELOPE, VIRAL PROTEIN/IMMUNE SYSTEM COMPLEX 
4q6i:D   (GLY128) to   (ASN210)  CRYSTAL STRUCTURE OF MURINE 2D5 FAB, A POTENT ANTI-CD4 HIV-1- NEUTRALIZING ANTIBODY IN COMPLEX WITH CD4  |   IG FOLD, ANTIBODY, ANTI-CD4, HIV-1 NEUTRALIZATION, CD4, IMMUNE SYSTEM 
4q6y:A   (SER254) to   (LYS338)  CRYSTAL STRUCTURE OF A CHEMOENZYMATIC GLYCOENGINEERED DISIALYLATED FC (DI-SFC)  |   IMMUNE SYSTEM 
4q6y:B   (SER254) to   (LYS338)  CRYSTAL STRUCTURE OF A CHEMOENZYMATIC GLYCOENGINEERED DISIALYLATED FC (DI-SFC)  |   IMMUNE SYSTEM 
4q6y:C   (ASN361) to   (LEU443)  CRYSTAL STRUCTURE OF A CHEMOENZYMATIC GLYCOENGINEERED DISIALYLATED FC (DI-SFC)  |   IMMUNE SYSTEM 
4q6y:D   (SER254) to   (SER337)  CRYSTAL STRUCTURE OF A CHEMOENZYMATIC GLYCOENGINEERED DISIALYLATED FC (DI-SFC)  |   IMMUNE SYSTEM 
5e6i:H   (LYS138) to   (TRP238)  CRYSTAL STRUCTURE OF TCR PF8 IN COMPLEX WITH FLU MP(58-66) EPITOPE PRESENTED BY HLA-A2  |   IMMUNE SYSTEM, TCR, HLA-A2, FLU, COMPLEX 
4q74:A   (ARG255) to   (LYS338)  F241A FC  |   IMMUNE SYSTEM 
4q74:B   (SER254) to   (LYS338)  F241A FC  |   IMMUNE SYSTEM 
4q7d:A   (THR260) to   (LYS338)  WILD TYPE FC (WTFC)  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
4q7d:B   (SER254) to   (SER337)  WILD TYPE FC (WTFC)  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
4q9b:A   (SER262) to   (LYS342)  IGNAR ANTIBODY DOMAIN C2  |   PROTEIN EVOLUTION, ANTIBODY STRUCTURE, PROTEIN FOLDING, IMMUNE SYSTEM 
4q9c:A   (SER366) to   (ASN448)  IGNAR ANTIBODY DOMAIN C3  |   PROTEIN EVOLUTION, ANTIBODY STRUCTURE, PROTEIN FOLDING, IMMUNE SYSTEM 
3ave:A   (SER254) to   (LYS338)  CRYSTAL STRUCTURE OF THE FUCOSYLATED FC FRAGMENT FROM HUMAN IMMUNOGLOBULIN G1  |   IMMUNOGLOBULIN, IGG1, IMMUNE SYSTEM, IMMUNOGLOBULIN-LIKE BETA- SANDWICH 
3ave:B   (SER254) to   (LYS338)  CRYSTAL STRUCTURE OF THE FUCOSYLATED FC FRAGMENT FROM HUMAN IMMUNOGLOBULIN G1  |   IMMUNOGLOBULIN, IGG1, IMMUNE SYSTEM, IMMUNOGLOBULIN-LIKE BETA- SANDWICH 
5e94:A   (ASN137) to   (ASN210)  ANTIBODY-BOUND GLUCAGON-LIKE PEPTIDE-1 RECEPTOR EXTRACELLULAR DOMAIN  |   ANTIBODY ANTAGONIST GLP-1 RECEPTOR, IMMUNE SYSTEM, MEMBRANE PROTEIN 
3ay4:A   (SER254) to   (LYS338)  CRYSTAL STRUCTURE OF NONFUCOSYLATED FC COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA  |   IMMUNE SYSTEM, COMPLEX, FC FRAGMENT, IGG, RECEPTOR, CD16, GAMMA 
3ay4:B   (SER254) to   (LYS338)  CRYSTAL STRUCTURE OF NONFUCOSYLATED FC COMPLEXED WITH BIS-GLYCOSYLATED SOLUBLE FORM OF FC GAMMA RECEPTOR IIIA  |   IMMUNE SYSTEM, COMPLEX, FC FRAGMENT, IGG, RECEPTOR, CD16, GAMMA 
4qex:L   (GLY128) to   (ARG209)  CRYSTAL STRUCTURE OF PFEBA-175 RII IN COMPLEX WITH A FAB FRAGMENT FROM INHIBITORY ANTIBODY R217  |   DUFFY BINDING LIKE (DBL) DOMAIN, IMMUNOGLOBULIN DOMAIN, INVASION, ADHESION, IMMUNITY, PFEBA-175, ANTIBODY, CELL SURFACE, EXTRECELLULAR, CELL ADHESION, RECEPTOR, LIGAND, IMMUNE SYSTEM 
4qex:M   (GLY128) to   (ARG209)  CRYSTAL STRUCTURE OF PFEBA-175 RII IN COMPLEX WITH A FAB FRAGMENT FROM INHIBITORY ANTIBODY R217  |   DUFFY BINDING LIKE (DBL) DOMAIN, IMMUNOGLOBULIN DOMAIN, INVASION, ADHESION, IMMUNITY, PFEBA-175, ANTIBODY, CELL SURFACE, EXTRECELLULAR, CELL ADHESION, RECEPTOR, LIGAND, IMMUNE SYSTEM 
2a6j:A   (GLY128) to   (ASN210)  CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-ARSONATE GERMLINE ANTIBODY 36- 65  |   GERMLINE, IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
4qhk:P   (ASN128) to   (ALA207)  UCA (UNBOUND) FROM CH103 LINEAGE  |   FAB FRAGMENT, HIV-1, ANTIBODY, IMMUNE SYSTEM 
4qhl:D   (ASN128) to   (PRO208)  I3.2 (UNBOUND) FROM CH103 LINEAGE  |   FAB FRAGMENT, HIV-1, ANTIBODY, IMMUNE SYSTEM 
4qhu:A   (ASN130) to   (ALA209)  CRYSTAL STRUCTURE OF IL-17A/FAB6785 COMPLEX  |   ANTIBODY-ANTIGEN INTERACTION, RECEPTOR DIFFERENTIATION, MOLECULAR ASYMMETRY, CYSTINE KNOT, CYTOKINE IL-17, IL-17RA, IL-17RC, IMMUNE SYSTEM 
3mcg:2   (THR135) to   (ALA211)  THREE-DIMENSIONAL STRUCTURE OF A LIGHT CHAIN DIMER CRYSTALLIZED IN WATER. CONFORMATIONAL FLEXIBILITY OF A MOLECULE IN TWO CRYSTAL FORMS  |   IMMUNOGLOBULIN 
3mff:B   (GLN139) to   (SER243)  1F1E8HU TCR  |   T-CELL RECEPTOR, PROTEIN METAMORPHISM, ALPHA CONSTANT DOMAIN, IMMUNE SYSTEM 
3mff:D   (LYS140) to   (GLY241)  1F1E8HU TCR  |   T-CELL RECEPTOR, PROTEIN METAMORPHISM, ALPHA CONSTANT DOMAIN, IMMUNE SYSTEM 
4qnp:L   (GLY127) to   (ASN209)  CRYSTAL STRUCTURE OF THE 2009 PANDEMIC H1N1 INFLUENZA VIRUS NEURAMINIDASE WITH A NEUTRALIZING ANTIBODY  |   INFLUENZA, NEURAMINIDASE, ANTIBODY, NEUTRALIZING ANTIBODY, HYDROLASE- IMMUNE SYSTEM COMPLEX 
3b9k:L   (GLY128) to   (ARG211)  CRYSTAL STRUCTURE OF CD8ALPHA-BETA IN COMPLEX WITH YTS 156.7 FAB  |   IMMUNOGLOBULIN DOMAIN, V-SET, IGSF DIMER, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, TRANSMEMBRANE, IMMUNE SYSTEM 
3b9k:C   (GLY128) to   (ARG211)  CRYSTAL STRUCTURE OF CD8ALPHA-BETA IN COMPLEX WITH YTS 156.7 FAB  |   IMMUNOGLOBULIN DOMAIN, V-SET, IGSF DIMER, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, TRANSMEMBRANE, IMMUNE SYSTEM 
3mj8:L   (ASN128) to   (PRO211)  CRYSTAL STRUCTURE OF HL4E10 FAB, A HAMSTER AB STIMULATORY FOR GAMMADELTA T CELLS  |   ANTIBODY, HAMSTER IGG, IMMUNE SYSTEM 
5eor:L   (ASN138) to   (PRO217)  STRUCTURE OF THE MURINE ANTIBODY FAB 8E3 BOUND TO THE VACCINIA VIRUS A27 PEPTIDE 101-110  |   ANTIBODY, FAB, VACCINIA VIRUS, NEUTRALIZING, LINEAR EPITOPE, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
3mls:L   (ASN132) to   (PRO212)  CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 MAB 2557 FAB IN COMPLEX WITH A HIV- 1 GP120 V3 MIMOTOPE  |   HUMAN MONOCLONAL ANTIBODY, FAB, HIV-1, GP120, THIRD VARIABLE LOOP, ANTIBODY-ANTIGEN INTERACTION, MIMOTOPE, IMMUNE SYSTEM 
3mlt:A   (ASN132) to   (PRO212)  CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A UG1033 V3 PEPTIDE  |   HUMAN MONOCLONAL ANTIBODY, FAB, HIV-1, GP120, THIRD VARIABLE LOOP, ANTIBODY-ANTIGEN INTERACTION, IMMUNE SYSTEM 
3mly:I   (GLY134) to   (PRO213)  CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 3074 IN COMPLEX WITH A UR29 V3 PEPTIDE  |   HUMAN MONOCLONAL ANTIBODY, FAB, HIV-1, GP120, THIRD VARIABLE LOOP, ANTIBODY-ANTIGEN INTERACTION, IMMUNE SYSTEM 
4qrp:I   (LYS153) to   (GLY254)  CRYSTAL STRUCTURE OF HLA B*0801 IN COMPLEX WITH HSKKKCDEL AND DD31 TCR  |   HLA B*0801, HUAMN HEPATITIS C VIRUS, TCR, T CELL, IMMUNE SYSTEM 
4qrr:E   (GLY162) to   (GLY254)  CRYSTAL STRUCTURE OF HLA B*3501-IPS IN COMPLEX WITH A DELTA-BETA TCR, CLONE 12 TCR  |   HLA B*3501, HUAMN CMV, TCR, T CELL, IMMUNE SYSTEM 
3mob:L   (GLY128) to   (SER208)  CRYSTAL STRUCTURE OF THE NEUTRALIZING HIV ANTIBODY 2F5 FAB FRAGMENT (RECOMBINANTLY PRODUCED FAB) WITH 11 AA GP41 MPER-DERIVED PEPTIDE  |   HIV-1, HIV GP41 MPER, 13H11, 2F5, Z13, 4E10, FAB ANTIBODY, IMMUNE SYSTEM 
4qti:L   (GLY128) to   (ASN210)  CRYSTAL STRUCTURE OF HUMAN UPAR IN COMPLEX WITH ANTI-UPAR FAB 8B12  |   ALLOSTERIC REGULATION, CELL SURFACE, IMMUNE SYSTEM 
4bjl:A   (ASN132) to   (PRO212)  LOCW, A LAMBDA 1 TYPE LIGHT-CHAIN DIMER (BENCE-JONES PROTEIN) CRYSTALLIZED IN DISTILLED WATER  |   BENCE JONES, ANTIBODY, MULTIPLE QUATERNARY STRUCTURES, IMMUNOGLOBULIN 
5ewi:L   (GLY128) to   (SER208)  CRYSTAL STRUCTURE OF THE HUMAN FAB VRC38.01, AN HIV-1 V1V2-DIRECTED NEUTRALIZING ANTIBODY ISOLATED FROM DONOR N90  |   FAB, HIV-1, V1V2, ENV, ANTIBODY, ENVELOPE, NEUTRALIZING, IMMUNE SYSTEM 
3muh:L   (ASN128) to   (PRO211)  CRYSTAL STRUCTURE OF PG9 LIGHT CHAIN  |   PG9, HIV, IMMUNE SYSTEM 
4bm7:A   (ARG255) to   (LYS338)  CRYSTAL STRUCTURE OF IGG FC F241A MUTANT WITH NATIVE GLYCOSYLATION  |   IMMUNE SYSTEM, GLYCAN 
4bm7:B   (ARG255) to   (LYS338)  CRYSTAL STRUCTURE OF IGG FC F241A MUTANT WITH NATIVE GLYCOSYLATION  |   IMMUNE SYSTEM, GLYCAN 
3bn9:E   (ASN137) to   (ARG211)  CRYSTAL STRUCTURE OF MT-SP1 IN COMPLEX WITH FAB INHIBITOR E2  |   ANTIBODY-PROTEASE COMPLEX, PROTEIN-PROTEIN COMPLEX, ENZYME- INHIBITOR COMPLEX, DISEASE MUTATION, GLYCOPROTEIN, HYDROLASE, MEMBRANE, POLYMORPHISM, SERINE PROTEASE, SIGNAL- ANCHOR, TRANSMEMBRANE 
3mv9:E   (GLN149) to   (GLY251)  CRYSTAL STRUCTURE OF THE TK3-GLN55ALA TCR IN COMPLEX WITH HLA- B*3501/HPVG  |   HLA B*3501, EBV, TCR, TCRPMHC COMPLEX, HPVG, TCR POLYMORPHISM, IMMUNE SYSTEM 
3bt2:L   (GLY127) to   (ASN211)  STRUCTURE OF UROKINASE RECEPTOR, UROKINASE AND VITRONECTIN COMPLEX  |   PROTEIN-PROTEIN INTERACTION, GLYCOPROTEIN, GPI-ANCHOR, LIPOPROTEIN, MEMBRANE, RECEPTOR, SECRETED, BLOOD COAGULATION, EGF-LIKE DOMAIN, FIBRINOLYSIS, HYDROLASE, KRINGLE, PHOSPHOPROTEIN, PLASMINOGEN ACTIVATION, PROTEASE, SERINE PROTEASE, ZYMOGEN, CELL ADHESION, HEPARIN-BINDING, SULFATION, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
4bsw:A   (ARG255) to   (LYS338)  HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2  |   IMMUNE SYSTEM, BISPECIFIC, SCAFFOLD, ANTIBODY ENGINEERING, FC DOMAIN, IGG, IGG1, IMMUNOGLOBULIN G, ZYMEWORKS INC. 
4bsw:B   (SER254) to   (SER337)  HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2  |   IMMUNE SYSTEM, BISPECIFIC, SCAFFOLD, ANTIBODY ENGINEERING, FC DOMAIN, IGG, IGG1, IMMUNOGLOBULIN G, ZYMEWORKS INC. 
3c2a:M   (ASN128) to   (ALA210)  ANTIBODY FAB FRAGMENT 447-52D IN COMPLEX WITH UG1033 PEPTIDE  |   ANTIBODY FAB HIV-1 PEPTIDE, ENVELOPE PROTEIN, IMMUNE SYSTEM 
4r26:L   (ASP138) to   (PRO208)  CRYSTAL STRUCTURE OF HUMAN FAB PGT124, A BROADLY NEUTRALIZING AND POTENT HIV-1 NEUTRALIZING ANTIBODY  |   IMMUNE SYSTEM, IGG FOLD, ANTIBODY, HIV-1 BINDING 
4r4n:D   (ASN137) to   (ARG211)  CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C IN COMPLEX WITH HIV- 1 93UG037 GP120  |   HIV-1 ATTACHMENT GLYCOPROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM-INHIBITOR COMPLEX 
4r4n:O   (GLY128) to   (SER208)  CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C IN COMPLEX WITH HIV- 1 93UG037 GP120  |   HIV-1 ATTACHMENT GLYCOPROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM-INHIBITOR COMPLEX 
4r4n:U   (GLY128) to   (SER208)  CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C IN COMPLEX WITH HIV- 1 93UG037 GP120  |   HIV-1 ATTACHMENT GLYCOPROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM-INHIBITOR COMPLEX 
4r4n:X   (GLY128) to   (SER208)  CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C IN COMPLEX WITH HIV- 1 93UG037 GP120  |   HIV-1 ATTACHMENT GLYCOPROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM-INHIBITOR COMPLEX 
3c5z:B   (GLN135) to   (ASP240)  CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR B3K506  |   TCR-PMHC COMPLEX, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC II, TRANSMEMBRANE, SUGAR BINDING PROTEIN-IMMUNE SYSTEM COMPLEX 
3c5z:F   (GLN135) to   (TRP236)  CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR B3K506  |   TCR-PMHC COMPLEX, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC II, TRANSMEMBRANE, SUGAR BINDING PROTEIN-IMMUNE SYSTEM COMPLEX 
5fhc:L   (ASN137) to   (ASN210)  CRYSTAL STRUCTURE OF PROTECTIVE HUMAN ANTIBODIES 100 AND 114 IN COMPLEX WITH EBOLA VIRUS FUSION GLYCOPROTEIN (GP)  |   IG DOMAIN, FAB, IMMUNE SYSTEM, FUSION, EBOLA VIRUS, GLYCOPROTEIN, GP, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
3c6s:G   (GLY128) to   (ASN210)  CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG PENTADECASACCHARIDE  |   O-ANTIGEN, LPS, SHIGELLA FLEXNERI, ANTIBODY COMPLEX, IMMUNE SYSTEM 
4r7d:L   (GLY128) to   (SER208)  FAB HU 15C1  |   TLR4 ANTIBODY, IMMUNE SYSTEM 
4byh:A   (SER254) to   (LYS338)  CRYSTAL STRUCTURE OF SIALYLATED IGG FC  |   IMMUNE SYSTEM, ANTIBODY, SIALYATION, IMMUNOGLOBULIN 
4byh:B   (SER254) to   (LYS338)  CRYSTAL STRUCTURE OF SIALYLATED IGG FC  |   IMMUNE SYSTEM, ANTIBODY, SIALYATION, IMMUNOGLOBULIN 
4bz1:L   (GLY134) to   (ASN218)  STRUCTURE OF DENGUE VIRUS EDIII IN COMPLEX WITH FAB 3E31  |   IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, FUSION LOOP, VIRION 
4r7n:B   (GLY128) to   (ARG211)  FAB C2E3  |   TLR4 ANTIBODY, IMMUNE SYSTEM 
4r7n:F   (GLY128) to   (ARG211)  FAB C2E3  |   TLR4 ANTIBODY, IMMUNE SYSTEM 
4r7n:L   (GLY128) to   (SER208)  FAB C2E3  |   TLR4 ANTIBODY, IMMUNE SYSTEM 
4r7n:R   (GLY128) to   (ARG211)  FAB C2E3  |   TLR4 ANTIBODY, IMMUNE SYSTEM 
4r7n:T   (GLY128) to   (ARG211)  FAB C2E3  |   TLR4 ANTIBODY, IMMUNE SYSTEM 
3ngb:L   (ASN139) to   (ASN212)  CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 GP120  |   HIV, GP120, ANTIBODY, VRC01, NEUTRALIZATION, VACCINE, ENVELOPE GLYCOPROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4c54:A   (ARG255) to   (LYS338)  CRYSTAL STRUCTURE OF RECOMBINANT HUMAN IGG4 FC  |   IMMUNE SYSTEM, IMMUNOGLOBULIN, IGG1 
4c54:B   (SER254) to   (LYS338)  CRYSTAL STRUCTURE OF RECOMBINANT HUMAN IGG4 FC  |   IMMUNE SYSTEM, IMMUNOGLOBULIN, IGG1 
3nig:F   (GLY128) to   (ASN210)  THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING  |   INTEGRIN, HEADPIECE, ALPHAIIB, BETA3, CELL ADHESION-IMMUNE SYSTEM COMPLEX, CELL ADHESION-BLOOD CLOTTING COMPLEX 
4c55:A   (SER254) to   (LYS338)  CRYSTAL STRUCTURE OF SERUM-DERIVED HUMAN IGG4 FC  |   IMMUNE SYSTEM, IGG, ANTIBODY, IMMUNOGLOBULIN, IGG1 
4c55:B   (ARG255) to   (LYS338)  CRYSTAL STRUCTURE OF SERUM-DERIVED HUMAN IGG4 FC  |   IMMUNE SYSTEM, IGG, ANTIBODY, IMMUNOGLOBULIN, IGG1 
4c56:B   (GLN139) to   (GLY241)  X-RAY STRUCTURE OF THE COMPLEX BETWEEN STAPHYLOCOCCAL ENTEROTOXIN B, T CELL RECEPTOR AND MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II  |   IMMUNE SYSTEM-TOXIN COMPLEX 
4c56:H   (GLY149) to   (GLY241)  X-RAY STRUCTURE OF THE COMPLEX BETWEEN STAPHYLOCOCCAL ENTEROTOXIN B, T CELL RECEPTOR AND MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II  |   IMMUNE SYSTEM-TOXIN COMPLEX 
3ck0:L   (GLY127) to   (ARG210)  ANTI-ANTI-IDIOTYPIC ANTIBODY AGAINST HUMAN ANGIOTENSIN II, COMPLEX WITH HUMAN ANGIOTENSIN II  |   IMMUNOGLOBULIN, IMMUNE SYSTEM 
4c83:B   (GLY128) to   (ASN210)  CRYSTAL STRUCTURE OF THE IGG2A LPT3 IN COMPLEX WITH AN 8- SUGAR INNER CORE ANALOGUE OF NEISSERIA MENINGITIDIS  |   IMMUNE SYSTEM, LIPOOLIGOSACCHARIDES, ANTIBODIES, ANTIGEN-ANTIBODY COMPLEX 
4cdh:A    (SER35) to   (SER118)  CRYSTALLOGRAPHIC STRUCTURE OF THE HUMAN IGG1 ALPHA 2-6 SIALILATED FC-FRAGMENT  |   IMMUNE SYSTEM, C-LECTIN CRD, SIGN-R1, INMUNE SYSTEM, CAPSULAR POLYSACCHARIDE 
4cdh:B    (ARG36) to   (LYS119)  CRYSTALLOGRAPHIC STRUCTURE OF THE HUMAN IGG1 ALPHA 2-6 SIALILATED FC-FRAGMENT  |   IMMUNE SYSTEM, C-LECTIN CRD, SIGN-R1, INMUNE SYSTEM, CAPSULAR POLYSACCHARIDE 
5ftt:E    (ASN67) to   (ARG151)  OCTAMERIC COMPLEX OF LATROPHILIN 3 (LEC, OLF) , UNC5D (IG, IG2, TSP1) AND FLRT2 (LRR)  |   SIGNALING PROTEIN, SIGNALLING PROTEIN, LEUCINE-RICH REPEAT, LRR, UNC5, UNC5D, FLRT2, LPHN3, LPHN, ADGRL, ADGRL3, ADGR, GPCR, UNCOORDINATED-5, NETRIN RECEPTOR, FLRT, LATROPHILIN, ADHESION, REPULSION, GUIDANCE, BETA PROPELLER, IMMUNOGLOBULIN, THROMBOSPONDIN, OLFACTOMEDIN, LECTIN, OCTAMER 
4rqq:C   (GLY128) to   (SER208)  CRYSTAL STRUCTURE OF HUMAN FAB PGDM1400, A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY  |   IGG, ANTI-HIV-1 ANTIBODY, HIV-1 ENV TRIMER, IMMUNE SYSTEM 
4rrp:E   (ASN137) to   (ASN210)  CRYSTAL STRUCTURE OF THE FAB COMPLEXED WITH ANTIGEN ASF1P, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET PDR16  |   STRUCTURAL GENOMICS, PSI-BIOLOGY, PROTEIN STRUCTURE INITIATIVE, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, NESG, CHAPERONE-ENABLED STUDIES OF EPIGENETIC REGULATION ENZYMES, CEBS, IMMUNE SYSTEM 
4rrp:F   (GLY128) to   (ASN210)  CRYSTAL STRUCTURE OF THE FAB COMPLEXED WITH ANTIGEN ASF1P, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET PDR16  |   STRUCTURAL GENOMICS, PSI-BIOLOGY, PROTEIN STRUCTURE INITIATIVE, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, NESG, CHAPERONE-ENABLED STUDIES OF EPIGENETIC REGULATION ENZYMES, CEBS, IMMUNE SYSTEM 
3csy:F   (ASN137) to   (ARG211)  CRYSTAL STRUCTURE OF THE TRIMERIC PREFUSION EBOLA VIRUS GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY FROM A HUMAN SURVIVOR  |   GLYCOPROTEIN-ANTIBODY COMPLEX, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
3o0r:L   (GLY128) to   (ASN212)  CRYSTAL STRUCTURE OF NITRIC OXIDE REDUCTASE FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH ANTIBODY FRAGMENT  |   OXIDOREDUCTASE, ELECTRON TRANSPORT, HEME, IRON, MEMBRANE, CYTOPLASMIC MEMBRANE, IMMUNE SYSTEM-OXIDOREDUCTASE COMPLEX 
3o2w:L   (GLY128) to   (SER208)  CRYSTAL STRUCTURE OF THE 1E9 PHEL89SER/LEUH47TRP/METH100BPHE FAB IN COMPLEX WITH A 39A11 TRANSITION STATE ANALOG  |   IGG ANTIBODY FAB, IMMUNE SYSTEM 
5fyj:L   (ASN129) to   (PRO209)  CRYSTAL STRUCTURE AT 3.4 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE G X1193.C1 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01  |   VIRAL PROTEIN, HIV, ENVELOPE, GLYCAN, TRIMER 
5fyk:E   (ASN128) to   (THR209)  CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE JR-FL SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01  |   VIRAL PROTEIN, HIV, ENVELOPE, GLYCAN, TRIMER 
5fyk:L   (ASN129) to   (PRO209)  CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE JR-FL SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122, 35O22 AND VRC01  |   VIRAL PROTEIN, HIV, ENVELOPE, GLYCAN, TRIMER 
4cni:L   (GLY128) to   (SER208)  CRYSTAL STRUCTURE OF THE FAB PORTION OF OLOKIZUMAB IN COMPLEX WITH IL-6  |   IMMUNE SYSTEM,  CDP6038, INTERLEUKIN 6 
4s1d:F   (GLY128) to   (ASN212)  STRUCTURE OF IGG1 FAB FRAGMENT IN COMPLEX WITH BIOTINCYTIDINAMIDE  |   ANTIBODY, FAB FRAGMENT, HAPTEN, MAB_M33_FAB_FRAGMENT, IMMUNE SYSTEM 
4s1d:P   (GLY128) to   (ASN210)  STRUCTURE OF IGG1 FAB FRAGMENT IN COMPLEX WITH BIOTINCYTIDINAMIDE  |   ANTIBODY, FAB FRAGMENT, HAPTEN, MAB_M33_FAB_FRAGMENT, IMMUNE SYSTEM 
3d3v:E   (GLN141) to   (TRP242)  THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED HTLV-1 TAX (Y5(3,4-DIFLUOROPHENYLALANINE)) PEPTIDE  |   HTLV-1 TAX PEPTIDE, 3, 4-DIFLUOROPHENYLALANINE, MHC CLASS I, HLA-A2, T-CELL RECEPTOR A6, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, PHOSPHOPROTEIN, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, SECRETED, DISEASE MUTATION, GLYCATION, PYRROLIDONE CARBOXYLIC ACID, IMMUNE SYSTEM 
3d69:L   (ASN129) to   (PRO209)  CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF AN ANTI-FACTOR IX ANTIBODY 10C12  |   ANTICOAGULANT, 10C12, FACTOR IX, GLA DOMAIN, IMMUNE SYSTEM 
3d6g:A   (SER254) to   (SER337)  FC FRAGMENT OF IGG1 (HERCEPTIN) WITH PROTEIN-A MIMETIC PEPTIDE DENDRIMER LIGAND.  |   FC FRAGMENT, IGG1, GLYCOSILATED PROTEIN, PROTEIN A MIMETIC PEPTIDE DENDRIMER LIGAND, GLYCOPROTEIN, IMMUNOGLOBULIN C REGION, IMMUNOGLOBULIN DOMAIN, SECRETED, IMMUNE SYSTEM 
3d6g:B   (SER254) to   (LYS338)  FC FRAGMENT OF IGG1 (HERCEPTIN) WITH PROTEIN-A MIMETIC PEPTIDE DENDRIMER LIGAND.  |   FC FRAGMENT, IGG1, GLYCOSILATED PROTEIN, PROTEIN A MIMETIC PEPTIDE DENDRIMER LIGAND, GLYCOPROTEIN, IMMUNOGLOBULIN C REGION, IMMUNOGLOBULIN DOMAIN, SECRETED, IMMUNE SYSTEM 
4tnw:N   (ASN131) to   (ARG211)  C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION  |   MEMBRANE PROTEIN, LIGAND-GATED ION CHANNEL, NEUROTRANSMITTER RECEPTOR, CYS-LOOP RECEPTOR, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX 
3det:F   (GLY127) to   (ALA211)  STRUCTURE OF THE E148A, Y445A DOUBLY UNGATED MUTANT OF E.COLI CLC_EC1, CL-/H+ ANTIPORTER  |   CLC_EC1, ANTIPORTER, EXCHANGE-TRANSPORTER, DOUBLY UNGATED MUTANT, CHLORIDE, INNER MEMBRANE, ION TRANSPORT, MEMBRANE, STRESS RESPONSE, TRANSMEMBRANE, MEMBRANE PROTEIN 
3dj9:A   (SER254) to   (SER337)  CRYTAL STRUCTURE OF AN ISOLATED, UNGLYCOSYLATED ANTIBODY CH2 DOMAIN  |   ANTIBODY, IMMUNOGLOBULIN, CH2 DOMAIN, GLYCOPROTEIN, IMMUNOGLOBULIN C REGION, IMMUNOGLOBULIN DOMAIN, SECRETED, IMMUNE SYSTEM 
4d2n:C   (SER254) to   (LYS338)  CRYSTAL STRUCTURE OF DEGLYCOSYLATED SERUM-DERIVED HUMAN IGG4 FC  |   IMMUNE SYSTEM, IGG, IMMUNOGLOBULIN, IGG1 
4d2n:D   (SER254) to   (SER337)  CRYSTAL STRUCTURE OF DEGLYCOSYLATED SERUM-DERIVED HUMAN IGG4 FC  |   IMMUNE SYSTEM, IGG, IMMUNOGLOBULIN, IGG1 
3okk:A   (GLY128) to   (ASN212)  CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.4)KDO  |   ANTIBODY, FAB, IGG, CARBOHYDRATE, IMMUNE SYSTEM 
3do3:A   (SER254) to   (SER337)  HUMAN 1GG1 FC FRAGMENT, 2.5 ANGSTROM STRUCTURE  |   IMMUNOGLOBULIN FOLD, GLYCOPROTEIN, IMMUNOGLOBULIN C REGION, IMMUNOGLOBULIN DOMAIN, SECRETED, IMMUNE SYSTEM 
3do3:A   (GLY371) to   (SER442)  HUMAN 1GG1 FC FRAGMENT, 2.5 ANGSTROM STRUCTURE  |   IMMUNOGLOBULIN FOLD, GLYCOPROTEIN, IMMUNOGLOBULIN C REGION, IMMUNOGLOBULIN DOMAIN, SECRETED, IMMUNE SYSTEM 
4d9r:L   (GLY128) to   (SER208)  INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D  |   FACTOR D, COMPLEMENT, ANTIBODY, EXOSITE, FAB, CHYMOTRYPSIN, PROTEASE, HYDROLASE-IMMUNE SYSTEM COMPLEX 
4d9r:D   (GLY128) to   (SER208)  INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D  |   FACTOR D, COMPLEMENT, ANTIBODY, EXOSITE, FAB, CHYMOTRYPSIN, PROTEASE, HYDROLASE-IMMUNE SYSTEM COMPLEX 
4dag:L   (ASN148) to   (PRO228)  STRUCTURE OF THE HUMAN METAPNEUMOVIRUS FUSION PROTEIN WITH NEUTRALIZING ANTIBODY IDENTIFIES A PNEUMOVIRUS ANTIGENIC SITE  |   VIRAL PROTEIN, MPV FUSION PROTEIN, ANTIBODY, IMMUNE SYSTEM, DS7 ANTIBODY STRUCTURE, DS7, FAB STRUCTURE, VACCINE, VIRAL PROTEIN- IMMUNE SYSTEM COMPLEX 
3dxa:E   (GLN152) to   (GLY254)  CRYSTAL STRUCTURE OF THE DM1 TCR IN COMPLEX WITH HLA-B*4405 AND DECAMER EBV ANTIGEN  |   MHC, GLYCOPROTEIN, GLYCATION, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, PYRROLIDONE CARBOXYLIC ACID, DISEASE MUTATION, IMMUNE SYSTEM 
3dxa:J   (GLN152) to   (GLY254)  CRYSTAL STRUCTURE OF THE DM1 TCR IN COMPLEX WITH HLA-B*4405 AND DECAMER EBV ANTIGEN  |   MHC, GLYCOPROTEIN, GLYCATION, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, PYRROLIDONE CARBOXYLIC ACID, DISEASE MUTATION, IMMUNE SYSTEM 
3dxa:O   (GLN152) to   (GLY254)  CRYSTAL STRUCTURE OF THE DM1 TCR IN COMPLEX WITH HLA-B*4405 AND DECAMER EBV ANTIGEN  |   MHC, GLYCOPROTEIN, GLYCATION, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, PYRROLIDONE CARBOXYLIC ACID, DISEASE MUTATION, IMMUNE SYSTEM 
3p0v:L   (GLY128) to   (ASN210)  ANTI-EGFR/HER3 FAB DL11 ALONE  |   BETA-SANDWICH, IMMUNE SYSTEM, ANTIGENS EGFR AND HER3 
3p11:L   (THR129) to   (ASN210)  ANTI-EGFR/HER3 FAB DL11 IN COMPLEX WITH DOMAINS I-III OF THE HER3 EXTRACELLULAR REGION  |   BETA-SANDWICH, ANTIGENS HER3, IMMUNE SYSTEM 
4ub0:L   (ASN137) to   (ASN210)  NEW DESIGN FOR MONOVALENT BISPECIFIC IGG THROUGH CYSTEINE ENGINEERING OF THE CH1-CL INTERFACE  |   FAB, KNOBS-INTO-HOLES, BISPECIFIC, IMMUNE SYSTEM 
4ubd:D   (GLY129) to   (SER209)  CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA  |   HEMAGGLUTININ, H3N2, MONOCLONAL ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4ubd:X   (GLY129) to   (SER209)  CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA  |   HEMAGGLUTININ, H3N2, MONOCLONAL ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4ubd:H   (GLY129) to   (SER209)  CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA  |   HEMAGGLUTININ, H3N2, MONOCLONAL ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4ubd:P   (GLY129) to   (SER209)  CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA  |   HEMAGGLUTININ, H3N2, MONOCLONAL ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4ubd:L   (GLY129) to   (SER209)  CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA  |   HEMAGGLUTININ, H3N2, MONOCLONAL ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
5hvw:A   (SER254) to   (LYS338)  MONOMERIC IGG4 FC  |   BIOTECHNOLOGY, ANTIBODY ENGINEERING, MONOMERIC FC, MONOVALENT TARGETING, FUSION PROTEIN, IMMUNE SYSTEM 
4udu:B   (GLN138) to   (GLY240)  CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN E IN COMPLEX WITH A T CELL RECEPTOR  |   IMMUNE SYSTEM, SUPERANTIGEN, T CELL RECEPTOR, MAJOR HISTOCOMPATIBILITY COMPLEX 
5hyj:E   (GLN141) to   (ALA245)  1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING AQWGPDPAAA  |   IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM 
5hyj:J   (GLN141) to   (ALA245)  1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING AQWGPDPAAA  |   IMMUNO, HLA-A02, 1E6-TCR, CROSS-REACTIVITY, IMMUNE SYSTEM 
4dw2:L   (GLY128) to   (ASN210)  THE CRYSTAL STRUCTURE OF UPA IN COMPLEX WITH THE FAB FRAGMENT OF MAB- 112  |   UROKINASE-TYPE PLASMINOGEN ACTIVATOR, ANTIBODY, SERINE PROTEASE, ZYMOGEN, HYDROLASE-IMMUNE SYSTEM COMPLEX 
4uik:L   (GLY128) to   (ARG211)  CRYSTAL STRUCTURE OF QUININE-DEPENDENT FAB 314.1  |   IMMUNE SYSTEM, QUININE-DEPENDENT, MOUSE MAB 
3pjs:C   (THR131) to   (ASN212)  MECHANISM OF ACTIVATION GATING IN THE FULL-LENGTH KCSA K+ CHANNEL  |   ION CHANNEL, CONDUCTS K+ IONS, CELL MEMBRANE, TRANSPORT PROTEIN 
4dz8:A   (SER254) to   (SER337)  HUMAN IGG1 FC FRAGMENT HETERODIMER  |   FC FRAGMENT, ANTIBODY, IMMUNE SYSTEM 
4dz8:B   (SER254) to   (LYS338)  HUMAN IGG1 FC FRAGMENT HETERODIMER  |   FC FRAGMENT, ANTIBODY, IMMUNE SYSTEM 
4uom:L   (GLY128) to   (ARG211)  ELECTRON CRYO-MICROSCOPY OF VENEZUELAN EQUINE  ENCEPHALITIS VIRUS TC-83 IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB F5  |   VIRAL PROTEIN, ALPHAVIRUS, VENEZUELAN, ANTIBODY NEUTRALIZATION, FAB 
5i8e:D   (GLY128) to   (SER208)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING HIV-1 FUSION PEPTIDE- TARGETING ANTIBODY VRC34.01 FAB  |   HIV-1, ENVELOPE, TRIMER, FUSION PEPTIDE, ANTIBODY, NEUTRALIZING, IMMUNE SYSTEM 
5i8h:L   (ASN129) to   (PRO209)  CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH V3 LOOP-TARGETING ANTIBODY PGT122 FAB AND FUSION PEPTIDE-TARGETING ANTIBODY VRC34.01 FAB  |   HIV-1, ENVELOPE, TRIMER, FUSION PEPTIDE, ANTIBODY, NEUTRALIZING, IMMUNE SYSTEM 
5i8h:J   (ASN129) to   (PRO209)  CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH V3 LOOP-TARGETING ANTIBODY PGT122 FAB AND FUSION PEPTIDE-TARGETING ANTIBODY VRC34.01 FAB  |   HIV-1, ENVELOPE, TRIMER, FUSION PEPTIDE, ANTIBODY, NEUTRALIZING, IMMUNE SYSTEM 
5id1:A   (GLY128) to   (SER208)  CETUXIMAB FAB IN COMPLEX WITH MPT-CYS MEDITOPE  |   ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM 
3pqy:O   (GLN148) to   (GLY250)  CRYSTAL STRUCTURE OF 6218 TCR IN COMPLEX WITH THE H2DB-PA224  |   H2DB, INFLUENZA, TCR, T CELL, PA EPITOPE, REPERTOIRE, VIRAL IMMUNITY, CHIMERIC TCR, IMMUNE SYSTEM 
5ikc:L   (GLY128) to   (ASN212)  X-RAY STRUCURE OF THE N-TERMINAL DOMAIN OF HUMAN DOUBLECORTIN IN COMPLEX WITH FAB  |   DCX DOMAIN, UBIQUITIN-LIKE FOLD, MICROTUBULE ASSOCIATED, SIGNALING PROTEIN, TRANSFERASE 
4ei5:D   (LYS140) to   (ALA243)  CRYSTAL STRUCTURE OF XV19 TCR IN COMPLEX WITH CD1D-SULFATIDE C24:1  |   SULFATIDE, LIPID, CD1D, NKT TYPEII, TCR, IMMUNE SYSTEM 
3pwp:E   (LYS142) to   (GLY243)  THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND HUD PEPTIDE  |   TAX PEPTIDE, HUD EPITOPE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS-REACTIVITY, PROTEIN BINDING 
3q6g:M   (ASN128) to   (PRO208)  CRYSTAL STRUCTURE OF FAB OF RHESUS MAB 2.5B SPECIFIC FOR QUATERNARY NEUTRALIZING EPITOPE OF HIV-1 GP120  |   IG, NEUTRALIZATION OF HIV-1 VIRUSES, QUATERNARY EPITOPE OF HIV-1 GP120, IMMUNE SYSTEM 
4ezm:A   (SER353) to   (THR434)  CRYSTAL STRUCTURE OF THE HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23  |   IMMUNOGLOBULIN FOLD LECTIN, ANTIBODY RECEPTOR, IMMUNE SYSTEM 
4ezm:B   (SER353) to   (THR434)  CRYSTAL STRUCTURE OF THE HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23  |   IMMUNOGLOBULIN FOLD LECTIN, ANTIBODY RECEPTOR, IMMUNE SYSTEM 
3qdm:E   (GLN138) to   (GLY240)  THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) DECAMERIC PEPTIDE  |   MART-1 PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR DMF5, TCR DMF4, CROSS-REACTIVITY, CANCER, MELANOMA, IMMUNE SYSTEM 
3qeh:F   (GLY127) to   (SER207)  CRYSTAL STRUCTURE OF HUMAN N12-I15, AN ADCC AND NON-NEUTRALIZING ANTI- HIV-1 ENV ANTIBODY  |   ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ENV ANTIBODY N12-I15, CD4I ANTIBODY, FAB FRAGMENT, BINDS TO VIRAL GLYCOPROTEIN GP120, IMMUNE SYSTEM 
3qeu:E   (GLN140) to   (TRP241)  THE CRYSTAL STRUCTURE OF TCR DMF5  |   MART-1 PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR DMF5, TCR DMF4, CROSS-REACTIVITY, CANCER, MELANOMA, IMMUNE SYSTEM 
4f2m:C   (SER143) to   (LYS218)  CRYSTAL STRUCTURE OF A TGEV CORONAVIRUS SPIKE FRAGMENT IN COMPLEX WITH THE TGEV NEUTRALIZING MONOCLONAL ANTIBODY 1AF10  |   BETA-BARREL, IMMUNOGLOBULIN, VIRUS ENTRY, VIRUS NEUTRALIZATION, CELLULAR RECEPTOR, AMINOPEPTIDASE N, GLYCOSYLATION, VIRUS MEMBRANE, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
3qfj:E   (GLN141) to   (TRP242)  THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED TAX (Y5F) PEPTIDE  |   TAX PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS- REACTIVITY, Y5F MUTATION, IMMUNE SYSTEM 
4f37:K   (GLY133) to   (ASN215)  STRUCTURE OF THE TETHERED N-TERMINUS OF ALZHEIMER'S DISEASE A PEPTIDE  |   AMYLOID-BETA, ALZHEIMER'S DISEASE, IMMUNE SYSTEM 
3qiu:D   (GLN139) to   (ALA243)  CRYSTAL STRUCTURE OF THE 226 TCR IN COMPLEX WITH MCC/I-EK  |   IMMUNOGLOBULIN DOMAIN, T CELL RECEPTOR, MHC MOLECULE, IMMUNE SYSTEM 
3qiw:D   (GLN139) to   (ALA243)  CRYSTAL STRUCTURE OF THE 226 TCR IN COMPLEX WITH MCC-P5E/I-EK  |   IMMUNOGLOBULIN DOMAIN, T CELL RECEPTOR, MHC MOLECULE, IMMUNE SYSTEM 
3qny:A   (ASN142) to   (ASN215)  MONOCLINIC FORM OF HUMAN IGA1 FAB FRAGMENT, SHARING SAME FV AS IGG  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
3qny:C   (ASN142) to   (ASN215)  MONOCLINIC FORM OF HUMAN IGA1 FAB FRAGMENT, SHARING SAME FV AS IGG  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
3qo0:A   (GLY133) to   (SER213)  MONOCLINIC FORM OF IGG1 FAB FRAGMENT (IN COMPLEX WITH ANTIGENIC PEPTIDE) SHARING SAME FV AS IGA  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
3qo1:A   (GLY133) to   (SER213)  MONOCLINIC FORM OF IGG1 FAB FRAGMENT (APO FORM) SHARING SAME FV AS IGA  |   IMMUNOGLOBULIN FOLD, ANTIBODY, SERUM, IMMUNE SYSTEM 
3qum:C   (GLY128) to   (ARG211)  CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN (PSA) IN FAB SANDWICH WITH A HIGH AFFINITY AND A PCA SELECTIVE ANTIBODY  |   KALLIKREIN FOLD, PROSTATE-SPECIFIC ANTIGEN, SERINE PROTEASE, NEGATIVE REGULATION OF ANGIOGENESIS, NATURAL POST-TRANSDUCTIONAL MODIFICATION, N-LINKED AND O-LINKED GLYCOSYLATION, IMMUNE SYSTEM 
4ffv:L   (GLY128) to   (ARG210)  CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPP4, DPP-IV, CD26) IN COMPLEX WITH 11A19 FAB  |   HYDROLASE, HYDROLASE-IMMUNE SYSTEM, INHIBITOR COMPLEX 
4ffw:C   (GLY127) to   (ARG210)  CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPP4, DPP-IV, CD26) IN COMPLEX WITH FAB + SITAGLIPTIN  |   HYDROLASE, HYDROLASE-IMMUNE SYSTEM, INHIBITOR COMPLEX 
4fg6:D   (GLY127) to   (ALA211)  STRUCTURE OF ECCLC E148A MUTANT IN GLUTAMATE  |   TRANSPORTER, MEMBRANE, TRANSPORT PROTEIN 
4fg6:F   (GLY127) to   (ALA211)  STRUCTURE OF ECCLC E148A MUTANT IN GLUTAMATE  |   TRANSPORTER, MEMBRANE, TRANSPORT PROTEIN 
3qwo:B   (GLY128) to   (SER208)  CRYSTAL STRUCTURE OF A MOTAVIZUMAB EPITOPE-SCAFFOLD BOUND TO MOTAVIZUMAB FAB  |   IMMUNE COMPLEX, IMMUNE SYSTEM 
4w4n:A   (SER254) to   (LYS338)  CRYSTAL STRUCTURE OF HUMAN FC AT 1.80 A  |   HUMAN FC ASYMMETRY DYNAMICS IMMUNE MOLECULE, IMMUNE SYSTEM 
4w4n:B   (SER254) to   (SER337)  CRYSTAL STRUCTURE OF HUMAN FC AT 1.80 A  |   HUMAN FC ASYMMETRY DYNAMICS IMMUNE MOLECULE, IMMUNE SYSTEM 
4w4o:A   (SER254) to   (LYS338)  HIGH-RESOLUTION CRYSTAL STRUCTURE OF FC BOUND TO ITS HUMAN RECEPTOR FC-GAMMA-RI  |   IMMUNE COMPLEX IGG1 PROTEIN-PROTEIN COMPLEX ASYMMETRY, IMMUNE SYSTEM 
4w4o:B   (SER254) to   (LYS338)  HIGH-RESOLUTION CRYSTAL STRUCTURE OF FC BOUND TO ITS HUMAN RECEPTOR FC-GAMMA-RI  |   IMMUNE COMPLEX IGG1 PROTEIN-PROTEIN COMPLEX ASYMMETRY, IMMUNE SYSTEM 
3raj:L   (GLY127) to   (ASN208)  CRYSTAL STRUCTURE OF HUMAN CD38 IN COMPLEX WITH THE FAB FRAGMENT OF ANTIBODY HB7  |   CD38, ADP-RIBOSYL CYCLASE, CYCLIC ADP-RIBOSE, X-CRYSTALLOGRAPHY, CALCIUM SIGNALING, AGONISTIC ANTIBODY, HB7, HYDROLASE-IMMUNE SYSTEM COMPLEX 
5jhl:L   (GLY129) to   (ARG212)  CRYSTAL STRUCTURE OF ZIKA VIRUS ENVELOPE PROTEIN IN COMPLEX WITH A FLAVIVIRUS BROADLY-PROTECTIVE ANTIBODY  |   ZIKA VIRUS, ENVELOPE PROTEIN, FLAVIVIRUS, BROADLY-PROTECTIVE ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4fqi:L   (ASN128) to   (PRO208)  CRYSTAL STRUCTURE OF FAB CR9114 IN COMPLEX WITH A H5N1 INFLUENZA VIRUS HEMAGGLUTININ  |   NEUTRALIZING ANTIBODIES, ANTIBODY AFFINITY, ANTIGENS, EPITOPES, GLYCOSYLATION, HEMAGGLUTININ GLYCOPROTEINS, IMMUNOGLOBULIN FAB FRAGMENTS, H5N1 SUBTYPE, INFLUENZA VACCINES, AVIAN FLU, ENVELOPE PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4fqr:b   (GLY128) to   (SER208)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ  |   VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4fqr:f   (GLY128) to   (SER208)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ  |   VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4fqr:p   (ASN137) to   (ASN210)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ  |   VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4fqy:L   (ASN128) to   (ALA207)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR9114 BOUND TO H3 INFLUENZA HEMAGGLUTININ  |   VIRAL FUSION PROTEIN, IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4ftv:E   (GLN141) to   (ALA245)  THE COMPLEX BETWEEN THE HIGH AFFINITY VERSION OF A6 TCR (A6C134) AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND TAX NONAMERIC PEPTIDE  |   TAX PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR A6, CROSS- REACTIVITY, HIGH AFFINITY, C134, IMMUNE SYSTEM 
3rif:L   (ASN131) to   (SER210)  C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB, IVERMECTIN AND GLUTAMATE.  |   MEMBRANE PROTEIN, TRANSPORT PROTEIN, CYS-LOOP RECEPTOR, LIGAND-GATED ION CHANNEL, NEUROTRANSMITTER RECEPTOR, IVERMECTIN, PICROTOXIN, GLYCOSYLATION, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX 
5jxa:L   (GLY128) to   (SER208)  CRYSTAL STRUCTURE OF LIGAND-FREE VRC03 ANTIGEN-BINDING FRAGMENT.  |   HIV-1, CD4 BINDING SITE, NEUTRALIZING, ANTIBODY DEVELOPMENT, IMMUNE SYSTEM 
5jxe:C   (THR133) to   (SER212)  HUMAN PD-1 ECTODOMAIN COMPLEXED WITH PEMBROLIZUMAB FAB  |   HUMAN PD-1 PEMBROLIZUMAB FAB, IMMUNE SYSTEM 
4g8e:B   (GLN157) to   (GLY259)  CRYSTAL STRUCTURE OF CLONE18 TCR  |   TCR, T CELL, CD1B, GMM, LIPID RECOGNITION, IMMUNE SYSTEM 
4gko:C   (LYS352) to   (THR434)  CRYSTAL STRUCTURE OF THE CALCIUM2+-BOUND HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23  |   IMMUNOGLOBULIN FOLD LECTIN, ANTIBODY RECEPTOR, IMMUNE SYSTEM 
4gms:L   (GLY128) to   (ARG211)  CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1 IN COMPLEX WITH INFLUENZA A H3 HEMAGGLUTININ  |   IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4gmt:H   (SER134) to   (PRO212)  CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1  |   FAB, FRAGMENT ANTIGEN BINDING, IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM 
4grg:D   (LYS352) to   (THR434)  CRYSTAL STRUCTURE OF IGE COMPLEXED WITH E2_79, AN ANTI-IGE INHIBITOR  |   IG-FOLD, IMMUNITY, HIGH/LOW AFFINITY RECEPTOR, IMMUNE SYSTEM- INHIBITOR COMPLEX 
5sws:E   (GLN150) to   (TRP251)  CRYSTAL STRUCTURE OF NP2-B17 TCR-H2DB-NP COMPLEX  |   H2DB, INFLUENZA, NP366, REVERSED DOCKING, NAIVE T CELL, NP1-B17 TCR, TCR, T CELL, IMMUNE SYSTEM 
5swz:E   (GLN151) to   (ALA255)  CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX  |   H2DB, INFLUENZA, NP366, REVERSED DOCKING, NAIVE T CELL, NP1-B17 TCR, TCR, T CELL, IMMUNE SYSTEM 
5swz:O   (GLN151) to   (GLY253)  CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX  |   H2DB, INFLUENZA, NP366, REVERSED DOCKING, NAIVE T CELL, NP1-B17 TCR, TCR, T CELL, IMMUNE SYSTEM 
5sx4:L   (GLY128) to   (ASN210)  CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3.  |   CETUXIMAB, PANITUMUMAB, EGFR, VECTIBIX, ERBITUX, TRANSFERASE-IMMUNE SYSTEM COMPLEX 
5t3s:L   (ASP138) to   (PRO208)  HIV GP140 TRIMER MD39-10MUTA IN COMPLEX WITH FABS PGT124 AND 35022  |   HIV-1 NEUTRALIZING ANTIBODY, IMMUNE SYSTEM 
5t3s:E   (LYS129) to   (PRO208)  HIV GP140 TRIMER MD39-10MUTA IN COMPLEX WITH FABS PGT124 AND 35022  |   HIV-1 NEUTRALIZING ANTIBODY, IMMUNE SYSTEM 
4wi6:B   (SER254) to   (LYS338)  STRUCTURAL MAPPING OF THE HUMAN IGG1 BINDING SITE FOR FCRN: HU3S193 FC MUTATION N434A  |   HUMAN IGG1, FCRN BINDING SITE, THERAPEUTIC ANTIBODY, IMMUNE SYSTEM 
1afv:L   (GLY132) to   (ARG215)  HIV-1 CAPSID PROTEIN (P24) COMPLEX WITH FAB25.3  |   COMPLEX (VIRAL CAPSID/IMMUNOGLOBULIN), HIV, CAPSID PROTEIN, P24, VIRAL PROTEIN/IMMUNE SYSTEM COMPLEX 
1afv:H   (SER141) to   (LYS216)  HIV-1 CAPSID PROTEIN (P24) COMPLEX WITH FAB25.3  |   COMPLEX (VIRAL CAPSID/IMMUNOGLOBULIN), HIV, CAPSID PROTEIN, P24, VIRAL PROTEIN/IMMUNE SYSTEM COMPLEX 
1afv:M   (GLY132) to   (ARG215)  HIV-1 CAPSID PROTEIN (P24) COMPLEX WITH FAB25.3  |   COMPLEX (VIRAL CAPSID/IMMUNOGLOBULIN), HIV, CAPSID PROTEIN, P24, VIRAL PROTEIN/IMMUNE SYSTEM COMPLEX 
4hbc:L   (GLY130) to   (ASN209)  CRYSTAL STRUCTURE OF A CONFORMATION-DEPENDENT RABBIT IGG FAB SPECIFIC FOR AMYLOID PREFIBRILLAR OLIGOMERS  |   FAB, RABBIT, CONFORMATION-SPECIFIC, AMYLOID, IMMUNE SYSTEM 
1bbd:L   (GLY134) to   (ASN216)  THREE DIMENSIONAL STRUCTURE OF THE FAB FRAGMENT OF A NEUTRALIZING ANTIBODY TO HUMAN RHINOVIRUS SEROTYPE 2  |   IMMUNOGLOBULIN 
4x4m:A   (SER254) to   (LYS338)  STRUCTURE OF FCGAMMARI IN COMPLEX WITH FC REVEALS THE IMPORTANCE OF GLYCAN RECOGNITION FOR HIGH AFFINITY IGG BINDING  |   IMMUNE SYSTEM 
4x4m:C   (SER254) to   (LYS338)  STRUCTURE OF FCGAMMARI IN COMPLEX WITH FC REVEALS THE IMPORTANCE OF GLYCAN RECOGNITION FOR HIGH AFFINITY IGG BINDING  |   IMMUNE SYSTEM 
4x8j:B   (GLY128) to   (ASN212)  CRYSTAL STRUCTURE OF MURINE 12F4 FAB MONOCLONAL ANTIBODY AGAINST ADAMTS5  |   MONOCLONAL, IMMUNE SYSTEM 
4xcy:B   (GLY128) to   (SER208)  CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDYLGLYCEROL (06:0 PG)  |   4E10 FAB ANTI HIV-1 GP41 MPER, MEMBRANE LIPIDS, IMMUNE SYSTEM, PHOSPHATIDYLGLYCEROL 
1c5d:A   (GLY127) to   (ASN209)  THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A RAT MONOCLONAL ANTIBODY AGAINST THE MAIN IMMUNOGENIC REGION OF THE HUMAN MUSCLE ACETYLCHOLINE RECEPTOR  |   IMMUNOGLOBULIN, IMMUNE SYSTEM 
2c1o:L   (GLY128) to   (ARG211)  ENAIIHIS FAB FRAGMENT IN THE FREE FORM  |   FAB FRAGMENT, ENANTIOSELECTIVE, FINROZOLE, IMMUNE SYSTEM, ANTIBODY, ENA11HIS ANTIBODY, IMMUNOGLOBULIN DOMAIN 
3fjt:A   (THR254) to   (SER337)  CRYSTAL STRUCTURE OF A HUMAN FC FRAGMENT ENGINEERED FOR EXTENDED SERUM HALF-LIFE  |   FC, IGG1, FCRN BINDING, CH3-CH3 ASSOCIATION, GLYCOPROTEIN, IMMUNOGLOBULIN C REGION, IMMUNOGLOBULIN DOMAIN, SECRETED, IMMUNE SYSTEM 
3fjt:B   (THR254) to   (LYS338)  CRYSTAL STRUCTURE OF A HUMAN FC FRAGMENT ENGINEERED FOR EXTENDED SERUM HALF-LIFE  |   FC, IGG1, FCRN BINDING, CH3-CH3 ASSOCIATION, GLYCOPROTEIN, IMMUNOGLOBULIN C REGION, IMMUNOGLOBULIN DOMAIN, SECRETED, IMMUNE SYSTEM 
1cic:A   (GLY128) to   (ASN210)  IDIOTOPE-ANTI-IDIOTOPE FAB-FAB COMPLEX; D1.3-E225  |   IMMUNOGLOBULIN, FAB COMPLEX, IDIOTOPE, ANTI-IDIOTOPE 
4xmp:L   (GLY128) to   (SER208)  CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC08 IN COMPLEX WITH HIV-1 CLADE A STRAIN Q842.D12 GP120  |   ANTIBODY, HIV-1, IMMUNE SYSTEM 
1d5b:A   (GLY128) to   (SER208)  UNLIGANDED MATURE OXY-COPE CATALYTIC ANTIBODY  |   IMMUNE SYSTEM 
4xpb:L   (GLY129) to   (ASN211)  X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER WITH SUBSITEB MUTATIONS (D121G/S426M) BOUND TO COCAINE  |   INTEGRAL MEMBRANE PROTEIN, ALL-ALPHA HELICAL ANTIDEPRESSANT COMPLEX, TRANPORT PROTEIN-INHIBITOR COMPLEX 
2ckb:B   (LYS142) to   (GLY243)  STRUCTURE OF THE 2C/KB/DEV8 COMPLEX  |   T CELL ANTIGEN RECEPTOR, MAJOR HISTOCOMPATIBILITY COMPLEX 
2ckb:D   (GLN141) to   (TRP242)  STRUCTURE OF THE 2C/KB/DEV8 COMPLEX  |   T CELL ANTIGEN RECEPTOR, MAJOR HISTOCOMPATIBILITY COMPLEX 
2ql1:A   (VAL259) to   (LYS338)  STRUCTURAL CHARACTERIZATION OF A MUTATED, ADCC-ENHANCED HUMAN FC FRAGMENT  |   ANTIBODY, ADCC, FC FRAGMENT, MUTATION, IMMUNE SYSTEM 
4xx1:L   (LYS130) to   (ALA208)  LOW RESOLUTION STRUCTURE OF LCAT IN COMPLEX WITH FAB1  |   A/B HYDROLASE, COMPLEX, HYDROLASE-IMMUNE SYSTEM COMPLEX 
4xx1:G   (ASN129) to   (PRO209)  LOW RESOLUTION STRUCTURE OF LCAT IN COMPLEX WITH FAB1  |   A/B HYDROLASE, COMPLEX, HYDROLASE-IMMUNE SYSTEM COMPLEX 
3giz:L   (ASN137) to   (ARG211)  CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CD20 ANTIBODY OFATUMUMAB  |   CD20, 2F2, OFATUMUMAB, HU-MAXCD20, FAB, ANTIBODY, FULLY HUMAN ANTIBODY, IMMUNE SYSTEM 
4y19:E   (GLN150) to   (ASP255)  IMMUNE COMPLEX  |   TCR MHC, IMMUNE SYSTEM 
1q0y:L   (ALA128) to   (SER210)  ANTI-MORPHINE ANTIBODY 9B1 COMPLEXED WITH MORPHINE  |   ANTI-MORPHINE ANTIBODY, FAB, IMMUNE SYSTEM 
4j6r:L   (GLY128) to   (SER208)  CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC23 IN COMPLEX WITH HIV-1 GP120  |   HIV, GP120, CD4-BINDING SITE, VRC23, NEUTRALIZATION, VACCINE, ANTIBODY, ENVELOPE PROTEIN, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
4jo1:L   (GLY128) to   (ASN207)  CRYSTAL STRUCTURE OF RABBIT MAB R56 FAB IN COMPLEX WITH V3 CROWN OF HIV-1 JR-FL GP120  |   IG, ANTIBODY, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
4jo1:M   (GLY128) to   (ASN207)  CRYSTAL STRUCTURE OF RABBIT MAB R56 FAB IN COMPLEX WITH V3 CROWN OF HIV-1 JR-FL GP120  |   IG, ANTIBODY, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX 
3h9z:B   (LYS352) to   (THR434)  CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS  |   IMMUNOGLOBIN, IGE, FC, FLEXIBILITY, HYDROPHOBIC POCKET, DISULFIDE BOND, GLYCOPROTEIN, IMMUNOGLOBULIN C REGION, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
3h9z:C   (CYS358) to   (PRO439)  CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS  |   IMMUNOGLOBIN, IGE, FC, FLEXIBILITY, HYDROPHOBIC POCKET, DISULFIDE BOND, GLYCOPROTEIN, IMMUNOGLOBULIN C REGION, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
3hg1:E   (GLN139) to   (TRP240)  GERMLINE-GOVERNED RECOGNITION OF A CANCER EPITOPE BY AN IMMUNODOMINANT HUMAN T CELL RECEPTOR  |   T-CELL RECEPTOR, CDR3, PHAGE DISPLAY, MELAN-1, MART-1, IMMUNE SYSTEM, DISULFIDE BOND, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, GLYCOPROTEIN, IMMUNE RESPONSE, IMMUNOGLOBULIN DOMAIN, MHC I, PYRROLIDONE CARBOXYLIC ACID, SECRETED 
1frt:C   (SER254) to   (LYS338)  CRYSTAL STRUCTURE OF THE COMPLEX OF RAT NEONATAL FC RECEPTOR WITH FC  |   COMPLEX (RECEPTOR-IMMUNOGLOBULIN), COMPLEX (RECEPTOR-IMMUNOGLOBULIN) COMPLEX 
1frt:C   (ASN361) to   (LEU443)  CRYSTAL STRUCTURE OF THE COMPLEX OF RAT NEONATAL FC RECEPTOR WITH FC  |   COMPLEX (RECEPTOR-IMMUNOGLOBULIN), COMPLEX (RECEPTOR-IMMUNOGLOBULIN) COMPLEX 
4yzf:H   (GLY132) to   (ASN214)  CRYSTAL STRUCTURE OF THE ANION EXCHANGER DOMAIN OF HUMAN ERYTHROCYTE BAND 3  |   IMMUNE SYSTEM, HUMAN MEMBRANE PROTEIN, ANION EXCHANGER, ERYTHROCYTES 
4yzf:L   (GLY132) to   (ASN214)  CRYSTAL STRUCTURE OF THE ANION EXCHANGER DOMAIN OF HUMAN ERYTHROCYTE BAND 3  |   IMMUNE SYSTEM, HUMAN MEMBRANE PROTEIN, ANION EXCHANGER, ERYTHROCYTES 
1g0d:A   (PHE488) to   (SER583)  CRYSTAL STRUCTURE OF RED SEA BREAM TRANSGLUTAMINASE  |   TISSUE TRANSGLUTAMINASE,ACYLTRANSFERASE 
4ki1:A   (LYS352) to   (PRO439)  PRIMITIVE TRICLINIC CRYSTAL FORM OF THE HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23  |   IMMUNOGLOBULIN FOLD, LECTIN, ANTIBODY RECEPTOR, IMMUNE SYSTEM 
4ki1:B   (CYS358) to   (PRO439)  PRIMITIVE TRICLINIC CRYSTAL FORM OF THE HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23  |   IMMUNOGLOBULIN FOLD, LECTIN, ANTIBODY RECEPTOR, IMMUNE SYSTEM 
4ki1:C   (LYS352) to   (PRO439)  PRIMITIVE TRICLINIC CRYSTAL FORM OF THE HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23  |   IMMUNOGLOBULIN FOLD, LECTIN, ANTIBODY RECEPTOR, IMMUNE SYSTEM 
4ki1:D   (LYS352) to   (THR434)  PRIMITIVE TRICLINIC CRYSTAL FORM OF THE HUMAN IGE-FC(EPSILON)3-4 BOUND TO ITS B CELL RECEPTOR DERCD23  |   IMMUNOGLOBULIN FOLD, LECTIN, ANTIBODY RECEPTOR, IMMUNE SYSTEM 
1gc1:L   (GLY130) to   (ARG213)  HIV-1 GP120 CORE COMPLEXED WITH CD4 AND A NEUTRALIZING HUMAN ANTIBODY  |   COMPLEX (HIV ENVELOPE PROTEIN-CD4-FAB), HIV-1 EXTERIOR ENVELOPE GP120, T-CELL SURFACE GLYCOPROTEIN CD4, ANTIGEN-BINDING FRAGMENT OF HUMAN IMMUNOGLOBULIN 17B, GLYCOSYLATED PROTEIN, VIRAL PROTEIN- RECEPTOR-IMMUNE SYSTEM COMPLEX 
3v7m:A   (SER254) to   (LYS338)  CRYSTAL STRUCTURE OF MONOCLONAL HUMAN ANTI-RHESUS D FC IGG1 T125(YB2/0) IN THE PRESENCE OF ZN2+  |   FC IGG1, FC-GAMMA RECEPTOR, IMMUNE SYSTEM 
4l9l:B   (GLN149) to   (ALA253)  CRYSTAL STRUCTURE OF A HUMAN VALPHA7.2/VBETA13.2 MAIT TCR IN COMPLEX WITH BOVINE MR1  |   IMMUNOGLOBULIN DOMAIN, MHC-CLASS I-LIKE, ANTIGEN PRESENTATION,ANTIGEN RECOGNITION, VITAMIN METABOLITES, CELL MEMBRANE, IMMUNE SYSTEM 
4zto:L   (GLY128) to   (ASN207)  FAB/EPITOPE COMPLEX STRUCTURE OF RABBIT MONOCLONAL ANTIBODY R53 TARGETING AN EPITOPE IN HIV-1 GP120 C4 REGION  |   HIV-1, ENV, C4, CD4, MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
4zto:M   (GLY128) to   (ASN207)  FAB/EPITOPE COMPLEX STRUCTURE OF RABBIT MONOCLONAL ANTIBODY R53 TARGETING AN EPITOPE IN HIV-1 GP120 C4 REGION  |   HIV-1, ENV, C4, CD4, MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
2h2s:F   (GLY127) to   (ARG210)  CRYSTAL STRUCTURE OF E148A MUTANT OF CLC-EC1 IN SECN-  |   CLC; TRANSPORTER; CHLORIDE; ANTIPORT, ION TRANSPORT 
2wah:A   (GLY371) to   (LEU443)  CRYSTAL STRUCTURE OF AN IGG1 FC GLYCOFORM (MAN9GLCNAC2)  |   IMMUNOGLOBULIN C REGION, ANTIBODY ENGINEERING, IMMUNOGLOBULIN DOMAIN, SECRETED, ANTIBODY, KIFUNENSINE, GLYCOPROTEIN, OLIGOMANNOSE, IMMUNE SYSTEM, GLYCOSYLATION 
2wah:B   (SER254) to   (LYS338)  CRYSTAL STRUCTURE OF AN IGG1 FC GLYCOFORM (MAN9GLCNAC2)  |   IMMUNOGLOBULIN C REGION, ANTIBODY ENGINEERING, IMMUNOGLOBULIN DOMAIN, SECRETED, ANTIBODY, KIFUNENSINE, GLYCOPROTEIN, OLIGOMANNOSE, IMMUNE SYSTEM, GLYCOSYLATION 
4zyp:O   (ASN137) to   (ASN210)  CRYSTAL STRUCTURE OF MOTAVIZUMAB AND QUATERNARY-SPECIFIC RSV- NEUTRALIZING HUMAN ANTIBODY AM14 IN COMPLEX WITH PREFUSION RSV F GLYCOPROTEIN  |   IG DOMAIN, FAB, IMMUNE SYSTEM, FUSION, RESPIRATORY SYNCYTIAL VIRUS, PREFUSION 
4lmq:I   (GLY128) to   (ASN210)  DEVELOPMENT AND PRECLINICAL CHARACTERIZATION OF A HUMANIZED ANTIBODY TARGETING CXCL12  |   IMMUNOGLOBULIN, CELL ADHESION-IMMUNE SYSTEM COMPLEX 
3vxq:B   (GLN138) to   (TRP239)  H27-14 TCR SPECIFIC FOR HLA-A24-NEF134-10  |   HIV-1, NEF, IMMUNE SYSTEM, T CELL RECEPTOR, IMMUNOGLOBURIN DOMAIN, TCR, IMMUNE RESPONSE 
2wqr:A   (THR250) to   (LYS327)  THE HIGH RESOLUTION CRYSTAL STRUCTURE OF IGE FC  |   IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, GLYCOPROTEIN 
2wqr:A   (LYS352) to   (LYS435)  THE HIGH RESOLUTION CRYSTAL STRUCTURE OF IGE FC  |   IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, GLYCOPROTEIN 
2wqr:B   (PRO249) to   (LYS327)  THE HIGH RESOLUTION CRYSTAL STRUCTURE OF IGE FC  |   IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, GLYCOPROTEIN 
1iqd:A   (GLY129) to   (ASN211)  HUMAN FACTOR VIII C2 DOMAIN COMPLEXED TO HUMAN MONOCLONAL BO2C11 FAB.  |   FACTOR VIII, C2 DOMAIN, ANTIBODY, BLOOD COAGULATION, INHIBITOR, BO2C11, IMMUNE SYSTEM/BLOOD CLOTTING COMPLEX 
2igf:L   (GLY128) to   (ASN210)  CRYSTAL STRUCTURES OF AN ANTIBODY TO A PEPTIDE AND ITS COMPLEX WITH PEPTIDE ANTIGEN AT 2.8 ANGSTROMS  |   IMMUNOGLOBULIN 
3wfb:L   (GLY128) to   (ASN210)  REDUCED CYTOCHROME C-DEPENDENT NITRIC OXIDE REDUCTASE (CNOR) FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH ANTIBODY FRAGMENT  |   METAL-BINDING, MEMBRANE PROTEIN, IMMUNE SYSTEM-OXIDOREDUCTASE COMPLEX 
3wii:L   (GLY128) to   (ASN210)  CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF B2212A, A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1.  |   IMMUNOGLOBULIN FAB FRAGMENT, ANTI-HEPATOCELLULAR CARCINOMA ANTIBODY, THE THIRD FIBRONECTIN TYPE-III DOMAIN (FN3) OF HUMAN ROBO1, IMMUNE SYSTEM 
3wjj:A   (SER254) to   (LYS338)  CRYSTAL STRUCTURE OF IIB SELECTIVE FC VARIANT, FC(P238D), IN COMPLEX WITH FCGRIIB  |   RECEPTOR COMPLEX, FC RECEPTOR, ANTIBODY, IMMUNE SYSTEM 
3wjj:B   (SER254) to   (LYS338)  CRYSTAL STRUCTURE OF IIB SELECTIVE FC VARIANT, FC(P238D), IN COMPLEX WITH FCGRIIB  |   RECEPTOR COMPLEX, FC RECEPTOR, ANTIBODY, IMMUNE SYSTEM 
4ms8:D   (GLN136) to   (TRP237)  42F3 TCR PCPB9/H-2LD COMPLEX  |   IG, TCR MHC, IMMUNE SYSTEM 
4n0u:E   (THR254) to   (LYS338)  TERNARY COMPLEX BETWEEN NEONATAL FC RECEPTOR, SERUM ALBUMIN AND FC  |   ALPHA/BETA, DNA BINDING PROTEIN 
2mpa:L   (GLY133) to   (ASN215)  BACTERICIDAL ANTIBODY AGAINST NEISSERIA MENINGITIDIS  |   MURINE IMMUNOGLOBULIN IGG2A KAPPA, BACTERICIDAL ANTIBODY, EPITOPE P1.16 OF PORA FROM NEISSERIA MENINGITIDIS, COMPLEX (IMMUNOGLOBULIN- PEPTIDE), IMMUNE SYSTEM 
4nzu:L   (GLY128) to   (ARG211)  CRYSTAL STRUCTURE OF THE PRIMARY MONOCLONAL ANTIBODY 13PL FAB' FROM A MULTIPLE MYELOMA PATIENT  |   ANTIBODY FAB, MULTIPLE MYELOMA, PRIMARY ANTIBODY, IMMUNE SYSTEM 
4o5i:N   (ASN128) to   (PRO208)  CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/361/2011 (H3N2) INFLUENZA HEMAGGLUTININ  |   IMMUNOGLOBULIN, VIRUS ATTACHMENT AND ENTRY, IMMUNE RECOGNITION, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
5cgy:H   (ASP158) to   (PRO227)  FAB FRAGMENT OF CHIKUNGUNYA VIRUS NEUTRALIZING HUMAN MONOCLONAL ANTIBODY 4J21  |   ANTIBODY, FAB, IMMUNE SYSTEM 
2z93:B   (GLY128) to   (ASN212)  CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9 IN COMPLEX WITH CTX3C-ABCD  |   IMMUNOGLOBURIN LIKE FOLD, IMMUNE SYSTEM 
1mcw:M   (ASN132) to   (PRO212)  THREE-DIMENSIONAL STRUCTURE OF A HYBRID LIGHT CHAIN DIMER. PROTEIN ENGINEERING OF A BINDING CAVITY  |   IMMUNOGLOBULIN 
4p23:B   (GLN135) to   (ALA239)  J809.B5 TCR BOUND TO IAB/3K  |   TCR MHC PEPTIDE, IMMUNE SYSTEM 
1mlb:A   (GLY128) to   (ASN212)  MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG-WHITE LYSOZYME  |   IMMUNOGLOBULIN, IMMUNE SYSTEM 
4p2q:J   (GLN139) to   (TRP240)  CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C2/I-EK  |   T CELL RECEPTOR, PEPTIDE-MHC COMPLEX, IMMUNE SYSTEM 
4p2q:O   (GLN139) to   (TRP240)  CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C2/I-EK  |   T CELL RECEPTOR, PEPTIDE-MHC COMPLEX, IMMUNE SYSTEM 
4p99:A   (GLY130) to   (VAL218)  CA2+-STABILIZED ADHESIN HELPS AN ANTARCTIC BACTERIUM REACH OUT AND BIND ICE  |   CA2+-DEPENDENT, BACTERIAL IG-LIKE FOLD, ICE-BINDING ADHESIN, EXTENDER DOMAIN, UNKNOWN FUNCTION 
4p99:A   (GLY234) to   (VAL322)  CA2+-STABILIZED ADHESIN HELPS AN ANTARCTIC BACTERIUM REACH OUT AND BIND ICE  |   CA2+-DEPENDENT, BACTERIAL IG-LIKE FOLD, ICE-BINDING ADHESIN, EXTENDER DOMAIN, UNKNOWN FUNCTION 
3kxf:H   (GLN138) to   (ALA242)  CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH THE 'RESTRICTION TRIAD' MUTANT HLA-B*3508-13MER  |   MHC, HLA, TCR, DISULFIDE BOND, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
3kxf:P   (GLN138) to   (TRP239)  CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH THE 'RESTRICTION TRIAD' MUTANT HLA-B*3508-13MER  |   MHC, HLA, TCR, DISULFIDE BOND, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
4pj9:D   (GLN138) to   (TRP239)  STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT TRAJ20 TCR  |   MR1, TCR, IMMUNE COMPLEX, 5-OP-RU, IMMUNE SYSTEM 
5djc:A   (SER254) to   (LYS338)  FC HETERODIMER DESIGN 8.1 L368V/Y407A + T366V/K409F  |   HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM 
5djc:B   (SER254) to   (LYS338)  FC HETERODIMER DESIGN 8.1 L368V/Y407A + T366V/K409F  |   HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM 
5djc:B   (GLY371) to   (LEU443)  FC HETERODIMER DESIGN 8.1 L368V/Y407A + T366V/K409F  |   HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM 
5djc:D   (SER254) to   (LYS338)  FC HETERODIMER DESIGN 8.1 L368V/Y407A + T366V/K409F  |   HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM 
5djc:E   (SER254) to   (LYS338)  FC HETERODIMER DESIGN 8.1 L368V/Y407A + T366V/K409F  |   HETERODIMER, IMMUNOGLOBULIN, CH3, FC, BISPECIFIC ANTIBODY, IMMUNE SYSTEM 
4plk:K   (GLY128) to   (ARG211)  HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12  |   COMPLEX, NEUTRALIZING ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX 
5drn:B   (GLY128) to   (ASN207)  CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU24 IN COMPLEX WITH HYPUSINE  |   HYPUSINE, ANTIBODY, FABHPU24, EIF5A, IMMUNE SYSTEM 
5drn:L   (GLY128) to   (GLY209)  CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU24 IN COMPLEX WITH HYPUSINE  |   HYPUSINE, ANTIBODY, FABHPU24, EIF5A, IMMUNE SYSTEM 
5dtf:L   (GLY128) to   (ASN207)  CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU98.61 IN COMPLEX WITH HYPUSINE  |   HYPUSINE, ANTIBODY, FABHPU98.61, EIF5A, IMMUNE SYSTEM 
5dtf:B   (GLY128) to   (ASN207)  CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU98.61 IN COMPLEX WITH HYPUSINE  |   HYPUSINE, ANTIBODY, FABHPU98.61, EIF5A, IMMUNE SYSTEM 
5dvm:A   (SER254) to   (SER337)  FC DESIGN 20.8.37 B CHAIN HOMODIMER E357D/S364R/Y407A  |   HEAD-TO-TAIL HOMODIMER, IMMUNOGLOBULIN, FC, IMMUNE SYSTEM 
4b7i:A   (ARG255) to   (LYS338)  CRYSTAL STRUCTURE OF HUMAN IGG FC BEARING HYBRID-TYPE GLYCANS  |   IMMUNE SYSTEM, IGG, ANTIBODY, SWAINSONINE, HYBRID 
4b7i:B   (ARG255) to   (LYS338)  CRYSTAL STRUCTURE OF HUMAN IGG FC BEARING HYBRID-TYPE GLYCANS  |   IMMUNE SYSTEM, IGG, ANTIBODY, SWAINSONINE, HYBRID 
4qgt:A   (SER254) to   (LYS338)  THE CRYSTAL STRUCTURE OF HUMAN IGG FC DOMAIN WITH ENHANCED AROMATIC SEQUON  |   IGG1, IMMUNOGLOBULIN-LIKE BETA-SANDWICH, IMMUNE SYSTEM 
4qgt:B   (ARG255) to   (LYS338)  THE CRYSTAL STRUCTURE OF HUMAN IGG FC DOMAIN WITH ENHANCED AROMATIC SEQUON  |   IGG1, IMMUNOGLOBULIN-LIKE BETA-SANDWICH, IMMUNE SYSTEM 
3bdy:L   (GLY128) to   (SER208)  DUAL SPECIFIC BH1 FAB IN COMPLEX WITH VEGF  |   FAB COMPLEX, ANGIOGENESIS, DEVELOPMENTAL PROTEIN, DIFFERENTIATION, GLYCOPROTEIN, GROWTH FACTOR, HEPARIN-BINDING, MITOGEN, SECRETED, HORMONE 
3mlx:I   (GLY134) to   (PRO213)  CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 3074 IN COMPLEX WITH AN MN V3 PEPTIDE  |   HUMAN MONOCLONAL ANTIBODY, FAB, HIV-1, GP120, THIRD VARIABLE LOOP, ANTIBODY-ANTIGEN INTERACTION, IMMUNE SYSTEM 
4bsv:A   (ARG255) to   (LYS338)  HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 1  |   IMMUNE SYSTEM, ANTIBODY, BISPECIFIC, SCAFFOLD, ANTIBODY ENGINEERING, ZYMEWORKS INC. 
4bsv:B   (SER254) to   (LYS338)  HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 1  |   IMMUNE SYSTEM, ANTIBODY, BISPECIFIC, SCAFFOLD, ANTIBODY ENGINEERING, ZYMEWORKS INC. 
5fk9:B   (GLY148) to   (TRP239)  CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN A F47A MUTANT IN COMPLEX WITH A T CELL RECEPTOR  |   IMMUNE SYSTEM, SUPERANTIGEN, STAPHYLCOCOCCAL ENTEROTOXIN, T CELL RECEPTOR, MAJOR HISTOCOMPATIBILITY COMPLEX 
4rir:L   (ASN128) to   (ALA207)  STRUCTURAL ANALYSIS OF THE UNMUTATED ANCESTOR OF THE HIV-1 ENVELOPE V2 REGION ANTIBODY CH58 ISOLATED FROM AN RV144 HIV-1 VACCINE EFFICACY TRIAL VACCINEE AND ASSOCIATED WITH DECREASED TRANSMISSION RISK  |   ANTIBODY, IGG FOLD, IMMUNE SYSTEM, HIV-1 GP120 V2 REGION 
3dgg:A   (GLY131) to   (ASN215)  CRYSTAL STRUCTURE OF FABOX108  |   ANTIBODY FRAGMENTS, FABS, TRANSIENT EXPRESSION, STRUCTURAL GENOMICS, OXFORD PROTEIN PRODUCTION FACILITY, OPPF, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM 
5hys:G   (CYS358) to   (THR434)  STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB  |   IMMUNE SYSTEM 
5hys:I   (LYS352) to   (THR434)  STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB  |   IMMUNE SYSTEM 
5hys:J   (CYS358) to   (PRO439)  STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB  |   IMMUNE SYSTEM 
5i18:L   (GLY134) to   (SER214)  CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV1-69/IGKV4-1  |   MONOCLONAL ANTIBODY, IMMUNE SYSTEM 
4elk:D   (GLN140) to   (ALA244)  CRYSTAL STRUCTURE OF THE HY19.3 TYPE II NKT TCR  |   ANTIGEN PRESENTATION, TYPE II NKT CELLS, IMMUNE SYSTEM 
3qeq:E   (LYS139) to   (ALA242)  THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE  |   MART-1 PEPTIDE, NONAPEPTIDE, MHC CLASS I, HLA-A2, TCR DMF5, TCR DMF4, CROSS-REACTIVITY, CANCER, MELANOMA, IMMUNE SYSTEM 
3qq9:L   (GLY132) to   (SER212)  CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-HUMAN RSV (RESPIRATORY SYNCYTIAL VIRUS) F PROTEIN MAB 101F  |   IMMUNE SYSTEM, RSV F PROTEIN 
3rdt:B   (GLN135) to   (TRP236)  CRYSTAL STRUCTURE OF 809.B5 TCR COMPLEXED WITH MHC CLASS II I-AB/3K PEPTIDE  |   MHC, TCR, IMMUNE RECEPTOR, IG-LIKE DOMAIN, IMMUNE SYSTEM 
4g6m:L   (ASN137) to   (GLY212)  CRYSTAL STRUCURE OF HUMAN IL-1BETA IN COMPLEX WITH THERAPEUTIC ANTIBODY BINDING FRAGMENT OF GEVOKIZUMAB  |   IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM, INTERLEUKINE-1BETA 
4g80:F   (GLY128) to   (ASN210)  CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (WT, 3.8 A)  |   MEMBRANE PROTEIN, ALPHA HELIX, FRAGMENT ANTIBODY, VOLTAGE SENSING DOMAIN, SENSING VOLTAGE 
5kzc:G   (GLY130) to   (ARG213)  CRYSTAL STRUCTURE OF AN HIV-1 GP120 ENGINEERED OUTER DOMAIN WITH A MAN9 GLYCAN AT POSITION N276, IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY VRC01  |   HIV, ENV, GP120, NEUTRALIZING ANTIBODY, N-LINKED GLYCAN, IMMUNE SYSTEM 
5tf1:L   (GLY124) to   (SER204)  STRUCTURE OF CHIMERIC 02-CC FAB, A VRC01-LIKE GERMLINE ANTIBODY  |   FAB, GERMLINE, VRC01-LIKE, CD4-BS, HIV-1, CDRH3, IMMUNE SYSTEM